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ABSTRACT 
Introduction: While research indicates that Motivational Interviewing (MI) is effective 
for reducing substance use, little is known about whether brief MI-based interventions 
reduce drug use in a primary care setting, or what processes impact outcomes. Mixed 
findings in MI process studies have led investigators to call for research exploring 
alternative process variables that may predict outcomes. The current study is a secondary 
data analysis using coded audio-recordings from a randomized controlled trial that tested 
the efficacy of two brief MI-based interventions as part of the ‘Assessing Screening Plus 
brief Intervention’s Resulting Efficacy to stop drug use’ (ASPIRE) trial. It was 
hypothesized that skill in affirming clients and enhancing self-efficacy (also assessed as a 
composite self-enhancement variable) would be associated with lower frequency of drug 
use at 6 weeks and 6 months after controlling for baseline drug use and indicators of 
general MI proficiency. Methods: Audio-recordings from two intervention conditions 
[Enhanced Motivational Intervention (EMI; N=176) and Brief Negotiated Interview 
(BNI; N=174)] were coded with behavior counts and global interventionist skill ratings 
using an established coding system for MI and a study-specific coding manual. A series 
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of negative binomial regression models were conducted that were stratified by 
intervention due to the different goals and characteristics of the two interventions. 
Secondary and tertiary analyses examined moderators including MI Spirit and patient 
baseline ratings of self-efficacy. Results: There were no significant findings for the main 
effects models (Incidence Rate Ratio range .71-1.29). Only patient self-efficacy 
moderated the relationship between self-enhancement composite and 6 week outcome in 
the BNI condition; Self-enhancement composite was associated with lower frequency of 
drug use at 6 weeks in the BNI condition for those with low self-efficacy at baseline. 
Discussion: Overall, the results provided little support for the view that therapist skill in 
affirmation or enhancing self-efficacy was predictive of drug use outcomes in one-
session interventions in primary care. The restricted range of interventionist skill ratings 
may account, in part, for these intervention process findings. Future work should explore 
the role of these interventionist variables on proximal indicators of change (i.e., intention) 
and drug use in MI-based interventions with demonstrated efficacy. 
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INTRODUCTION 
Background 
Substance use disorders (SUD) affect millions of people worldwide (World 
Health Organization, 2012) and are associated with higher rates of mental health 
conditions (Kessler, 2004; Kessler, Chiu, Demler, & Walters, 2005), medical 
consequences (National Institute on Drug Abuse, 2012), and medical utilization 
(Cherpitel, 2003). Even substance users who do not meet the criteria for a SUD place 
themselves at risk for negative health outcomes and adverse consequences (Moore, Beck, 
Babor, Hays, & Reuben, 2002). Despite these consequences, the majority of substance 
users will never seek treatment (Compton, Thomas, Stinson, & Grant, 2007). Even 
among those who do seek treatment, it is often difficult to engage substance users in 
treatment, and even after treatment entry, patients often have low retention rates and high 
rates of relapse (Claus & Kindleberger, 2002; Greenfield et al., 2007; Leshner, 1997; 
McLellan, Lewis, O’Brien, & Kleber, 2000).  
Given these findings, there has been increased interest in developing strategies to 
address SUDs in opportunistic settings (Britt, Hudson, & Blampied, 2004; Emmons & 
Rollnick, 2009; Madras et al., 2009), including student health clinics (Borsari & Carey, 
2000; Juarez, Walters, Daugherty, & Radi, 2006; Marlatt et al., 1998), emergency rooms 
(Bernstein, Bernstein, & Levenson, 1997; Monti, Colby, Barnett, Spirito, & Rohsenow, 
1999), hospitals (Brown & Miller, 1993; Heather, Rollnick, Bell, & Richmond, 1996) and 
primary care offices (Bernstein et al., 2005; D’Amico, Miles, Stern, & Meredith, 2008). 
Many of these efforts consist of brief interventions (BIs) that are based on Motivational 
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Interviewing (MI), typically Adaptations of Motivational Interviewing (AMIs) (Burke, 
Arkowitz, & Menchola, 2003; Dunn, Deroo, & Rivara, 2001). AMIs are based on the 
idea that elements of MI may be particularly useful in the context of opportunistic 
healthcare settings (Lundahl et al., 2013; VanBuskirk & Wetherell, 2013), where there is 
significant time pressure combined with a need to address unhealthy or risky substance 
use behavior (Bertholet, Palfai, Gaume, Daeppen, & Saitz, 2013). While AMIs vary on a 
number of dimensions (e.g., length, format, type of health care provider, setting) they are 
based on the key principles of MI, including empathy, developing discrepancy between 
substance use and desired outcomes and goals, rolling with resistance in the interpersonal 
therapeutic context, and supporting self-efficacy (Burke et al., 2003; Miller & Rollnick, 
2002).  
Unlike SUD specialty clinics, where patients generally present with substance-
related treatment goals (Emmons & Rollnick, 2009; Saitz et al., 2010), patients in 
medical settings typically are not seeking treatment for substance use problems directly, 
even though they may be aware of the connection between their presenting problem and 
substance use (e.g., viral hepatitis and injection drug use). While there is a strong 
evidence base supporting AMIs as an effective treatment for hazardous/harmful alcohol 
use (Burke, Arkowitz, & Dunn, 2002; Burke et al., 2003; Dunn et al., 2001; Noonan & 
Moyers, 1997), the few studies of AMIs for other substance use have produced mixed 
results (Saitz et al., 2010). Furthermore, there is very little evidence for treating substance 
use disorders (excluding alcohol) for those presenting to primary care clinics, and 
researchers have stated the need for further investigation (Saitz et al., 2010). Despite the 
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increasing use of MI to address hazardous/harmful drinking and drug use in medical 
settings, there is very little known about how MI exerts its therapeutic effects (Burke et 
al., 2003; Carroll et al., 2006; Miller & Rose, 2009). Gaining a better understanding of 
the processes through which AMIs exert therapeutic effects is critical for improving the 
efficacy of these interventions, identifying potentially important moderators of 
intervention effectiveness, and providing more effective clinician training (Karno & 
Longabaugh, 2004; Miller & Rose, 2009). Understanding what elements of AMIs are 
associated with change is particularly important for developing more effective 
approaches to address substance use in primary care.  
In the current study, the influence of two types of intervention processes on drug 
use outcomes is examined: (1) strategies to enhance patient self-efficacy to enact 
behavior change, and (2) strategies to affirm patient strengths, traits, and efforts. 
Although self-efficacy and affirmation are hypothesized to contribute to improved 
substance use outcomes within the context of motivationally-based interventions (Miller 
& Rollnick, 2002), there is limited research that has examined whether these clinician 
behaviors improve outcomes in AMIs for drug use. Most studies of MI process to-date 
focus on either counselor language on client language, or client language on outcome, 
with very few that evaluate the relationship between counselor language and outcome 
(Vader, Walters, Prabhu, Houck, & Field, 2010). Developing a better understanding of 
efficacious therapist behaviors may be particularly important for improving brief 
interventions, enhancing training practices, and disseminating evidence-based practices 
(Kazdin, 2007). 
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Motivational Interviewing and Substance Use Disorders 
Reviews of the empirical evidence for MI-based interventions have shown that 
AMIs are effective when compared to no treatment and to other evidence-based 
treatments, with the most support for alcohol use in the context of specialty treatment 
settings (Burke et al., 2002; Burke et al., 2003; Dunn et al., 2001; Noonan & Moyers, 
1997). Although AMIs are based on MI principles, they may be tailored to the site and 
specific population’s needs, and may include components such as delivery of health 
information or feedback about substance use behavior (Miller, Sovereign, & Kresge, 
1988; Juarez et al., 2006), modifying perceptions of norms around substance use (Dimeff, 
Baer, Kivlahan, & Marlatt, 1999), developing plans for change collaboratively (Sobell & 
Sobell, 1993), or facilitating referral to more intensive treatment (Heather, 1995). In 
addition to evidence supporting efficacy related to substance use outcomes, AMIs have 
been found to improve social impact measures (i.e., measures that assess life problems 
including variables related to impairment in academic or work performance, physical 
symptoms, legal problems, and social problems) (Burke et al., 2003). AMIs have also 
been shown to enhance treatment engagement (Carroll et al., 2006), and have 
demonstrated effectiveness with diverse populations (Baer et al., 2006; Barrowclough et 
al., 2001; D’Amico et al., 2008; Hettema, Steele, & Miller, 2005; Villanueva, Tonigan, & 
Miller, 2007).  
In medical settings, AMIs have been included in approaches to identify and 
initiate treatment for patients who use substances, such as Screening, Brief Intervention 
and Referral to Treatment (SBIRT). SBIRT has received widespread support for reducing 
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hazardous and harmful alcohol use, although much less is known about the efficacy of 
SBIRT for other drugs (Saitz et al., 2010). An uncontrolled retrospective study examining 
SBIRT at several types of medical treatment centers (trauma centers, emergency rooms, 
hospitals, and primary health care centers) found that illicit drug use was significantly 
lower 6 months after baseline. However, there was little information about how many 
people were referred to further treatment (Madras et al., 2009). There is some evidence 
that suggests that brief interventions in primary care are effective in reducing drug use for 
adolescents (D’Amico et al., 2008; De Micheli, Fisberg, & Formigoni, 2004). Similarly, a 
randomized controlled study conducted in medical outpatient settings (including 
women’s health centers, homeless care clinics, and urgent care clinics) indicated 
improvement in abstinence rates among cocaine and heroin users (Bernstein et al., 2005). 
However, a recent large-scale randomized controlled trial provided mixed results for brief 
intervention for illicit drug use in the context of primary care settings, in that effects were 
small and therefore of uncertain clinical significance (Humeniuk et al., 2012). Several 
recent meta-analyses indicate that MI may be useful for alcohol use in various settings 
including primary care, although there is relatively little known about its effects on drug 
use (Lundahl et al., 2013; VanBuskirk & Wetherell, 2013). While the results of these 
studies are promising, more research evaluating various brief intervention and MI-based 
approaches specifically for drug use in primary care and the mechanisms by which these 
types of interventions exert their effects are needed (Burke et al., 2003; Heather, 2014; 
Miller & Rose, 2009; Saitz et al., 2010).  
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Motivational Interviewing 
 Motivational Interviewing is defined as a “client-centered, directive method for 
enhancing intrinsic motivation to change by exploring and resolving ambivalence” 
(Miller & Rollnick, 2002, p.25). Towards this end, Miller and Rollnick place great 
emphasis on the interpersonal skills that are conducive to change, rather than a specific 
set of techniques or strategies. In particular, they identify three key interpersonal skills 
which make up “MI Spirit”: (1) Collaboration with the client, (2) Evocation of the 
client’s own perspective and intrinsic knowledge, and (3) Autonomy Support, or support 
of the client’s experience of autonomy or choice. In addition to the guiding MI Spirit, 
Miller and Rollnick describe four main principles that build on the foundation of MI 
Spirit: expression of empathy, aiding the client in developing discrepancy between their 
substance use and desired outcomes, rolling with resistance in the interpersonal context 
of therapy, and supporting self-efficacy. The expression of empathy is characterized by a 
clinician’s acceptance of the person and their situation, utilizing skillful reflective 
listening to selectively reflect back elements related to change processes. Developing 
discrepancy between current behavior and ultimate goals should be undertaken in a 
manner that promotes the client verbalizing his/her own experience of discrepancy. 
Resistance in the interpersonal interaction is seen as a signal to take a different approach, 
rather than as an index of the patient’s denial or unwillingness to change; the clinician 
must be able to appreciate the client’s perspective, and see resistance as a natural reaction 
to the process of change and be able to change direction and not engage in a power 
struggle with the client, a skill set which in MI is called rolling with resistance. 
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Supporting the client’s confidence in their ability to make behavioral changes is thought 
to be important in motivation and subsequent behavior change. Furthermore, eliciting 
“change talk” is a central goal, because as change talk is elicited from the client and 
reinforced through reflection by the therapist, the clients begin to talk themselves into 
change. 
How Does MI Lead To Behavior Change? 
Although the principles of MI and strategies for promoting change have been 
well-characterized, there is relatively little known about why MI is efficacious or how it 
leads to behavior change (Burke et al., 2003; Carroll et al., 2006; Miller & Rose, 2009). 
MI was essentially developed from clinical experience rather than based on a specific 
theoretical framework, though it is influenced by a variety of theories, including 
cognitive dissonance theory (Festinger, 1957), self-perception theory (Bem, 1967, 1972), 
self-efficacy theory (Bandura 1977, 1982), and the work of Carl Rogers (1959) on 
accurate empathy (Britt et al., 2004; Miller, 1983; Miller & Rose, 2009). More recently, 
MI has been conceptualized within the transtheoretical model of change as an approach 
that helps people as they progress through the stages of change (DiClemente & 
Velasquez, 2002).   
Miller and Rollnick (2002) describe the process of change unfolding in two 
phases. In Phase 1, it is crucial to explore aspects of motivation, including the importance 
of change, confidence that the client could make the change, and readiness to change. 
Several techniques are employed to this end, including (1) asking open-ended questions, 
(2) affirmation of the client, (3) reflective listening, (4) summarizing, and (5) eliciting 
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change talk through the use of the aforementioned skills. Oftentimes, clients come in with 
a high level of ambivalence about change, and the authors posit that before any change 
can be made, the task of exploring and resolving ambivalence to some degree must 
precede developing an action-oriented plan. Clinical skills related to the exploration and 
resolution of ambivalence are viewed as central to the successful implementation of MI.    
Phase 2 involves strengthening the commitment to change and developing a plan 
to do so, including setting goals, generating options, determining an action plan, and 
strengthening the commitment to this plan. Once sufficient progress toward the resolution 
of clients’ ambivalence has been made, the intervention begins to change focus toward 
formulating a change plan and strengthening the commitment to follow-through. 
Thus, evidence of client movement toward behavior change such as perceptions 
of importance, self-efficacy and readiness to change should predict greater likelihood of 
behavior change (Miller & Rollnick, 2002). Core skills of MI include eliciting “change 
talk”, or clients verbalizing elements related to behavior change, exploring and resolving 
ambivalence by developing discrepancy between actions and values, and managing 
resistance in the interpersonal relationship (Westra & Aviram, 2013). Specific techniques 
employed by the therapist, including open questions, affirmation, reflections, summaries, 
and elicitation of change talk, should also mediate the efficacy of MI. According to 
Miller & Rollnick (2002), discussion related to behavioral change goals, developing a 
plan, and strengthening commitment to change should also predict outcome. Successful 
implementation of these two key elements (i.e., building motivation and commitment to 
change) are viewed as central to promoting behavioral change. 
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The two underlying factors hypothesized to explain how MI exerts its clinical 
effects within these two phases are the therapeutic relationship and techniques designed 
to elicit change talk from the client (Miller & Rose, 2009). The clinical style and 
techniques of MI essentially help build motivation for change and strengthen client 
commitment to change (Miller & Rollnick, 2002). In addition to the therapeutic style 
characterized by MI Spirit (including Collaboration, Evocation, and Autonomy Support), 
a variety of techniques are employed to build motivation and strengthen commitment 
including asking open-ended questions, affirmation of the client, reflective listening, 
summarizing, and eliciting change talk. In theory, the combination of a variety of 
techniques born from clinical practice in the context of an intervention guided by MI 
Spirit should be predictive of treatment outcomes, although the evidence is complex and 
at times contradictory (Bertholet et al., 2013). Although the guiding spirit and technical 
elements of MI have been well-defined and reliable measures have been developed and 
utilized to measure MI process (Houck, Moyers, Miller, Glynn, & Hallgren, 2012; Miller 
& Rollnick, 2002; Moyers, Martin, Manual, Miller, & Ernst, 2012), the scientific study of 
these elements provides a complex picture with many questions left to be answered.  
MI Process Research 
 Despite evidence that suggests that MI is efficacious, research has not established 
the mechanisms that underlie these effects or for whom MI works. Several researchers 
have called for further investigations into mechanisms of treatment effects in order to 
better understand what it is that makes MI work and who is most likely to benefit from 
more versus less intensive treatment (Burke et al., 2003; Dunn et al., 2001; Miller & 
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Rose, 2009). Understanding mechanisms of change including quality of strategies 
employed by clinicians, client in-session behaviors, and key patient moderators will 
allow researchers and clinicians to continue to design better-tailored and more effective 
brief motivationally-based interventions.  
Intervention Processes 
 Researchers have identified several mechanisms through which MI specifically 
may exert its effects, and there is a dynamic process between active ingredients of MI and 
mechanisms of change within the client while they participate in an intervention. Active 
ingredients of MI are defined as “the treatment elements, processes, and/or therapist 
behaviors that predict client mechanisms and/or long-term main effects” (Longabaugh & 
Magill, 2011, p. 383). These active ingredients are broken down into the relational (i.e., 
MI Spirit, empathy), and the technical (i.e., selective reinforcement of change talk) 
elements that make up an effective intervention. While many authors refer to mechanisms 
of change broadly, including both intervention-specific and within-client factors, 
researchers have more recently conceptualized mechanisms of change as those processes 
that are occurring within the client (Longabaugh & Magill, 2011; Morgenstern Kuerbis, 
Amrhein, Hail, & Lynch, 2012). Thus, there are both counselor and client-level process 
variables that account for MI Process. Arkowitz, Miller, Westra, and Rollnick (2008) 
discuss conflict resolution as a third level of process analysis, and includes elements 
related to exploring and resolving ambivalence, although this area has received less 
attention to date (Magill, Stout, & Apodaca, 2013).  
	  	  
11	  
Mechanisms of Change: Client behaviors 
 Given its theoretical importance in models of MI, change talk has often been 
examined as a mediator of MI efficacy (Amrhein, Miller, Yahne, Palmer, & Fulcher, 
2003; Apodaca & Longabaugh, 2009), although the nature of its relationship to outcomes 
has not been straightforward. Change talk is associated with better outcomes whereas 
counter change talk is associated with worse outcomes (Amrhein et al., 2003; Gaume, 
Gmel, Faouzi, & Daeppen, 2008; Moyers, Miller, & Hendrickson, 2005; Moyers et al., 
2007; Moyers, Martin, Houck, Christopher, & Tonigan, 2009). Typically, MI coding 
systems have characterized change talk in terms of categories of patient language, 
including statements that indicate commitment, desire, ability, need, readiness, and 
reasons (Amrhein et al., 2003; Gaume, Gmel, & Daeppen, 2008; Strang & McCambridge, 
2004; Moyers, Miller, & Hendrickson, 2005; Moyers et al., 2007; Moyers et al., 2009). 
However, it is unclear which aspects of change talk are most important in predicting 
outcome. Whereas some studies have found that commitment language is associated with 
outcome (Amrhein et al., 2003; Kuerbis, Armeli, Muench, & Morgenstern, 2013), others 
have suggested that ability (Gaume, Gmel, & Daeppen, 2008), action-oriented change 
talk (Strang & McCambridge, 2004), reasons to change (Baer et al., 2008), or a 
combination of ability, desire, and need to change (Gaume, Bertholet, Faouzi, Gmel, & 
Daeppen, 2013) are associated with outcome. While change talk is promising as a 
mediating variable, the question of how change talk is defined and what aspects of 
change talk are associated with outcomes remains to be clarified. 
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Evidence suggests that readiness to change measured at baseline did not appear to 
be linked to outcomes, which is an indicator of how little is understood about MI process 
in light of the fact that this factor is hypothesized to underlie the effectiveness of MI 
(Apodaca & Longabaugh, 2009; Miller & Rollnick, 2002). However, a recent study 
found a relationship between post-treatment readiness to change and improved twelve-
month alcohol outcomes (Heather & McCambridge, 2013). Furthermore, other 
researchers have suggested that variations in the definition of the construct and various 
methods of measurement of readiness to change may account for the mixed research 
results (Bertholet, Cheng, Palfai, Samet, & Saitz, 2009; Hallgren & Moyers, 2011) and 
that readiness to change may be a better indicator in certain populations or may work 
differently in minority populations (Burlew, Montgomery, Kosinski, & Forcehimes, 
2013). Readiness to change may be a dynamic factor that ideally should change over the 
course of treatment within an MI framework, and future research that incorporates more 
advanced measurement throughout the course of a single intervention or across sessions 
may be a better indicator than readiness to change measured at baseline, as has typically 
been reported in the literature.  
 Investigators have examined other client factors including client engagement, 
resistance, confidence, and client’s own experience of discrepancy. MI has demonstrated 
positive effects on engagement or involvement with the intervention (Borsari & Carey, 
2005; Carroll et al., 2006; Longshore, Grills, & Annon, 1999), which has also been linked 
to better substance use outcomes (Baird et al., 2007). Client resistance has also been 
linked to outcomes, and studies have found that a greater level of directiveness on the 
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part of the therapist predicts worse outcomes for patients high in trait resistance, whereas 
directiveness is associated with improved outcomes for those low in resistance (Karno, 
Beutler & Harwood, 2002; Karno & Longabaugh, 2004). Similarly, within-session client 
resistance predicted worse outcomes in a confrontational intervention as compared to MI 
(Miller, Benefield, & Tonigan, 1993). However, given that one of the most important 
strategies of MI is ‘rolling with resistance’, it is important to study this variable further 
(Apodaca & Longabaugh, 2009). Along a similar vein, despite the reported strategy of 
enhancing self-efficacy within MI-based interventions, the research measuring the 
relationship between client self-efficacy and outcomes is mixed (Apodaca & 
Longabaugh, 2009; Budney, Higgins, Radonovich, & Novy, 2000; Rohsenow et al., 
2004), although more recently researchers have called for novel measurement strategies 
including Ecological Momentary Assessment that go beyond single-time point self-report 
to measure this variable (Kuerbis et al., 2013). Finally, the client’s own experience of 
discrepancy has received some support as a factor that influences substance use outcomes 
(McNally, Palfai, & Kahler, 2005; Rohsenow et al., 2004).  
Active Ingredients of MI 
While it is important to research how client behaviors are associated with 
substance use outcomes, studying therapist behaviors lends itself more readily to 
designing brief interventions that contain the crucial elements proven to be effective. 
Studying active ingredients lends itself to training clinicians in these elements, 
disseminating the intervention, and adherence and fidelity monitoring. Furthermore, there 
is very little knowledge about the relationship between counselor behaviors as Active 
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Ingredients of MI and substance use outcome as compared to the impact of client 
language on outcomes (Vader et al., 2010) and little is known about the full chain from 
counselor behavior to client language to outcome (Kazdin, 2007; Moyers et al., 2009; 
Vader et al., 2010). Particularly in the context of brief interventions in opportunistic 
medical settings such as primary care offices, enhancing therapist effectiveness may be 
more fruitful than detailed exploration of client behaviors, as it is likely that therapists 
may have very few interactions with each individual client. Furthermore, therapist 
behaviors are also a driving force behind many of the client behaviors that are related to 
positive outcomes (Moyers & Martin, 2006; Moyers et al., 2009).  
The two main factors that are hypothesized to underlie MI outcomes are an 
interventionist style characterized by high MI Spirit and empathy and the use of specific 
techniques designed to facilitate change talk from the patient (Miller & Rollnick, 2002; 
Miller & Rose, 2009). Consistent with a wide range of interventions, empathy is 
associated with better outcomes (Keijsers, Schaap, & Hoogduin, 2000; Lambert & 
Barley, 2001; Miller, Taylor, & West, 1980; Najavits & Weiss, 1994; Valle, 1981). In a 
direct comparison, therapists with a client-centered approach had better drinking 
outcomes (i.e., amount of alcohol consumed, peak blood alcohol content, and number of 
days drinking per week) than therapists with a confrontational approach (Miller et al., 
1993). Therapist interpersonal skill, including global ratings of therapist empathy, 
acceptance, egalitarianism, warmth, and overall MI Spirit, was associated with improved 
client involvement, including cooperation, expression of affect, and disclosure, in a trial 
investigating alcohol use (Moyers et al., 2005). Similarly, MI Spirit, including counselor 
	  	  
15	  
empathy, egalitarianism, and collaboration, was positively associated with client 
engagement and working alliance in a trial investigating smoking (Boardman, Catley, 
Grobe, Little, & Ahluwalia, 2006).  
Moreover, specific therapist behaviors or techniques of MI have typically been 
examined as categories of MI-consistent behavior (MICO) and MI-inconsistent behavior 
(MIIN). MICO includes the following: advise with permission, affirm, emphasize 
control, ask open questions, reflection, reframing, and providing support (Moyers et al., 
2005). Examples of MIIN include confronting clients, directing, warning, advise without 
permission, and raise concern without permission (Moyers et al., 2005). The evidence 
suggests that both MICO and MIIN may be important predictors of in-session client 
behaviors and client outcomes (Moyers & Martin, 2006; Moyers et al., 2007; Moyers et 
al., 2009). MICO is associated with higher levels of client change talk (Moyers & Martin, 
2006) and there is preliminary support for a causal chain between MICO, client change 
talk, and improved substance use outcomes (Moyers et al., 2007; Moyers et al., 2009). 
Furthermore, experimental research has established a link between therapist actively and 
directly influencing change talk by attending to it (as compared to a functional analysis 
control condition) and increased client change talk, providing support for the role of the 
therapist in eliciting change talk from the client versus other client factors that may be 
associated with change talk such as client motivation or readiness to change (Glynn & 
Moyers, 2010). MIIN by the therapist, for example, is linked with client resistance and 
counter change talk (i.e., maintaining the status quo) (Moyers et al., 2007; Moyers et al., 
2009). Furthermore, MIIN has been strongly associated with substance use outcome, in 
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that higher levels of MIIN negatively impact outcome whereas lower levels lead to better 
outcomes (Bien, Miller, & Boroughs, 1993; Karno & Longabaugh, 2004; Karno & 
Longabaugh, 2005; Miller et al., 1993). Thus, there is evidence of a causal chain from 
therapist behaviors influencing client change talk, with MICO increasing change talk and 
MIIN increasing counter change talk, which in turn has been shown to influence 
substance use outcomes in a positive and negative direction, respectively (Moyers et al., 
2009).  
 In addition to this evidence on the potential role of MICO and MIIN therapist 
behaviors, there is some evidence that specific strategies designed to enhance 
ambivalence and develop motivation to change may influence alcohol and substance use 
outcomes, although similar to the evidence on interventionist style incorporating MI 
Spirit and empathy, the results related to specific techniques are complex. Techniques 
that were utilized in MI-based interventions and found to be associated with outcomes 
include decisional balance, giving feedback, enhancing personal responsibility, clear 
advice, clinician empathy, enhancing self-efficacy, and generating change options 
(Apodaca & Longabaugh, 2009; Bien, Miller, & Tonigan, 1993; LaBrie, Pederson, 
Earleywine, & Olsen, 2006; McNally et al., 2005; Strang & McCambridge, 2004; Vader 
et al., 2010). Although exploration and resolution of ambivalence are suggested to be key 
ingredients of an MI intervention, a recent study suggests that therapist focus on 
ambivalence may not predict drinking frequency, although the focus on ambivalence by 
the therapist does not necessarily mean that the patient had sufficiently explored or 
resolved ambivalence about change (Magill et al., 2013). In line with previous research 
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on patient commitment language (Amrhein et al., 2003; Apodaca & Longabaugh, 2009), 
therapist focus on commitment was associated with better drinking outcomes (Magill et 
al., 2013). The technique of delivering feedback within an MI-based intervention has 
been shown to be more effective than MI-Only condition (i.e., without the feedback 
component) (Vader et al., 2010). There is some evidence that MICO and change talk on 
the part of the patient is associated with change plan completion, which may be a marker 
of intention to change (Magill, Apodaca, Barnett, & Monti, 2010). Specific techniques 
are designed to be delivered in accordance with MI Spirit and utilizing MICO behaviors. 
For example, when giving feedback about substance use behavior, it is critical to do so in 
an empathic and nonjudgmental fashion, and to use MICO behaviors such as reflective 
listening and asking the client open questions about their reactions to the feedback or 
information provided.  
 A recent dismantling pilot study explored the question of whether relational or 
technical factors predicted better outcomes, using an MI condition (with both relational 
and technical elements), a Spirit-only MI condition (i.e., technical and directive elements 
were proscribed), and a self-change condition (Morgenstern et al., 2012). Surprisingly, all 
three conditions yielded equivalent outcomes, although MI relative to the other two 
conditions resulted in faster reduction of drinking early on in treatment.  
 In summary, studies to date on MI process have provided some support for the 
theoretically important ingredients of change including an interventionist style 
characterized by empathy and MI Spirit and specific techniques employed, but these 
findings are complex and mixed. MI Spirit has not consistently been shown to improve 
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outcomes (Bertholet et al., 2013) and while some studies have identified MIIN as 
predictive of outcomes, others have found stronger links between MICO and use (Gaume 
et al., 2008; Gaume, Gmel, Faouzi, & Daeppen, 2009; Moyers et al., 2009). Furthermore, 
other evidence suggests that change talk, while important, is independent of counselor 
communication skills (Daeppen, Bertholet, Gmel, & Gaume, 2007) and not all studies 
demonstrate effects of MI on substance use outcomes (Miller, Yahne, & Tonigan, 2003).  
Moderators  
Besides client mechanisms of change and active ingredients of MI, another 
avenue that has received much attention is exploring moderator variables, including the 
types of treatment, a variety of client attributes, comparative dose, problem area, and 
severity of alcohol or drug addiction (Burke et al., 2003; Dunn et al., 2001; Karno & 
Longabaugh, 2004; Project MATCH Research Group, 1997). The Institute of Medicine 
concluded in 1990 that more research was needed on which kinds of treatments worked 
best for which types of problems and which kinds of clients, and this has sparked 
research interest in these processes. Gaining a better understanding of what kinds of 
treatments work best for which kinds of patients would allow for the tailoring of 
treatments to patient variables. However, the promise of matching alcohol/substance use 
interventions to patient variables has been challenging in alcohol treatment research 
(Karno & Longabaugh, 2004; Project MATCH Research Group, 1997; UKATT Research 
Team, 2005).   
Several meta-analyses include results for AMIs for both alcohol and drug use 
(Burke et al., 2003; Dunn et al., 2001). Comparative dose of AMI accounted for a 
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significant variance in outcomes, but severity of drug or alcohol problems, quality of the 
study, and follow-up point did not moderate the outcome in one meta-analysis (Burke et 
al., 2003). However, in another meta-analysis, results indicated that severity of alcohol 
use moderated outcome in one study, with better results seen in those with mild to 
moderate dependence, versus individuals on the opposite extremes (i.e. at-risk drinkers, 
those with severe dependence) (Dunn et al., 2001; Gentilello et al., 1999). It appears that 
gender does not moderate treatment outcome (Dunn et al., 2001). One study found that 
MI was more effective for those who were unmarried, unemployed, and having no prior 
treatment for alcohol use disorders (Gentilello et al., 1999). Several studies have found 
higher effect sizes of MI within minority populations (Hettema et al., 2005; Villanueva, 
et al., 2007; Winhusen et al., 2008). The results related to client readiness to change were 
mixed (Apodaca & Longabaugh, 2001; Dunn et al., 2001). One study showed evidence 
that client resistance impacted substance use outcomes, (Miller et al., 1993), although this 
area is currently understudied (Apodaca & Longabaugh, 2009). Low client self-efficacy 
was found to be associated with stronger effects of MI on cocaine use outcomes in one 
study (Rohsenow et al., 2004), although more broadly speaking, the findings are mixed 
(Apodaca & Longabaugh, 2009). Given the limited and mixed findings in the reviews of 
the literature on drug and alcohol interventions, combined with precaution that findings 
from the alcohol literature may not apply to drug use (Saitz et al., 2010), the literature 
does not provide any clear solutions or prescriptions that would aid in improving 
treatments through the study of moderator variables to date, and researchers have called 
for further study of moderators (Apodaca & Longabaugh, 2009; Dunn et al., 2001).  
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Alternative Perspectives 
Although the research to date has shed some light on active ingredients and 
mechanisms of change, several questions remain to be answered and conflicting results in 
the literature regarding core characteristics of BIs and AMIs have called into question the 
assumptions about what factors contribute to change (Apodaca & Longabaugh, 2009; 
Bertholet et al., 2013). While certain elements that are theoretically related to MI have 
been supported in the literature, such as change talk as a mechanism of change, MICO as 
an active ingredient, and MIIN as a contra-indicated ingredient (Gaume et al., 2008; 
Gaume et al., 2009; Moyers et al., 2009), a recent study found that MI Spirit, a core 
relational element thought to underlie MI’s effectiveness, was not associated with 
drinking outcomes, whereas technical elements related to directiveness were 
inconsistently associated with outcomes (Bertholet et al., 2013).  
Further research exploring alternative perspectives and other processes that may 
be promoting change within MI-based interventions will enhance our understanding of 
underlying processes of MI (Markland, Ryan, Tobin, & Rollnick, 2005; Vansteenkiste & 
Sheldon, 2006), in particular those that are likely to promote change in the context of a 
brief intervention in an opportunistic healthcare setting. There are several variables that 
are theoretically associated with MI that have not been studied as of yet, and researchers 
have called for further investigation from alternative perspectives in order to better 
understand what may underlie treatment effects (Miller & Rose, 2009; Morgenstern & 
McKay, 2007). Several theories that overlap with processes thought to be important in 
MI have may serve as a useful lens through which to view MI in a new light, including 
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Self-Determination Theory (Deci & Ryan, 1985, 1991, 2012) and Self-Affirmation 
Theory (Steele, 1988).  
Self-Determination Theory 
 Researchers have called for the development of a theory that underlies MI’s 
effectiveness (Miller & Rose, 2009) and Self-Determination Theory (SDT) (Deci & 
Ryan, 1985, 1991) has been proposed as a useful framework for understanding MI 
process (Markland et al., 2005; Vansteenkiste & Sheldon, 2006). Whereas MI grew from 
clinical experience in a bottom-up approach, SDT was developed from a top-down 
approach and subsequently tested clinically, and the creators of MI have recently 
endorsed this framework as potentially useful in the context of exploring mechanisms of 
change in MI (Miller & Rollnick, 2012; Vansteenkiste, Williams, & Resnicow, 2012). 
Furthermore, the developers of SDT recently noted that they drew from MI techniques in 
the development of interventions for health-behavior change based on this theory (Deci & 
Ryan, 2012). Although these approaches were developed independently and in different 
ways (i.e., top-down versus bottom-up), they overlap in many characteristics and features 
(Deci & Ryan, 2012; Miller & Rollnick, 2012; Vansteenkiste et al., 2012). 
SDT is based on the idea that people are fundamentally inclined towards personal 
growth and resolution of inconsistencies in their self-concept (Ryan, 1995; Ryan & Deci, 
2000). According to SDT, there is a continuum of autonomy, ranging from taking actions 
or behaviors that are enforced by external demands to behaviors that are undertaken for 
internal reasons such as genuine interest in the activity, pleasure, or belief that it is 
important for well-being. Certain conditions are more likely to support this process, 
	  	  
22	  
including feelings of competence, autonomy, and relatedness. The factors hypothesized 
to be important in MI map onto these conditions that support progression to fully self-
determined behavior, in that supporting self-efficacy supports one’s perception of 
competence, rolling with resistance may support the person’s autonomy and freedom of 
choice, and empathy within the therapeutic alliance supports the need for relatedness 
(Markland et al., 2005; Miller & Rollnick, 2012; Vansteenkiste & Sheldon, 2006). MI 
and SDT are similar in many ways; both approaches take a supportive and non-
judgmental stance towards clients, both aim to deliver information that is tailored to the 
client’s readiness and needs, both strive to help clients explore their motivation, and both 
are linked to humanistic, client-centered approaches (Deci & Ryan, 2012; Sheldon, 
Joiner, & Williams, 2003; Vansteenkiste et al., 2012). Thus, SDT and MI interventions 
are focused on creating the conditions within a therapeutic interaction under which 
people are most likely to persist in behavior change.  
There is considerable overlap between established measures for MI and those 
related to SDT. The construct of Autonomy Support, central to SDT (Vansteenkiste et al., 
2012), is explicitly assessed in measures designed to evaluate MI treatment integrity, 
including the MITI and MISC (Houck et al., 2012; Miller, Moyers, Ernst, & Amrhein, 
2003; Moyers et al., 2012). Furthermore, Relatedness as a construct in SDT also maps 
onto variables measured in MI, including MI Spirit and Empathy (Miller & Rollnick, 
2012). While no studies to date have specifically measured therapist skill in supporting a 
patient’s perceived competence in the context of MI, this construct maps on to the 
concept of the therapist enhancing self-efficacy. Enhancing self-efficacy is one of the 
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four main principles that build on the foundation of MI Spirit (Miller & Rollnick, 2002; 
Miller & Rollnick, 2012), thus, it may be an important variable to study further in terms 
of MI Process, and maps onto the SDT concept of competence.  
 Self-efficacy has been defined as “the belief that one can successfully execute 
behaviors needed to produce a desired outcome” (Bandura, 1977; Kadden & Litt, 2011, 
pp. 1120-1121). There is an extensive literature base to support the role of self-efficacy in 
behavior change interventions from work functioning, to athletic performance, to health-
related behavior, notably in those interventions based in social cognitive theory (Bandura 
& Locke, 2003). Similarly, there is evidence to support self-efficacy as an important 
variable for behavior change in MI-based interventions for a variety of health behaviors, 
including weight loss (Walpole, Dettmer, Morrongiello, McCrindle, & Hamilton, 2011), 
physical activity (Hardcastle, Blake, & Hagger, 2012), fruit and vegetable consumption 
(Shaikh, Vinokur, Yaroch, Williams, & Resnicow, 2011) and diabetes management 
(Chen, Creedy, Lin, & Wollin, 2012). Self-efficacy has been identified as a key variable 
in predicting substance use outcomes across a variety of studies (for a review, see 
Kadden & Litt, 2011). There is evidence that MI promotes self-efficacy and better 
outcomes across substances and treatment settings, including treatment for smoking in 
primary care (Cupertino et al., 2011; Williams et al., 2006), alcohol use in a variety of 
settings (Babor & Del Boca, 2003; DiClemente, Carroll, Miller, Connors, & Donovan, 
2003; Kuerbis et al., 2013; LaChance, Ewing, Bryan, & Hutchison, 2009), group 
treatment for cocaine use (Rohsenow et al., 2004), and substance use in the context of 
detoxification (Berman, Forsberg, Durbeej, Kallmen, & Hermansson, 2010).  
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While these findings are encouraging, studies of self-efficacy processes have 
focused on the influence of interventions on client ratings rather than identifying how 
therapist strategies designed to enhance self-efficacy may be related to substance use 
outcomes. Very little is known about what treatments best promote self-efficacy, or how 
therapists may promote self-efficacy in the context of an MI-based intervention for 
substance use (Kadden & Litt, 2011). While self-efficacy is considered one of the key 
principles of MI, explicit guidelines for the best techniques to promote self-efficacy 
during treatment do not exist (Kadden & Litt, 2011). Miller and Rollnick (2002) provide 
suggestions for how to support self-efficacy, including reviewing past success with 
behavior change, discussing strengths, use of a confidence ruler, developing a menu of 
change options, and developing a specific change plan. However, relatively little research 
has been conducted to evaluate self-efficacy and strategies that are purported to promote 
this variable in the context of MI interventions for substance use (Kadden & Litt, 2011; 
Shaikh et al., 2011; Walpole et al., 2011). Particularly in the context of a brief 
motivationally-based intervention in a primary care setting, supporting self-efficacy in 
the interaction has the potential to benefit the client in terms of improving their outcomes, 
but this has not received research attention as of yet.  
Self-Affirmation Theory 
 Another potentially important process that may be related to behavior change in 
MI is affirmation, which is one of the therapist behaviors that is prescribed in MI under 
the umbrella of MI-Consistent behavior (Miller & Rollnick, 2002). Self-affirmation 
theory may offer a useful perspective to explain why this therapist skill may be important 
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in MI, particularly in the context of addressing substance use in opportunistic settings. 
Self-affirmation was originally defined as “the process of reflecting upon one’s cherished 
values, actions, or attributes,” (Steele, 1988; Harris & Epton, 2009, p. 4). More recently, 
the definition has been clarified to include affirmation of one’s personally important 
values and affirmation of one’s positive qualities or characteristics (Staple & van der 
Linde, 2011), which is also emphasized in MI (Wagner & Sanchez, 2002) and 
incorporated into coding manuals for MI (Houck et al., 2012).  
According to self-affirmation theory, people are motivated to protect, maintain, 
and restore their self-integrity, or the experience of themselves as “adaptively and 
morally adequate” (Steele, 1988, p. 262). There is increasing evidence to suggest that 
when people feel affirmed they are more likely to process information that could be 
threatening to self-integrity in a balanced fashion, including information related to risky 
health behaviors (McQueen & Klein, 2006; Sherman & Cohen, 2006). Self-affirmation 
theory has now been applied across a number of health behaviors to identify ways to 
enhance the impact of persuasion approaches to promote health behavior change.   
Self-Affirmation and Health Behaviors 
Health information that suggests that certain behaviors may be putting one’s 
health at risk is threatening to the self. When the self is threatened, people are motivated 
to repair their sense of self, and thus may react in a defensive manner (Sherman & Cohen, 
2006). There are several ways in which defensiveness may be expressed in the context of 
a health intervention, including denigrating or dismissing the information, viewing it as 
not personally relevant, or making a behavioral change (Harris & Epton, 2009; Jemmott, 
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Ditto & Croyle, 1986; Kunda, 1987). However, when feeling threatened, the most likely 
response is to reduce that threat in the most accessible and easy way possible, making 
behavior change a less likely response than some form of defensive reaction (Harris & 
Epton, 2009, 2010). While defensiveness in some instances can be adaptive and have 
certain benefits to health (Taylor & Brown, 1988), it can also interfere with adaptive 
behavior change that could reduce risk for disease and improve health. Therefore, it is 
important to find ways to balance the need to protect self-integrity with the need to 
consider health-related information and make health-related behavior change (Sherman & 
Hartson, 2011). Affirmation in the context of a brief motivational intervention may serve 
that purpose. Specific strategies that the clinician may use to affirm the client, such as 
making comments about the person’s values, strengths, positive traits, or efforts to enact 
behavior change, may enhance the client’s self-affirmation, or in other words their sense 
of self as a morally adequate person.  
According to Self-Affirmation theory, affirming the self may allow people to 
process information in a less biased manner because when one is affirmed in a domain 
unrelated to the threat, the self is enhanced and the threat to self-integrity is reduced. 
Affirmation may serve the purpose of allowing one to consider the conflict instead of 
avoiding the conflict. Because resources are not being utilized defending against the 
threat, this theoretically should enable one to consider the threatening information in a 
different way (Sherman & Cohen, 2006; Steele, 1988). Thus, one potential barrier to 
receptivity to health information is reduced (Harris & Epton, 2009, 2010; Sherman & 
Cohen, 2006). A review of the literature indicates that experimentally manipulated self-
	  	  
27	  
affirmation does indeed alter cognitions about health-related messages (Harris & Epton, 
2009, 2010), but much less is known about intentions, health behavior change, and 
thoughts related to health risk (Harris & Epton, 2009, 2010; McQueen & Klein, 2006).   
In general, there is support for the idea that self-affirmation increases message 
acceptance (Jessop, Simmonds, & Sparks, 2009; Reed & Aspinwall, 1998; van 
Koningsbruggen & Das, 2009), allows one to view the message as personally relevant 
(Harris, Mayle, Mabbott, & Napper, 2007; Harris & Napper, 2005; Napper, Harris & 
Epton, 2009; Sherman, Nelson, & Steele, 2000), and increases self-risk perceptions 
(Sherman et al., 2000; Harris & Napper, 2005). Much less is known about how this 
process influences intentions or behavior change (Harris & Epton, 2009, 2010). 
Affirmation of values impacted risk perception and intentions to reduce drinking in 
heavy-drinking female participants, although there was no associated behavior change 
either one week or one month later (Harris & Napper, 2005). However, other studies 
provide more promising results related to behavior change. Affirmed participants 
purchased more condoms and picked up information brochures after watching a video 
related to HIV-risk behaviors as compared to nonaffirmed controls (Sherman et al., 
2000). Affirmation resulted in significantly more consumption of fruits and vegetables at 
one-week follow-up (Epton & Harris, 2008). In a study among low socioeconomic status 
smokers, self-affirmation improved message acceptance, and behavior of taking an 
information leaflet (Armitage, Harris, Hepton, & Napper, 2008). Furthermore, evidence 
indicates that self-affirmation and subsequent delivery of health information related to 
alcohol consumption may be effective for reducing alcohol consumption up to four weeks 
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later in affirmed participants (Armitage, Harris, & Arden, 2011). A study investigating 
brief interventions for alcohol use found that the frequency of affirm statements by 
clinicians was correlated with reduced heavy drinking days, although this variable was no 
longer significant in the multiple regression model (Gaume et al., 2008). While these 
results are encouraging, the majority of the research to date has used experimental 
manipulations, mostly with undergraduate student populations. Examining how this 
process may occur in the context of a brief intervention with a diverse population would 
extend its applicability to real-world settings (Harris & Epton, 2009, 2010; McQueen & 
Klein, 2006).  
Enhancing Self-Efficacy, Affirmation, and Implications for AMIs for Drug Use in 
Primary Care  
 The processes of enhancing self-efficacy and affirming the client’s strengths, 
traits, or efforts may be especially useful in the context of brief motivational interviews 
conducted in the primary care setting. Patients in primary care are not necessarily seeking 
treatment for SUDs, but still may be suffering from health consequences as a result, and 
strategies to engage clients and reduce the likelihood of defensive responding may be 
particularly useful process variables. This represents a unique opportunity to provide an 
intervention outside of a specialized substance abuse treatment clinic, although this poses 
some challenges as well (Emmons & Rollnick, 2009; Saitz et al., 2010). Because these 
patients are not presenting for substance-related concerns, they will likely exhibit a 
spectrum of levels of motivation and perceived abilities to enact change. Given that the 
intervention is brief, elements that enhance the self in the context of a client-centered 
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empathic interview are promising candidates for process variables that impact outcome.  
Clients may perceive information suggesting that their behavior may be harmful 
to their health as more threatening or less personally relevant than those who are seeking 
treatment in a specialty setting. If the information is perceived as threatening, it is likely 
that clients will respond in a defensive manner according to Self-Affirmation theory 
(Harris & Epton, 2010; Sherman & Cohen, 2006). Similar to the stance within MI that 
ambivalence is a natural response to considering behavior change, the process of 
defensive responding may be viewed as a natural response to ensure that the self-integrity 
is protected, maintained, or restored. However, this type of response may be a barrier to 
considering health information related to substance use and behavior change (Sherman & 
Hartson, 2011). In line with the key principle of rolling with resistance within MI, 
evaluating affirmation as one potential strategy or technique for reducing defensive or 
resistant responses may improve both treatment outcome and within-session predictors of 
treatment outcomes, such as change talk.  
Affirmation has been categorized as a behavior that is consistent with MI and has 
been linked with beneficial outcomes under the umbrella of MICO (Moyers & Martin, 
2006), although this process has not been studied explicitly. Of the five early methods of 
the first phase of building motivation to change (open-ended questions, affirm, listen 
reflectively, summarize, and elicit change talk), there is the least research to date on the 
specific process of affirming the client (Miller & Rollnick, 2002). MI incorporates 
several principles that are designed to promote change, including empathy, developing 
discrepancy, rolling with resistance, and supporting self-efficacy. Affirmation within a 
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therapeutic interaction can be one way of expressing empathy through expressing 
understanding and appreciation of the client’s values and personal strengths. Affirmation 
on the part of the therapist may also aid in developing discrepancy by reducing the 
perceived threat to self-integrity such that the client can consider threatening information 
in a more balanced way. Similarly, affirmation may reduce resistance to new information 
or the possibility of change, again by bolstering self-integrity. Finally, affirmation may 
influence the experience of self-efficacy, as often affirmations in the context of therapy 
pertain to one’s strengths and personal values.  
Given the experimental evidence suggesting that self-affirmation reduces biased 
processing of information and the preliminary support for potential behavior change, 
there has been increased interest of late in exploring how this process may impact health-
related behaviors and interventions that target them. While most research to date includes 
methods of affirming the self, such as asking people to think about recent acts of 
kindness, to consider what values are important to them, or to give them positive 
feedback about a particular attribute, affirmation in the context of a therapeutic 
interaction has not been studied to date, although the process of affirmation is included in 
MI theory (Miller & Rollnick, 2002) and is incorporated in coding systems under the 
umbrella of MICO (e.g., Moyers & Martin, 2006). Certainly, in the context of a brief 
intervention in a medical setting, elucidating a mechanism that may reduce the likelihood 
of defensive or biased processing that serves to maintain unhealthy behavior, and gaining 
an understanding of how this may promote adaptive behavior change would be of great 
benefit to both clinicians and ultimately the health of the clients they serve.  
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The quality of support of self-efficacy by the therapist is proposed to reduce 
another behavior-change barrier, namely low confidence to enact behavior change that 
may be experienced by the client. In this context, therapists have the opportunity to 
explore patients’ substance use behavior and associated health consequences, so it is 
crucial to utilize strategies that would facilitate client engagement, reduce defensive 
response style, promote their sense of perceived competence, and allow the client the 
opportunity to explore issues related to a behavior that may be harmful to their health. 
Research to date on self-efficacy has focused on the client’s experience of self-efficacy, 
and little is known about this variable in the context of MI-based interventions, or what 
treatments or therapist behaviors may promote self-efficacy (Kadden & Litt, 2011).  
In summary, elucidating mechanisms that may enhance client confidence and 
reduce the likelihood of defensive or biased processing that serve to maintain unhealthy 
behavior would be of great benefit to both clinicians and ultimately the health of the 
clients they serve. Based on theoretical considerations and empirical evidence, therapist 
skill in enhancing self-efficacy and affirmation of the client are promising areas for 
investigation in the context of brief treatment for substance use in the primary care 
setting.  
Study Rationale 
 Both Enhancing Self-Efficacy and Affirmation are specifically delineated as 
processes thought to be important according to Miller and Rollnick (2002). Measurement 
of related variables is incorporated into many studies involving MI process, although this 
study expanded the way in which these variables have been measured. While Affirm 
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behavior counts are already measured as part the umbrella of MICO in the MITI (Moyers 
et al., 2012), a global variable related to measuring Affirmation processes was developed. 
Measurement of client self-efficacy is often incorporated into research on health behavior 
change including substance use and MI (Kadden & Litt, 2011), although enhancing self-
efficacy on the part of the therapist has not been measured on a global level to date. This 
study used global ratings (1-5) of therapist skill in Enhancing Self-Efficacy and 
Affirmation (as well as a composite Self-Enhancement variable) of two types of MI-
based interventions conducted in primary care to explore the relationship between these 
processes and drug use outcomes (i.e., number of days of drug use in the past thirty days) 
measured both 6-weeks and 6-months later.  
Study Objectives 
Primary Aim:  
1) To examine whether interventions with higher ratings of Self-Efficacy, Affirmation, 
and Self-Enhancement (as indicated by higher scores on a Self-Enhancement composite 
variable) are associated with better outcomes (lower number of days of use in the past 30 
days of the drug of most concern assessed at 6-month follow up), controlling for relevant 
baseline substance use and MI Process indicators. 
• H1. Higher global rating of Enhancing Self-Efficacy by the therapist would be 
associated with lower number of days of use at 6-month follow-up, controlling for 
baseline substance use indicators and relevant MI processes.  
• H2.  Higher global rating of Affirmation by the therapist would be associated with 
lower number of days of use at 6-month follow-up, controlling for baseline substance use 
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indicators and relevant MI processes.  
• H3.  Higher composite ratings of Self-Enhancement by the therapist would be 
associated with lower number of days of use at 6-month follow-up, controlling for 
baseline substance use indicators and relevant MI processes.  
Secondary Aims:  
2a) To examine whether higher Enhancing Self-Efficacy, Affirmation, and composite 
Self-Enhancement scores are associated with drug use outcomes at 6-weeks controlling 
for baseline substance use.  
• H4.  The analysis of Enhancing Self-Efficacy on 6-week drug use outcome 
parallel those described above in H1 for 6-month outcomes. 
• H5.  The analysis of Affirmation on 6-week drug use outcome parallel those 
described above in H2 for 6-month outcomes. 
• H6.  The analysis of composite Self-Enhancement scores on 6-week drug use 
outcome parallel those described above in H3 for 6-month outcomes. 
2b) To examine whether the impact of higher Self-Enhancement composite scores on 
drug use outcomes is moderated by the quality of MI Spirit (including global scores for 
Collaboration, Evocation, and Autonomy Support).  
• H7.  Higher Self-Enhancement composite scores would be associated with 
improved outcomes on number of days of use at 6-week and 6-month follow-up for 
patients exposed to high MI Spirit (i.e., median split of the mean of global scores in MI 
Spirit, namely Collaboration, Evocation, and Autonomy Support), controlling for 
baseline substance use.  
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Tertiary Aims:  
3a) To examine whether the impact of higher Self-Enhancement composite scores on 
drug use outcomes (number of days of use in the past 30 days of the drug of most concern 
at 6-weeks and 6-months) is moderated by patient Self-Efficacy for reducing/abstaining 
at screening.  
• H8. Higher Self-Enhancement composite scores would be associated with a stronger 
impact on drug use outcomes for patients with lower confidence (i.e., Self-Efficacy) 
ratings to abstain from drug use at baseline.  
• H9. Higher Self-Enhancement composite scores would be associated with a 
stronger impact on drug use outcomes for those with lower confidence (i.e., Self-
Efficacy) ratings to reduce drug use at screening. Analyses parallel those for H8. 
3b) To examine whether the impact of Delivery of Health Information on substance use 
outcomes (number of days abstinent at 6-weeks and 6-months) is moderated by global 
Affirmation scores. 
• H10. Higher Affirmation global scores would be associated with a stronger 
impact on drug use outcomes for sessions with higher global ratings of Delivery of 
Health Information. A series of negative binomial regression analyses were used to test 
the models separately for EMI and BNI conditions for both 6-week and 6-month number 
of days of use outcome. 
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METHODS 
The current study was a secondary data analysis based on a randomized controlled 
trial of brief intervention for substance use in primary care, the ASPIRE study. The 
ASPIRE study was approved by the Institutional Review Board at Boston Medical 
Center, and was conducted in collaboration with the Massachusetts Screening and Brief 
Intervention and Referral to Treatment (MASBIRT) program, a state SBIRT program 
based on a national model. Participants in the research project received one of three 
conditions: BI condition influenced by MI (Brief Negotiated Interview [BNI], one 15-
minute session); AMI (Enhanced – Motivational Interview [EMI], one 45-min session 
with an optional booster session, only the first session was coded); and a no-BI control 
condition. All participants completed follow-up assessments at 6-weeks and 6-months 
after baseline. Data for this study consisted of coded audio recordings of the interventions 
delivered at baseline and assessments conducted throughout the study.   
Participants 
 Participants were patients presenting to primary care clinics at Boston Medical 
Center, an urban, safety-net hospital that provides significant care to low-income, often 
uninsured, and vulnerable populations (National Association of Public Hospitals and 
Health Systems, 2013). The inclusion criteria for the study were designed to be broad-
based, such that participants would represent a wide range of drug use behavior. 
Individuals age 18 and above who had used any drug (other than alcohol and nicotine) at 
least once in the past 90 days were eligible. A score greater or equal to 4 on the Alcohol, 
Smoking and Substance Involvement Screening Test (ASSIST) was also necessary to 
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determine eligibility, which is indicative of at least monthly use or less frequent use with 
consequences from drug use. Participants were excluded if they could not provide contact 
information for two people, could not consent or interview in English, were unwilling to 
participate in follow-up, were pregnant, had a brief intervention in the past 3 months, or 
participation in addiction treatment currently (Saitz et al., under review). The sample was 
made up of 528 individuals, with 178 participants in the control condition (33.7%), 174 
participants in the Brief Negotiated Interview condition (32.9%), and 176 in the 
Enhanced Motivational Intervention (33.3%). The present sample includes the two 
conditions that received an intervention (BNI and EMI); thus, the sample for the present 
study includes 350 individuals. 
Study Interventions 
The Brief Negotiated Interview (BNI) was a 15-minute structured interview 
delivered by health educators who had completed high school (or equivalent) and had 
either a Bachelor’s degree or relevant experience. The BNI uses some features of MI and 
was designed to be structured, with incorporated feedback, exploration of the “pros and 
cons” of substance use, and completion of a change plan.  
The Enhanced Motivational Interview (EMI) was designed to be an AMI and was 
a 45-minute intervention followed up by an optional booster session. EMIs were 
delivered by graduate student clinicians in the Department of Psychology at Boston 
University who received training in MI and weekly supervision. EMIs were structured to 
be flexible, 45-minute sessions that focused on the drug of most concern through the use 
of a menu of potential strategies, including delivering feedback about substance use 
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behavior, delivery of health-related information tied to substance use, exploring pros and 
cons of substance use from the client’s perspective, developing discrepancy, enhancing 
self-efficacy, exploring change-related options, and eliciting change talk and self-
motivational statements. More details about the interventions can be found in Saitz et al., 
(under review).  
Procedure 
 All BNI and EMI interventions were audio-recorded and audible files were coded. 
The audio-recorded counseling sessions were coded by three graduate research assistants 
at Boston University using the 1) Motivational Interviewing Treatment Integrity (MITI) 
(Moyers, Martin, Manuel, Hendrickson, & Miller, 2005); the latest version of this manual 
is version 3.1 (Moyers et al., 2012); and 2) and a series of global items developed for 
both the EMI and BNI interventions. 
 The MITI 3.1 is an instrument that includes both behavior counts and global 
ratings. The behavior counts included in the MITI are: 1) Giving Information, 2) MI-
Adherent [further broken down into 2a) Affirm – simple; 2b) Affirm elaborate and 2c) 
MIA – other, which included ask permission, emphasize control, and support], 3) MI-
Non-adherent (which included advise without permission, confront, direct), 4) Questions 
(which included open questions and closed questions) and 5) Reflections (which include 
simple reflections and complex reflections). The global ratings were each on a scale of 1-
5, with 1 being the least skilled and 5 being the most skilled, and included the following 
categories: 1) Evocation, 2) Collaboration, 3) Autonomy/Support, 4) Direction, and 5) 
Empathy. The MITI 3.1 is available at <http://casaa.unm.edu/download/miti3_1.pdf>.  
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 The global items for the ASPIRE project were developed collaboratively by 
experts who developed the EMI and BNI conditions. Similar to the MITI, the ASPIRE-
specific global items were rated on a 1-5 scale, with 1 being the least skilled and 5 being 
the most skilled. The ASPIRE global items included the following: 1) Opening and 
orientation to the interview 2) Optimal use of self-report assessment and medical record 
information 3) Delivery of health-related information 4) Pros/Cons/Ambivalence 5) 
Developing discrepancy 6) Enhancing self-efficacy 7) Direct affirmation of the patient 8) 
Assess readiness to change and 9) Change plan. All of the categories were defined for 
both the EMI and BNI conditions, except for the ‘opening and orientation to the 
interview’, as clinicians in each condition were instructed to do this differently, thus the 
therapist skill measurement involved tailoring this variable to each condition. The global 
items for Enhancing Self-Efficacy and Affirmation can be found in Appendix A.   
 All raters attended a two-day workshop on coding with the MITI 3.1 with an 
expert who helped develop these instruments, and participated in practice exercises with 
sample MI sessions until an adequate level of accuracy was achieved. The coding training 
took place over approximately 8 weeks with a total of about 40 hours of training. There 
were three raters, and each rater listened to both EMI and BNI interventions. Twenty 
percent of the sample was coded by multiple coders for the purposes of reliability 
analysis. Ratings for the double- or triple-coded sessions were assessed for reliability 
using Intraclass Correlations (Cicchetti, 1994) and were combined into a mean rating 
when added to the overall database including all coded files. Raters listened to the audio-
recorded sessions and coded each statement the clinician made into a behavior count. 
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Raters then coded global ratings. The coders met with an expert on MI weekly for coding 
supervision, in which the behavior counts and global ratings for one of the triple-coded 
sessions were discussed. The purpose of supervision was to maintain a high level of inter-
rater reliability and prevent coding drift, thus assuring consistent quality in ratings across 
the year-long coding process. All raters maintained their ratings after discussion, which 
were entered into the overall dataset. The scores for both behavior counts and global 
ratings of the double- and triple-coded sessions were averaged across raters for the final 
data set in order to preserve one rating per session for the regression analyses, and the 
reliability dataset was maintained with all ratings separately.  
Measures 
Primary Independent Variables 
Enhancing Self-Efficacy.  The global score for the therapist’s Enhancing Self-Efficacy 
from the ASPIRE intervention coding manual was used to measure this construct. The 
reliability of this variable based on Intraclass correlations was (.73) indicating good 
reliability (Cichetti, 1994; Saitz et al., under review).  
Affirmation.  The global score for therapist Affirmation from the ASPIRE intervention 
coding manual was used to measure this construct. The reliability of this variable based 
on Intraclass correlations was (.71) indicating good reliability (Cichetti, 1994; Saitz et al., 
under review).  
Composite Score for “Self-Enhancement” Processes.  The construct of “Self-
Enhancement” used for this study was constructed from two intervention components: 
Affirmation and Enhancing Self-Efficacy. The following variables from audio recordings 
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were utilized for this construct: global scores for Enhancing Self-Efficacy and 
Affirmation of the Patient from the ASPIRE intervention manual, and behavior counts of 
Affirm frequency (i.e., number of affirm coded behaviors) from the MITI 3.1 (Moyers et 
al., 2005; Moyers et al., 2012). Behavior counts and global ratings for each of the three 
components was transformed to a z-score and the mean of these three z-scores reflects the 
Self-Enhancement composite within the ASPIRE interventions. This was calculated for 
the BNI and EMI separately, as the purpose of the present analyses was to evaluate how 
these processes may function in each of these two interventions, rather than as a 
comparison of one intervention to the other. As the interventions were different lengths, 
were designed to emphasize different strategies, and were delivered by clinicians of 
different skill levels and training, all the analyses were stratified by condition.  
Covariates and Moderators  
The analyses covaried for drug use severity, number of days of use of the drug of most 
concern identified at baseline, whether the drug of most concern was marijuana, and an 
MI Process indicator. The drug use covariates were included because they were 
theoretically related to outcome and were controlled in the main study (Saitz et al., under 
review) and MI process was included to look for the significant findings of the primary 
independent variables above and beyond MI.   
Drug Use Severity. The Alcohol Smoking and Substance Involvement Screening Test 
(ASSIST) (Humeniuk et al., 2008) score for the Drug of Most Concern (DOMC) was 
used as a covariate to control for drug use severity at baseline.  
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Indices of MI Quality. Among the objectives of this analysis are to:  (1) identify the 
impact of Self-Enhancement processes in MI as unique predictors of outcomes and (2) 
explore the importance of Self-Enhancement processes in the context of other features of 
Motivational Interviewing designed to promote change. To control for other variables 
within MI that may predict outcomes, the global scores that comprise the variable MI 
Spirit (namely Evocation, Collaboration, and Autonomy Support) and Empathy as 
measured with the MITI 3.1 were considered. MI Spirit and Empathy were highly 
correlated (BNI=.714; EMI=.615), and the Empathy variable was chosen as a covariate in 
the analyses because it is a parsimonious measure of psychotherapy process that accounts 
for outcomes in both the MI field and in other types of treatment. Furthermore, the 
literature is mixed in terms of the association between MI Spirit and outcome (Bertholet 
et al., 2013). The one exception is for the analyses for Hypothesis 7, in which the impact 
of MI Spirit on the relationship between Affirmation and substance use outcomes was 
tested, and as these two variables are highly correlated, Empathy was not included in the 
model testing Hypothesis 7. The reliability of MI Spirit variable based on Intraclass 
correlations was (.80) indicating excellent reliability (Cichetti, 1994; Saitz et al., under 
review). The reliability of the Empathy variable based on Intraclass correlations was (.75) 
indicating excellent reliability (Cichetti, 1994; Saitz et al., under review).  
Confidence Rulers. Confidence to abstain and reduce drug use was measured with the use 
of confidence rulers (Miller & Rollnick, 2002, p. 53), which are scales from 1-10 of the 
patient’s self-reported confidence to reduce or abstain drug use with 10 indicating the 
most confidence (see Appendix B). This variable was split at the median to create 
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variables indicative of high self-efficacy to reduce/abstain and low self-efficacy to 
reduce/abstain. The confidence rulers served as the measures of client Self-Efficacy. 
Delivery of Health Information.  Delivery of Health Information was measured with a 
global code from the ASPIRE coding manual. This code reflects the quality with which 
the therapist informed the patient about the connection between substance use and health 
and was coded using a global 1-5 Likert scale. The reliability of this variable based on 
Intraclass correlations was (.76) indicating excellent reliability (Cicchetti, 1994; Saitz et 
al., under review).  
Additional Covariates.  To account for sources of variability in outcomes that are likely 
to be distinct from intervention processes, analyses were run including Number of days of 
use of the DOMC in the past 30 days at Baseline, ASSIST score for the drug of most 
concern, and comparison of marijuana as the drug of most concern as compared to other 
drugs (e.g., marijuana Y/N) at baseline in the model. 
Dependent Variables 
Substance Use Outcomes.  Substance use outcomes were assessed using the Timeline 
Follow-Back method (TLFB; Sobell & Sobell, 1980; Ehrman & Robbins, 1994) at both 
the 6-week follow-up and 6-month follow-up time points. The primary outcome was 
number of days of use of the drug of most concern in the past 30 days at the 6-month 
follow-up. Secondary analyses for the main effects models evaluated the number of days 
of use of the drug of most concern in the past 30 days at 6-weeks, and secondary and 
tertiary moderator analyses explored both 6-week and 6-month outcomes.  
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Data Analysis 
All statistical analyses were performed using SPSS v. 22. Data were entered and 
accuracy checks were conducted prior to conducting the analyses. As this was a 
secondary data analysis, the sample size was already known. Consequently, the power 
analysis was conducted to determine whether the sample size in the available data set 
would provide sufficient power to detect estimated effect size for the primary hypothesis. 
Based on previous work on MI processes and the goal of identifying process variables 
that may have clinical value, the current study estimated an effect size of approximately 
f2 = .09 where f2 = .02 is considered a small effect and f2  = .15 is considered a medium 
effect (Cohen, 1988). Sample size requirements presented below assumes a small to 
medium effect size (f2 = .09) and alpha was set at .05 for significance testing. For the 
main analysis with an estimated effect size of f2  = .09, a sample size of 88 subjects 
provides 80% power to detect effects, 117 subjects provides 90% power, and 144 
subjects provides 95% power. Given the sample size of 153 in the BNI condition and 168 
in the EMI condition, an effect size as low as f2 = .05 could be detected at 80% power. 
The primary dependent variables of interest in this investigation were substance 
use outcomes, operationalized as number of days of use in the past 30 days of the drug of 
most concern identified at screening at both 6-week and 6-month outcome. As noted 
above, there were three intervention indicators that are relevant to the construct of Self-
Enhancement; (1) frequency of Affirm behaviors in the intervention, (2) interview rating 
of Enhancing Self-Efficacy, (3) interview rating of Affirmation. The moderating 
variables for secondary aims were those related to MI Spirit, including global scores for 
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Collaboration, Evocation, and Autonomy Support as measured by the MITI 3.1. This 
variable was split at the median in order to compare high versus low MI Spirit. The 
moderating variables for tertiary aims were client’s ratings of confidence to a) abstain or 
b) reduce drug use on a 1-10 scale with 10 indicating the most confidence (Miller & 
Rollnick, 2002) and Delivery of Health Information. Client self-efficacy to abstain and 
client self-efficacy to reduce drug use were split at the median to compare high versus 
low self-efficacy to abstain/reduce drug use.  
In order to use any of these codes as part of the analyses, they were required to 
show at least adequate reliability as measured through intraclass correlation analyses 
(inter-rater reliability = .40 or better); all variables met this criteria, as presented above. 
The distribution of each indicator and its association with other indicators was 
considered. The composite indicator of Self-Enhancement Composite was based on (1) 
the global code for Enhancing Self-Efficacy, (2) the global code of Affirmation, and (3) 
the behavior code of Affirm and was calculated by computing z-scores to represent each 
variable and taking the mean z-score to represent the Self-Enhancement Composite 
variable. 
All analyses were conducted on EMI and BNI interventions separately. This 
stratified analysis approach was necessary as the interventions were of different length, 
had different emphasis on MI style, and emphasized unique components relevant to Self-
Enhancement.   
Frequency distributions and descriptive statistics were generated for all variables 
under study prior to testing the study hypotheses. Bi-variate correlations among the 
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independent variables and covariates were calculated and assessed for possible 
multicollinearity (please see Tables 2 and 3). Negative binomial regression models were 
chosen because the outcomes were overdispersed count data of number of days of drug 
use in the past 30 days. Tertiles were created for the main independent variables of 
enhancing self-efficacy, affirmation, and self-enhancement composite because the data 
did not meet the assumption of linearity between independent and dependent variables, 
and analyses utilizing tertiles do not require the assumption of linearity.  
The moderator analyses testing the impact of patient self-efficacy to abstain and 
self-efficacy to reduce drug use at baseline used a subsample of the BNI and EMI 
conditions including those who had one or more days of drug use in the past 30 days as 
measured at baseline. Because the study was designed to be inclusive of a wide range of 
substance use behavior, there were individuals who met criteria for the study based on 
drug use in the past 90 days, and ASSIST score greater than or equal to 4, but were not 
currently using drugs (i.e. using drugs in the past 30 days); therefore in considering self-
efficacy to abstain or reduce drug use, a subsample of current users was included for 
these analyses.  	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RESULTS 
Descriptive Statistics 
The sample included in the present analyses were participants with an ASSIST 
Score greater than or equal to 4 who were assigned to the BNI condition (N= 174; 32.9%) 
and the EMI condition (N=176; 33.3%). In the BNI condition, the mean age was 40.00 
with a standard deviation of 12.24. The majority of participants were African American 
at 68.2%, with 18.8% Caucasian, 10.6% Hispanic, and 2.4% who identified as Other. 
Only 28.7% of the sample was female. Only 9.2% of the sample was married and 13.8% 
of the sample spent at least one night in a shelter/on the street in the past three months. 
The majority identified their drug of most concern as marijuana, with 62.6% of the 
sample, followed by 18.4% cocaine, 17.8% opioids, and 1.1% PCP/Amphetamines/Other. 
The mean number of days of use of the DOMC in the past 30 days was 15.11 (SD=11.70) 
with a range of 0-30. The mean total ASSIST score was 21.76 (SD=18.41) and the 
ASSIST score for the DOMC was 16.57 (SD= 9.90), which is indicative of an overall 
moderate level of risk related to substance use (Humeniuk et al., 2008).  
In the EMI condition, the mean age was 42.4 with a standard deviation of 12.06. 
The majority of participants were African American at 72.8%, with 20.8% Caucasian, 
6.4% Hispanic, and 0% who identified as Other. Only 29% of the sample were female, 
12.5% of the sample were married, and 18.2% of the sample spent at least one night in a 
shelter/on the street in the past three months. The majority identified their drug of most 
concern as marijuana, with 62.5% of the sample, followed by 18.8% cocaine, 15.9% 
opioids, and 2.8% PCP/Amphetamines/Other. The mean number of days of use of the 
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DOMC in the past 30 days was 13.77 (SD=11.24) with a range of 0-30. The mean total 
ASSIST score was 22.07 (SD=18.59) and the mean ASSIST score for the DOMC was 
16.60 (SD=8.78), which is indicative of an overall moderate level of risk related to 
substance use (Humeniuk et al., 2008). Please refer to Table 1 for descriptive statistics by 
intervention condition.  
Primary Aim 
Hypothesis 1: Higher global rating of Enhancing Self-Efficacy by the therapist 
would be associated with lower number of days of use at 6-month follow-up, controlling 
for baseline substance use indicators (ASSIST for the DOMC, marijuana (yes/no), and 
number of days use in the past 30 at baseline) and relevant MI processes (Empathy). 
Negative binomial regression analyses were used to test the models separately for BNI 
and EMI conditions.  
Results for the Test of Model Effects for the main effects models for both the BNI 
and EMI conditions (Hypotheses 1-6) are presented in Table 4. Results for the Incidence 
Rate Ratios (IRRs) and 95% Confidence Intervals (95% CI) for the main effects models 
(Hypotheses 1-6) are presented in Table 6 for the BNI condition and Table 7 for the EMI 
condition. No significant effects were found for Enhancing Self-Efficacy on 6-month 
outcome in the BNI condition [High tertile: IRR = .965; 95% CI (.581, 1.602); p = .891; 
Middle tertile: IRR = 1.113; 95% CI = (.737, 1.680); p = .611]. No significant effects 
were found for Enhancing Self-Efficacy on 6-month outcome in the EMI condition [High 
tertile: IRR = 1.065; 95% CI = (.711, 1.594); p = .761; Middle tertile: IRR= 1.288; 95% 
CI = (.905, 1.831); p = .160]. Thus, Hypothesis 1 was not supported by the current 
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analyses in either the BNI or EMI condition.  
Hypothesis 2: Higher global rating of Affirmation by the therapist would be 
associated with lower number of days of use at 6-month follow-up, controlling for 
baseline substance use indicators and relevant MI processes. Negative binomial 
regression analyses were used to test the models separately for BNI and EMI conditions.  
No significant effects were found for Affirmation on 6-month outcome in the BNI 
condition [High tertile: IRR = .829; 95% CI = (.467, 1.470); p = .521; Middle tertile: IRR 
= .940; 95% CI = (.551, 1.603); p = .820]. No significant effects were found for 
Affirmation on 6-month outcome in the EMI condition [High tertile: IRR = 1.102; 95% 
CI = (.698, 1.738); p = .677; Middle tertile: IRR = .767; 95% CI = (.524, 1.122); p = 
.171]. Thus, the current analyses did not provide support for Hypothesis 2 in either 
condition.  
Hypothesis 3:  Higher composite ratings of Self-Enhancement by the therapist 
would be associated with lower number of days of use at 6-month follow-up, controlling 
for baseline substance use indicators and relevant MI processes. Negative binomial 
regression analyses were used to test the models separately for BNI and EMI conditions.  
No significant effects were found for the Self-Enhancement Composite on 6-
month outcome in the BNI condition [High tertile: IRR = .812; 95% CI = (.514, 1.284); p 
= .373; Middle tertile: IRR = 1.032; 95% CI = (.659, 1.615); p = .890]. No significant 
effects were found for the Self-Enhancement Composite on 6-month outcome in the EMI 
condition [High tertile: IRR = .984; 95% CI = (.658, 1.472); p = .937; Middle tertile: IRR 
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= .984; 95% CI = (.492, 1.057); p = .094]. The results of the present analyses did not 
support Hypothesis 3 in either condition.  
 
Secondary Aims 
Hypothesis 4:  The analysis of Enhancing Self-Efficacy on 6-week drug use 
outcome paralleled those described above in H1 for 6-month outcomes. 
No significant effects were found for Enhancing Self-Efficacy on 6-week 
outcome in the BNI condition [High tertile: IRR = .857; 95% CI = (.583, 1.260); p = 
.433; Middle tertile: IRR = .799; 95% CI = (.591, 1.080); p = .144]. No significant effects 
were found for Enhancing Self-Efficacy on 6-week outcome in the EMI condition [High 
tertile: IRR = .916; 95% CI = (.561, 1.497); p = .726; Middle tertile: IRR = .915; 95% CI 
= (.596, 1.405); p = .686]. Similar to the results of Hypothesis 1 testing the impact of 
Enhancing Self-Efficacy on 6-month outcomes, the present findings did not find support 
for Hypothesis 4 for 6-week outcomes in either the BNI or EMI condition.  
Hypothesis 5:  The analysis of Affirmation on 6-week drug use outcome 
paralleled those described above in H2 for 6-month outcomes. 
No significant effects were found for Affirmation on 6-week outcome in the BNI 
condition [High tertile: IRR = .867; 95% CI = (.569, 1.321); p = .507; Middle tertile: IRR 
= 1.019; 95% CI = (.692, 1.499); p = .925]. No significant effects were found for 
Affirmation on 6-week outcome in the EMI condition [High tertile: IRR = .896; 95% CI 
= (.530, 1.515); p = .683; Middle tertile: IRR = .710; 95% CI = (.456, 1.107); p = .131]. 
Again, as found in Hypothesis 2 testing the impact of Affirmation on 6-month outcomes, 
the evidence did not provide support for Hypothesis 5 on 6-week outcomes in either the 
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BNI or EMI condition.  
Hypothesis 6:  The analysis of composite Self-Enhancement scores on 6-week 
drug use outcome paralleled those described above in H3 for 6-month outcomes. 
No significant effects were found for the Self-Enhancement Composite on 6-week 
outcome in the BNI condition [High tertile: IRR = .877; 95% CI = (.626, 1.229); p = 
.447; Middle tertile: IRR = .882; 95% CI = (.640, 1.215); p = .442]. No significant effects 
were found for the Self-Enhancement Composite on 6-week outcome in the EMI 
condition [High tertile: IRR = .912; 95% CI = (.569, 1.463); p = .702; Middle tertile: IRR 
= .764; 95% CI = (.485, 1.203); p = .245]. Similar to the results of Hypothesis 3 testing 
the impact of Self-Enhancement Composite on 6-month outcomes, the evidence did not 
provide support for Hypothesis 6 on 6-week outcomes in either the BNI or EMI 
condition.  
Hypothesis 7:  Higher Self-Enhancement composite scores would be associated 
with improved outcomes on number of days of use at 6-week and 6-month follow-up for 
patients with high MI Spirit (i.e., median split of the mean of global scores in MI Spirit, 
namely Collaboration, Evocation, and Autonomy Support), controlling for baseline 
substance use indicators (ASSIST for the DOMC, marijuana (yes/no), and number of 
days use in the past 30 at baseline). A series of negative binomial regression analyses 
were used to test the models separately for BNI and EMI conditions for both 6-week and 
6-month outcome. The predictor and moderator main effects were regressed onto number 
of days of use of the drug of most concern and an interaction term was included in the 
model.     
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Results for the Test of Model Effects for the Interaction Models for both the BNI 
and EMI conditions are presented in Table 5. No significant interaction effects were 
observed between MI Spirit and Self-Enhancement Composite on 6-week outcomes in 
the BNI condition (p = .501). No significant interaction effects were observed between 
MI Spirit and Self-Enhancement Composite on 6-month outcomes in the BNI condition 
(p = .603). Thus, Hypothesis 7 was not supported in the BNI condition for both the 6-
week and 6-month outcomes.  
No significant interaction effects were observed between MI Spirit and Self-
Enhancement Composite on 6-week outcomes in the EMI condition (p = .309). No 
significant interaction effects were observed between MI Spirit and Self-Enhancement 
Composite on 6-month outcomes in the EMI condition (p = .407). Similar to the findings 
for the BNI condition, Hypothesis 7 was not supported for either the 6-week or 6-month 
outcomes in the EMI condition.  
 
Tertiary Aims 
 
  Hypothesis 8: Higher Self-Enhancement composite scores would be associated 
with a stronger impact on drug use outcomes for patients with lower confidence (i.e., 
median split of the patient rating of self-efficacy to abstain from drug use at baseline), 
controlling for baseline substance use indicators (ASSIST for the DOMC, marijuana 
(yes/no), and number of days use in the past 30 at baseline) and global Empathy. A series 
of negative binomial regression analyses were used to test the models separately for BNI 
and EMI conditions for both 6-week and 6-month outcome. The predictor and moderator 
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main effects were regressed onto number of days of use of the drug of most concern and 
an interaction term was included in the model. 
  There was a significant interaction between patient Self-Efficacy to abstain and 
Self-Enhancement Composite on 6-week outcomes in the BNI condition (p = .021). 
Further tests of this interaction effect with a subsample of patients with low Self-Efficacy 
at baseline (N=78) revealed that high Self-Enhancement Composite was associated with 
reduced drug use at 6-weeks in the BNI condition [IRR = .584; 95% CI (396, .863); p = 
.007] and the middle tertile of Self-Enhancement Composite was not significant [IRR = 
.749; 95% CI (.523, 1.073); p=.115]. Results of the exploration of the interaction effect 
are presented in Table 8. Thus, high level of interventionist skill in Self-Enhancement as 
measured by the Self-Enhancement Composite variable was associated with a 42% 
reduction in frequency of drug use 6-weeks later for patients low in Self-Efficacy to 
abstain from drug use in the BNI condition. This effect was not observed in the 
subsample with high Self-Efficacy (N=63) which was not significant [High tertile: IRR = 
1.296; 95% CI = (.744, 2.259); p = .360; Middle tertile: IRR = 1.138; 95% CI = (.623, 
2.080); p = .673].  
No significant interaction effects were observed between Self-Efficacy to abstain 
and Self-Enhancement Composite on 6-month outcomes in the BNI condition (p = .592). 
Thus, the current analyses provide partial support for Hypothesis 8 within the BNI 
condition, in that Self-Enhancement Composite was associated with better drug use 
outcomes at 6-weeks, but not 6-months, for clients with low Self-Efficacy to abstain at 
baseline.  
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No significant interaction effects were observed between Self-Efficacy to abstain 
and Self-Enhancement Composite on 6-week outcomes in the EMI condition (p = .273).  
The parallel model for 6-month outcomes revealed an interaction approaching 
significance (p = .082) between patient Self-Efficacy to abstain and Self-Enhancement 
Composite on 6-month outcomes in the EMI condition. Further tests of this interaction 
effect with a subsample of patients with low Self-Efficacy at baseline (N=79) revealed 
that high Self-Enhancement Composite was approaching significance for the association 
with reduced drug use at 6-months in the EMI condition (IRR = .589; 95% CI (.312, 
1.114); p = .104) and the middle tertile of Self-Enhancement Composite was not 
significant (IRR = .768; 95% CI (.413, 1.430); p= .406). Results of the exploration of this 
interaction effect are presented in Table 9. Results should be interpreted with caution, as 
it is not a significant finding, although this provides suggestive evidence that there may 
be an association between high level of interventionist skill in Self-Enhancement and 
reduced frequency of drug use 6-months later for patients low in Self-Efficacy to abstain 
from drug use in the EMI condition. Results in the subsample who scored high on Self-
Efficacy to abstain at baseline (N=77) were not significant [High Self-Efficacy to 
abstain*Self-Enhancement high tertile: IRR = 1.420; 95% CI (.804, 2.506); p = .227; 
High Self-Efficacy to abstain*Self-Enhancement middle tertile: IRR = .776; 95% CI 
(.413, 1.430); p = .768]. Thus, the results were suggestive that there may be an effect of 
Self-Enhancement Composite on improved drug use outcomes at 6-months, but not 6-
weeks, in the EMI condition, although the results only approached significance and thus 
provide only suggestive evidence that should be interpreted with caution.  
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Hypothesis 9: Higher Self-Enhancement composite scores would be associated 
with a stronger impact on drug use outcomes for those with lower confidence (i.e., Self-
Efficacy) ratings to reduce drug use at screening. Analyses paralleled those for H8. 
  There was a significant interaction between patient Self-Efficacy to reduce drug 
use and Self-Enhancement Composite on 6-week outcomes in the BNI condition (p = 
.027). Further tests of this interaction effects with a subsample of patients with low Self-
Efficacy to reduce drug use at baseline (N=81) revealed that high Self-Enhancement 
Composite was marginally associated with lower frequency of drug use at 6-weeks in the 
BNI condition [IRR = .676; 95% CI (.441, 1.035); p= .072] whereas the middle tertile of 
Self-Enhancement Composite was significant [IRR = .680; 95% CI (.464, .996); p = 
.047]. Results of the exploration of this interaction effect are presented in Table 10. This 
is somewhat difficult to interpret, given that one might expect that a high level of 
interventionist skill in Self-Enhancement would be more likely to result in significantly 
reduced drug use than a middle level of interventionist skill. This effect was not observed 
in the subsample with high Self-Efficacy (N=60) which was not significant [High tertile: 
IRR = 1.151; 95% CI = (.672, 1.972); p = .608; Middle tertile: IRR = 1.581; 95% CI = 
(.864, 2.891); p = .137].  
 No significant interaction effects were observed between Self-Efficacy to reduce 
and Self-Enhancement Composite on 6-month outcomes in the BNI condition p = (.883). 
Thus, the results for the subsample of clients with low Self-Efficacy to reduce drug use 
indicate that there may be an effect of Self-Enhancement Composite on improved drug 
use outcomes at 6-weeks, but not 6-months, although the findings are difficult to interpret 
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given that a significant effect was seen for the middle tertile of Self-Enhancement 
Composite, but the results for high Self-Enhancement Composite were only approaching 
significance.  
No significant interaction effects were observed between Self-Efficacy to reduce 
and Self-Enhancement Composite on 6-week outcomes in the EMI condition (p = .761).  
No significant interaction effects were observed between Self-Efficacy to reduce 
and Self-Enhancement Composite on 6-month outcomes in the EMI condition (p = .159). 
Thus, Hypothesis 9 was not supported for either 6-week or 6-month outcomes in the EMI 
condition.  
Hypothesis 10: Higher Affirmation global scores would be associated with a 
stronger impact on drug use outcomes for sessions with higher global ratings of Delivery 
of Health Information, controlling for baseline substance use indicators (ASSIST for the 
DOMC, marijuana (yes/no), and number of days use in the past 30 at Baseline) and 
global empathy. A series of negative binomial regression analyses were used to test the 
models separately for BNI and EMI conditions for both 6-week and 6-month number of 
days of use outcome. The predictor and moderator main effects were regressed onto 
number of days of use of the drug of most concern and an interaction term was included 
in the model. 
No significant interaction effects were observed between Affirmation and 
Delivery of Health Information on 6-week outcomes in the BNI condition (p = .512).  
No significant interaction effects were observed between Affirmation and 
Delivery of Health Information on 6-month outcomes in the BNI condition (p = .629). 
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Hypothesis 10 was not supported for either 6-week or 6-month outcomes in the BNI 
condition.  
No significant interaction effects were observed between Affirmation and 
Delivery of Health Information on 6-week outcomes in the EMI condition (p = .687).  
No significant interaction effects were observed between Affirmation and 
Delivery of Health Information on 6-month outcomes in the EMI condition (p = .832). 
Hypothesis 10 was not supported for either 6-week or 6-month outcomes in the EMI 
condition.  
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DISCUSSION 	   Overall,	  the results of the present study did not support the hypotheses that 
therapist skill level in Enhancing Self-Efficacy and Affirmation (as well as a composite 
variable of Self-Enhancement processes) was associated with improved drug use 
outcomes either six weeks or six months later in the context of a one-session AMI 
conducted in the primary care setting. These particular variables were chosen for both 
theory-driven and practice-related reasons as processes that may contribute to the 
relationship between MI-based interventions and outcome, and have been understudied to 
date.  
Measurement of related variables is incorporated into many studies involving MI 
process, although this study expanded the way in which these variables have been 
measured. While Affirm behavior counts are already measured as part the umbrella of 
MICO in the MITI (Moyers et al., 2012), and research suggests that MICO is associated 
with both client change talk and potentially substance use outcomes, (Gaume et al., 2008; 
Moyers et al., 2007; Moyers et al., 2009) little is known about this variable independent 
of MICO. One study found that Affirm behavior count was correlated with outcome, 
although results were not significant in regression models (Gaume et al., 2008). The 
global variable related to measuring Affirmation processes was developed for the 
ASPIRE-specific coding manual, and provided a unique measure that has not been 
evaluated as of yet. In terms of the research on Self-Affirmation theory, most studies 
focus on outcome variables related to message acceptance (Jessop & Sparks, 2009; Reed 
& Aspinwall, 1998; van Koningsbruggen & Das, 2009), and much less is known about 
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intention to change and behavior change (Harris & Epton, 2009, 2010). The study of this 
variable is in its infancy, and while the current results do not provide support for this 
variable in the context of a one-session intervention in primary care, it could be a 
promising variable in the context of a longer intervention conducted in other settings. 
Although there is a strong research base indicating that Self-Efficacy is an 
important variable in terms of MI and predicting substance use outcomes (Cupertino et 
al., 2011; Babor & Del Boca, 2003; DiClemente et al., 2003; Kuerbis et al., 2013; 
LaChance et al., 2009; Williams et al., 2006), most studies use measures of client Self-
Efficacy (Apodaca & Longabaugh, 2009; Kadden & Litt, 2011), and none to date on the 
construct of therapist Enhancing Self-Efficacy, despite its purported contribution to MI 
according to Miller & Rollnick (2002). Stronger effects of MI were seen in one study in 
patients with low Self-Efficacy (Rohsenow et al., 2004), which is somewhat in-line with 
findings from moderator analyses, although the results related to client Self-Efficacy are 
mixed in the current study. The majority of studies within the Self-Determination 
literature measure a patient’s rating of their clinician’s support of their competence to 
enact behavior change, and again, this study took a novel approach in developing a global 
measure of the construct of Enhancing Self-Efficacy on the part of the therapist as rated 
by trained coders.  
While there is a broad evidence base to suggest that MI is efficacious and 
effective in reducing substance use (Lundahl et al., 2013; VanBuskirk & Wetherell, 
2013), evidence surrounding MI for drug use specifically in a primary-care setting is 
limited (Saitz et al., 2010; Saitz et al., under review). Furthermore, the findings around 
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processes that are key to MI are complex and mixed (Apodaca & Longabaugh, 2009; 
Bertholet et al., 2013; Miller & Rose, 2009). Broadly speaking, the findings fit in some 
ways with the knowledge base in that the results are complex when it comes to studying 
process variables and how this relates to substance use outcomes. Despite the fact that 
both Enhancing Self-Efficacy and Affirmation are theorized to be important factors in MI 
(Miller & Rollnick, 2002), the present study did not find evidence that these variables in 
particular led to improved outcomes in the context of a one-session AMI in a primary 
care setting.  
Analyses that examined whether MI Spirit moderated the impact of Affirmation 
on drug use outcomes were not significant. MI Spirit has been associated with variables 
related to client engagement (Boardman et al., 2006; Moyers et al., 2005) as well as 
improved outcomes for alcohol use (Gaume et al., 2008; McNally et al., 2005; 
Morgenstern et al., 2012) but not marijuana use (Strang & McCambridge, 2004). Other 
studies evaluating several trials suggest that findings related to the impact of MI Spirit on 
substance use outcome are mixed (Apodaca & Longabaugh, 2009; Bertholet et al., 2013). 
Findings from the present study are consistent with the literature in that MI Spirit is not 
consistently associated with improved outcomes.  
Moderator analyses on whether Affirmation moderated the impact of Delivery of 
Health Information on drug use outcomes were also insignificant. The research on the 
impact of self-affirmation to-date has explored mostly proximal variables around the 
health message delivered, including message acceptance (Jessop & Sparks, 2009; Reed & 
Aspinwall, 1998; van Koningsbruggen & Das, 2009), personal relevance (Harris et al., 
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2007; Harris & Napper, 2005; Napper et al., 2000) and risk perceptions (Sherman et al., 
2000; Harris & Napper, 2005), although very little is known about behavior change or 
how the affirmation process interacts with health information to influence behavior 
change (Harris & Epton, 2009, 2010). Several studies explored exercises designed to 
increase self-affirmation on behaviors such as picking up information leaflets about HIV 
risk behaviors and smoking (Armitage et al., 2008; Sherman et al., 2000) and increasing 
fruit and vegetable consumption (Epton & Harris, 2008) although only one study 
indicated that affirmation and delivery of health information reduces the consumption of 
alcohol (Armitage et al., 2011). Thus, the results of the current study suggest that the 
interaction between Affirmation and Delivery of Health Information may interact 
differently with outcomes related to substance use in a one-session intervention in 
primary care. 
Moderator analyses of client Self-Efficacy on the relationship between Self-
Enhancement and drug use outcomes indicated that client Self-Efficacy at baseline 
moderates the relationship between the Self-Enhancement composite variable and drug 
use outcomes under certain conditions, and the results for the BNI condition differed 
from the EMI condition.  
In the BNI condition, a significant interaction was observed between client Self-
Efficacy to abstain from drug use and the Self-Enhancement composite on the 6-week 
drug use outcome, controlling for baseline drug use indicators and Empathy. When this 
interaction effect was explored, it was found that for the subsample of clients that were 
high in Self-Efficacy to abstain at baseline (N = 63), Self-Enhancement did not impact 
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substance use outcomes. However, for the subsample of clients that were low in Self-
Efficacy to abstain at baseline (N = 78), the high Self-Enhancement composite tertile was 
associated in significantly less drug use at 6-week outcome (IRR = .584; p=.007) whereas 
the middle tertile was not significant (IRR = .749; p=.115). This can be interpreted as 
interventions high in Self-Enhancement Composite were associated with a 42% reduction 
in drug use in the past 30 days measured at 6-weeks compared to the low tertile of Self-
Enhancement composite for those low in Self-Efficacy at baseline in the BNI condition. 
Results for the moderating effects of Self-Efficacy to abstain were not significant for the 
6-month outcome.  
A similar finding emerged in the analyses of Self-Efficacy to reduce drug use (as 
compared to Self-Efficacy to abstain) in the BNI condition, although in this case the 
findings are somewhat more difficult to interpret. A significant interaction was again 
observed for the moderating effect of Self-Efficacy to reduce substance use on 6-week 
outcomes. Again, among the subsample of clients with high Self-Efficacy to reduce drug 
use at baseline (N = 60), the findings were not significant. However, further exploration 
among the subsample of clients low in Self-Efficacy to reduce drug use (N = 81) 
indicated that the middle tertile of Self-Enhancement was associated with significantly 
less drug use (IRR = .680; p=.047), whereas the high tertile only approached significance 
(IRR = .676; p=.072). This would suggest that middle level of Self-Enhancement was 
associated with a 32% reduction in drug use for clients who were low in Self-Efficacy to 
reduce drug use at baseline in the BNI condition. It is unclear why a middle level of Self-
Enhancement would be more helpful in reducing drug use outcomes than a high level of 
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Self-Enhancement among those low in Self-Efficacy to reduce drug use. Furthermore, the 
IRRs were almost identical. Given that both moderator analyses for Self-Efficacy to 
abstain and Self-Efficacy to reduce drug use broke down the BNI condition into smaller 
subsamples based on a median split of the Self-Efficacy to abstain/reduce drug use 
variables, it is possible that the smaller sample size could be influencing these findings, 
therefore these results should be interpreted with an abundance of caution.  
In the EMI condition, an interaction that approached significance (p= .082) was 
found between Self-Efficacy to abstain and Self-Enhancement Composite variable was 
observed for the 6-month, but not the 6-week, outcome. Similar to the findings within the 
BNI condition, when the sample was split and analyses were run with the subsample of 
clients with high Self-Efficacy to abstain at baseline (N = 77), the findings were not 
significant. In the subsample of clients with low Self-Efficacy to abstain at baseline 
(N=79), the results for the high tertile of Self-Enhancement Composite only approached 
significance (IRR = .589; p=.104) and the middle tertile was not significant (IRR = .768; 
p=.406). In contrast to the findings with the BNI condition, there were no significant 
results for the 6-week outcome, and given that the findings for high Self-Enhancement 
Composite in the clients with low Self-Efficacy to abstain at baseline on 6-month 
outcome was only approaching significant, firm conclusions cannot be drawn.  
Taken together, these results provide suggestive evidence that interventionist Self-
Enhancement (i.e., processes related to both Affirmation and Enhancing Self-Efficacy) 
may be particularly important for clients who are low in Self-Efficacy to abstain or 
reduce drug use at baseline in the context of a BNI conducted in primary care. However, 
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the impact of Self-Enhancement on drug use outcomes for clients with low Self-Efficacy 
may only extend to short-term outcomes and were not seen six months after the BNI 
intervention took place. In the EMI condition, models incorporating the interaction term 
indicated that there may be an interaction for Self-Efficacy to abstain at baseline and 
Self-Enhancement on 6-month outcomes, and that this may be driven by clients with low 
Self-Efficacy at baseline, although further analyses with the low Self-Efficacy sample 
were not significant. There did not appear to be a significant interaction for Self-Efficacy 
to reduce drug use at baseline and Self-Enhancement composite scores in the EMI 
condition at either 6-week or 6-month outcomes. It is unclear why different potential 
interactions were observed in the BNI condition and the EMI condition in terms of length 
of follow-up (i.e., 6-week versus 6-month), although tests of the interaction in the EMI 
condition were not significant for either Self-Efficacy to abstain or Self-Efficacy to 
reduce drug use at either the 6-week or 6-month outcome. As mentioned above, these 
results should be interpreted as providing suggestive evidence of a moderating effect of 
client Self-Efficacy to abstain and/or reduce drug use in the BNI condition, and should be 
interpreted with caution. Further research would be necessary to replicate these findings 
and gain a better understanding of the interaction of client variables and interventionist 
variables, as well as how different types of interventions may influence outcomes and 
how long the reductions in drug use frequency are observed.   
 Although the overall results did not provide support for the idea that therapist skill 
in Affirmation and Enhancing Self-Efficacy is associated with improved substance use 
outcomes, there are several ways to interpret these findings. Certainly it is possible that 
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these variables do not, in fact, account for change even under ideal circumstances with 
highly skilled clinicians. While MI accounts for these processes in its overall theory, it is 
possible that Affirmation and Enhancing Self-Efficacy either do not play a role in drug 
use outcomes, or do not play a role in the way one might expect.  
Alternate explanations are also possible, and several comments in regards to the 
main study and the current secondary analysis involving process variables warrant 
attention. Overall, the results of the main study (Saitz et al., under review) indicated that 
neither the BNI or EMI condition were significantly better than the control condition in 
reducing drug use either 6-weeks or 6-months later. Authors concluded that this type of 
intervention was not effective for drug use, and should not be recommended as part of 
SBIRT programs. This could in part explain the results of the present analyses. That 
being said, researchers have identified datasets with null findings as potentially fruitful 
for investigating active processes, in particular for studying the interaction between active 
ingredients and client mechanisms (Longabaugh, 2007).  
The ASPIRE trial investigated drug use other than alcohol, which could account 
for the results of the main trial, as there may be something very different about illicit drug 
use as compared to alcohol use, which is legal and generally more socially accepted. The 
sample also had a wide range of drug use behavior, including frequency of use, drug of 
choice, severity of associated consequences, and comorbid medical and mental health 
conditions. Prior research on substances other than alcohol indicates that it may be 
difficult to detect change due to the variability across different substances (Carroll et al., 
2006; Rounsaville, Petry, & Carroll, 2003).  
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It is possible that there was not adequate power to detect effects, although given 
the sample size of 153 in the BNI condition and 168 in the EMI condition, an effect size 
as low as f2 = .05 could be detected at 80% power; therefore, it does not appear that 
inadequate power explained the null findings. 
Given that both interventions were very brief, it is also possible that the dose of 
the EMI and BNI interventions was not adequate to see a change in drug use outcomes, 
and meta-analytic research suggests that high dose of treatment produces larger effect 
sizes than small dose of treatment (Burke et al., 2003). Perhaps the processes of 
Affirmation and Enhancing Self-Efficacy would in fact result in improved drug use 
outcomes, given an adequate dose of treatment. There also may be something unique 
about primary care patients versus individuals who are specifically seeking treatment for 
alcohol or drug use disorders or those being treated in a mental health clinic (VanBuskirk 
& Wetherell, 2013). The patients in this sample were recruited as they were seeking care 
in a medical clinic and were presumably not explicitly seeking care for substance-related 
issues specifically.  
 Despite the mostly null findings and limitations of the present study, several 
strengths deserve mention. The ASPIRE trial was a large, well-controlled trial of two 
interventions that were delivered with fidelity (Saitz et al., under review), with a sample 
size larger than most other analyses including process variables. The current study was 
grounded in both theory and practice, and explored processes not yet studied extensively 
in the literature related to MI process. The coders received extensive supervision and 
achieved good to excellent reliability throughout the coding process. Twenty percent of 
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the large sample was coded by more than one rater, which provides strong support for the 
reliability of the overall codes, despite the low variability in ratings.  
 Future research should explore these variables in the context of studies that 
employed efficacious interventions. It may also be useful to explore other indicators of 
behavior change, including more proximal indicators such as client engagement in 
treatment, referral to more intensive substance use treatment, intention to change, 
readiness to change, and discrepancy-related processes (Miller et al., 2003). Research on 
these variables may prove more fruitful in other samples, for instance in individuals 
seeking substance use treatment or already in specialized substance use services. While 
the overall results were null, the current findings suggest that these variables may interact 
with client moderators, including self-efficacy, and future research should also explore 
other moderators that may influence the relationship between Self-Enhancement 
processes and client in-session behavior, proximal indicators, and substance use 
outcomes. 
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APPENDIX A  
Global codes for Enhancing Self-Efficacy and Affirmation from ASPIRE coding 
manual 
 
Enhancing Self-Efficacy  
• affirmation of patient strengths regarding behaviour change 
• highlight past successes at behaviour change  
• self-efficacy instrument may be used 
• identify strengths of the patient in efforts to change 
• identify social supports for change 
 
      1               2               3               4               5                
Low                            Adequate                     High 
 
5.  High:  The interventionist creates and makes use of opportunities to ask the patient to 
identify and elaborate on events that would help bolster self-efficacy to change.  This will 
include efforts to:  (1) elicit current and past successes, especially about behavior change, 
(2) identify patient strengths and strengths in the patient’s life/environment to support 
behavior change (e.g., social supports) and/or (3) corroborate information from the self-
efficacy measure.  This followed by asking the patient to elaborate information related to 
self-efficacy (e.g., providing details and examples of current and past success in 
behaviour change, reflecting on past affect).  Through open-ended questions and/or 
reflections, the interventionist attempts to link these elements to the patient’s current 
potential for behaviour change/maintenance.    
 
 
4.  The interventionist seeks to bolster self-efficacy to change by identifying relevant 
strengths, highlighting previous successes, and/or using the self-efficacy measure. The 
interventionist seeks to identify more than one source of self-efficacy for the patient in 
relation to behaviour change and attempts to have the patient elaborate on each of these 
domains by examples or more information (e.g., elaborate on how others are, or have 
been, supportive). 
 
 
3.  Adequate:  The interventionist identifies at least one domain in the patient’s life that 
may be related to self-efficacy for behaviour change.  This may include the patient’s 
previous or current success in behavior change, sources of support, or resiliency.  The 
interventionist provides an affirmation of this source of self-efficacy (e.g., that person 
must be a great help to you) and seeks some elaboration response from the patient 
[affective, elaboration] regarding the source of self-efficacy. 
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2.  The interventionist makes minimal use of information related to self-efficacy or 
previous behavior-change efforts and does not ask for elaboration from the patient. 
 
 
1. Low: No discussion of past successes or strengths regarding self-change occurs in 
the interview and the interventionist does not make any efforts to address self-efficacy 
with either structured instruments or through discussion.   	  
Direct Affirmation of patient  
• statements about patient positive qualities 
• statements indicating appreciation/enjoyment of interaction 
      1               2               3               4               5                
Low                            Adequate                     High 
5.  High:  The interventionist makes multiple direct statements to the patient about how 
he/she admires, values, notices the patient’s positive traits, enjoyable style of interaction 
and other positive qualities.  Some of these statements regarding positive characteristics 
will be unrelated to the behaviour change target (e.g., You are a kind person).  The 
interventionist conveys an appreciation of the patient as part of the interview and 
communicates in a manner that suggests that he/she is enjoying/appreciating the 
experience of being with the patient.  The interview contains compliments where 
appropriate and the interventionist makes use of opportunities in the interview to express 
feelings of positive regard for the patient.   The interventionist also may seek to elicit 
confirmation from the patient (e.g., through open ended questions) about some of these 
positive traits/characteristics. These are direct statements about the patient’s general 
characteristics (e.g., “you are someone that really cares about others” vs. “you really care 
about your children”) or the therapists positive experience (“You are really fun to talk 
to”).  These statements may be related to the behaviour change target but not specific to 
behavior (e.g., you are a really hard worker vs. you really worked hard in that program). 
 
4.  The interventionist communicates that he/she values or appreciates the patient with 
two or more direct statements.  These statements are more than simple statements of 
appreciation regarding participation in the interview to include direct statements about 
positive qualities of the patient him/herself (e.g., traits, interaction style, life 
accomplishments) that is distinct from specific success addressing the behavior change 
target itself.  These are direct statements about the patient’s general characteristics or the 
therapists positive experience.  These statements may be related to the behaviour change 
target but not specific to behaviour change target (e.g., you are a really hard worker vs. 
you really worked hard in that program). 
 
3.  Adequate:  The interventionist communicates that he/she values or appreciates the 
patient with direct statements.  This will go beyond simple statements of appreciation 
regarding participation in the interview to include one direct statement about to the 
patient’s positive qualities (e.g., traits, interaction style, life accomplishments) that is 
distinct from specific success addressing the behavior change target itself.  These are 
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direct statements about the patient’s general characteristics (e.g., “you are someone that 
really cares about others” vs. “you really care about your children”) or the therapists 
positive experience (“I really enjoy talking to you”).  These statements will typically be 
related to the behaviour change target but not about the specific to behaviour change 
target (e.g., you are a really hard worker vs. you really worked hard in that program). 
 
2.  The interventionist makes a minimal effort (e.g., I appreciate that you are here today) 
to communicate that he/she values, appreciates, enjoys the patient.  Little effort is made 
to express regard for the patient other than listening to comments and making positive 
statements about efforts to address the change target specifically. 
 
1.  Low:  The interventionist does not communicate that he/she values the patient in any 
way.  Interactions may be formal, technical, but more importantly, no effort is made to 
communicate regard or appreciation for the patient.  The interventionist may cutoff the 
patient while speaking or ignore what the patient has said.  
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APPENDIX B 
Patient self-efficacy questions 	  	  
1. If you decide to cut back on your use of _____________ (insert drug of most 
concern), how confident are you that you would succeed? 
 
0 1 2 3 4 5 6 7 8 9 10 
N/A Not confident  Somewhat confident Very confident 
 
 
 
2. If you decide to abstain from using ____________ (insert drug of most concern), 
how confident are you that you would succeed? 
 
0 1 2 3 4 5 6 7 8 9 10 
N/A Not confident  Somewhat confident Very confident 
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ABSTRACT 
 
Introduction: While research suggests that Motivational Interviewing (MI) is effective for 
reducing drug use, little is known about whether brief MI-based interventions reduce drug use in 
a primary care setting, or how these interventions impact outcomes.  Mixed findings in studies of 
motivational intervention processes have led investigators to call for research to examine 
alternative process variables that may predict outcomes. The current study is a secondary data 
analysis using coded audio-recordings from a randomized controlled trial that tested the efficacy 
of two brief MI-based interventions to reduce substance use in primary care, the ‘Assessing 
Screening Plus brief Intervention’s Resulting Efficacy to stop drug use’ (ASPIRE) trial. It was 
hypothesized that skill in affirming clients and enhancing their self-efficacy would be associated 
with lower frequency of drug use at 6 weeks and 6 months after controlling for baseline drug use 
and indicators of general MI proficiency. Methods: Audio-recordings from two intervention 
conditions [Enhanced Motivational Intervention (EMI; N=176) and Brief Negotiated Interview 
(BNI; N=174)] were coded with behavior counts and global interventionist skill ratings using an 
established coding system for MI and a study-specific coding manual. A series of negative 
binomial regression models were conducted that were stratified by intervention condition to test 
the association between interventionist processes and substance use outcomes. Secondary and 
tertiary analyses examined moderators including MI Spirit and patient baseline ratings of self-
efficacy. Results: There were no significant findings for the main effects models (Incidence Rate 
Ratio range .71-1.29). Only patient self-efficacy moderated the relationship between self-
enhancement composite and 6 week outcome in the BNI condition; Self-enhancement composite 
was associated with lower frequency of drug use at 6 weeks in the BNI condition for those with 
low self-efficacy at baseline. Discussion: Overall, the results provided little support for the view 
that therapist skill in affirmation or enhancing self-efficacy was predictive of drug use outcomes 
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in one-session interventions in primary care. Although these results may indicate that these 
variables are not central to successful intervention outcomes, the absence of overall intervention 
effects qualifies conclusions about their impact. Future work should explore the role of these 
interventionist variables on proximal indicators of change (i.e., intention) in MI-based 
interventions for drug use with demonstrated efficacy. 
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Introduction 
 
Substance use disorders (SUD) affect millions of people worldwide (World Health 
Organization, 2012) and are associated with higher rates of negative health consequences 
(Kessler, Chiu, Demler, & Walters, 2005; National Institute on Drug Abuse, 2012). The majority 
of substance users will never seek treatment (Compton, Thomas, Stinson, & Grant, 2007), and 
those who do, are often difficult to engage in treatment, and are susceptible to relapse (Claus & 
Kindleberger, 2002; Greenfield et al., 2007; Leshner, 1997; McLellan, Lewis, O’Brien, & Kleber, 
2000).  
Given these findings, there has been increased interest in developing strategies to address 
SUDs in opportunistic healthcare settings (Britt, Hudson, & Blampied, 2004; Emmons & 
Rollnick, 2009; Madras et al., 2009), such as emergency rooms (Bernstein, Bernstein, & 
Levenson, 1997; Monti, Colby, Barnett, Spirito, & Rohsenow, 1999) and primary care offices 
(Bernstein et al., 2005; D’Amico, Miles, Stern, & Meredith, 2008). Many of these efforts consist 
of brief interventions (BIs) that are based on Motivational Interviewing (MI), typically 
Adaptations of Motivational Interviewing (AMIs) (Burke, Arkowitz, & Menchola, 2003; Dunn, 
Deroo, & Rivara, 2001). AMIs may be particularly useful in the context of opportunistic 
healthcare settings (Lundahl et al., 2013; VanBuskirk & Wetherell, 2013), where there is 
significant time pressure combined with the high rates of unhealthy or risky alcohol and 
substance use behavior (Bertholet, Palfai, Gaume, Daeppen, & Saitz, 2013). While AMIs vary on 
a number of dimensions (e.g., length, format, type of health care provider, setting) they are based 
on the key principles of MI, including empathy, developing discrepancy between substance use 
and desired outcomes and goals, rolling with resistance in the interpersonal therapeutic context, 
and supporting self-efficacy (Burke et al., 2003; Miller & Rollnick, 2002).  
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While there is a strong evidence to support the use of AMIs as an effective intervention 
for hazardous/harmful drinking (Burke, Arkowitz, & Dunn, 2002; Burke et al., 2003; Dunn et al., 
2001; Noonan & Moyers, 1997), studies of AMIs for drug use have produced mixed results (Saitz 
et al., 2010), and there is very little evidence for interventions that address drug use among those 
presenting to primary care clinics (Saitz et al., 2010). Despite the increasing use of MI to address 
hazardous/harmful drinking and drug use in medical settings, very little is known about how MI 
exerts its therapeutic effects (Burke et al., 2003; Carroll et al., 2006; Miller & Rose, 2009).  
 The two main factors that are hypothesized to underlie MI outcomes are an 
interventionist style characterized by MI Spirit (i.e., evocation of a client’s own reasons for 
change, collaboration with the client, and support of their autonomy) and empathy and the use of 
specific techniques designed to facilitate change talk from the patient (Miller & Rollnick, 2002; 
Miller & Rose, 2009). Consistent with a wide range of interventions, empathy is associated with 
better outcomes (Keijsers, Schaap, & Hoogduin, 2000; Lambert & Barley, 2001; Miller, Taylor, 
& West, 1980; Najavits & Weiss, 1994; Valle, 1981). MI Spirit has been shown to improve 
drinking outcomes, client engagement, and expression of affect in several studies, although other 
studies indicate that findings related to MI Spirit are mixed (Apodaca & Longabaugh, 2009; 
Bertholet et al., 2013).  
Specific therapist behaviors or techniques of MI have typically been examined as 
categories of MI-consistent behavior (MICO) and MI-inconsistent behavior (MIIN). The 
evidence suggests that both MICO and MIIN may be important predictors of in-session client 
behaviors and client outcomes (Moyers & Martin, 2006; Moyers et al., 2007; Moyers et al., 2009) 
in that MICO is associated with client change talk and improved outcomes, whereas MIIN is 
associated with counter change talk and worse outcomes (Bien, Miller, & Boroughs, 1993; Karno 
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& Longabaugh, 2004; Karno & Longabaugh, 2005; Miller et al., 1993; Moyers et al., 2007; 
Moyers et al., 2009).  
 Specific techniques that were utilized in MI-based interventions and found to be 
associated with outcomes include decisional balance, giving feedback, enhancing personal 
responsibility, clear advice, clinician empathy, enhancing self-efficacy, and generating change 
options (Apodaca & Longabaugh, 2009; Bien, Miller, & Tonigan, 1993; LaBrie, Pederson, 
Earleywine, & Olsen, 2006; McNally et al., 2005; Strang & McCambridge, 2004; Vader et al., 
2010). 
Moderator variables are also potential avenues for gaining a better understanding of what 
kinds of treatments work best for which kinds of patients would allow for the tailoring of 
treatments to patient variables. Several meta-analyses include results for AMIs for both alcohol 
and drug use (Burke et al., 2003; Dunn et al., 2001). Comparative dose of AMI accounted for a 
significant variance in outcomes (Burke et al., 2003), although severity of substance use is 
contradictory (Burke et al., 2003; Dunn et al., 2001; Gentilello et al., 1999). Several studies have 
found higher effect sizes of MI within minority populations (Hettema et al., 2005; Villanueva, et 
al., 2007; Winhusen et al., 2008). The results related to client readiness to change were mixed 
(Apodaca & Longabaugh, 2001; Dunn et al., 2001). One study showed evidence that client 
resistance impacted substance use outcomes, (Miller et al., 1993), although this area is currently 
understudied (Apodaca & Longabaugh, 2009). Low client self-efficacy was found to be 
associated with stronger effects of MI on cocaine use outcomes in one study (Rohsenow et al., 
2004), although more broadly speaking, the findings are mixed (Apodaca & Longabaugh, 2009). 
Given the limited and mixed findings in the reviews of the literature on drug and alcohol 
interventions, combined with precaution that findings from the alcohol literature may not apply to 
drug use (Saitz et al., 2010), the literature does not provide any clear solutions regarding 
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moderator variables, and researchers have called for further study (Apodaca & Longabaugh, 
2009; Dunn et al., 2001).  
Several questions remain to be answered and conflicting results in the literature regarding 
core characteristics of BIs and AMIs have called into question the assumptions about what factors 
contribute to change (Apodaca & Longabaugh, 2009; Bertholet et al., 2013). There are several 
variables that are theoretically associated with MI that have not been studied as of yet, and 
researchers have called for further investigation from alternative perspectives in order to better 
understand what may underlie treatment effects (Miller & Rose, 2009; Morgenstern & McKay, 
2007). Several theories that overlap with processes thought to be important in MI have may serve 
as a useful lens through which to view MI in a new light, including Self-Determination Theory 
(Deci & Ryan, 1985, 1991, 2012) and Self-Affirmation Theory (Steele, 1988).  
Self-Determination Theory (SDT) (Deci & Ryan, 1985, 1991) has been proposed as a 
useful framework for understanding MI process (Markland et al., 2005; Vansteenkiste & Sheldon, 
2006). The creators of MI have recently endorsed this framework as potentially useful in the 
context of exploring mechanisms of change in MI (Miller & Rollnick, 2012; Vansteenkiste, 
Williams, & Resnicow, 2012). SDT is based on the idea that people are fundamentally inclined 
towards personal growth and resolution of inconsistencies in their self-concept (Ryan, 1995; 
Ryan & Deci, 2000). Certain conditions are more likely to support this process, including feelings 
of competence, autonomy, and relatedness. The factors hypothesized to be important in MI map 
onto these conditions and are reflected in MI measures, Autonomy Support is incorporated into 
MI measures (Miller, Moyers, Ernst, & Amrhein, 2003; Moyers et al., 2012), and empathy within 
the therapeutic alliance supports the need for relatedness (Markland et al., 2005; Miller & 
Rollnick, 2012; Vansteenkiste & Sheldon, 2006) and is also incorporated into measures of MI 
(Miller, Moyers, Ernst, & Amrhein, 2003; Moyers et al., 2012), and supporting self-efficacy 
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(measured with confidence rulers) supports one’s perception of competence. However, very little 
is known about what treatments best promote self-efficacy, or how therapists may promote self-
efficacy in the context of an MI-based intervention for substance use (Kadden & Litt, 2011). 
Particularly in the context of a brief motivationally-based intervention in a primary care setting, 
supporting self-efficacy in the interaction has the potential to benefit the client in terms of 
improving their outcomes, but this has not received research attention as of yet.  
 Another potentially important process that may be related to behavior change in MI is 
affirmation, which is one of the therapist behaviors that is prescribed in MI under the umbrella of 
MI-Consistent behavior (Miller & Rollnick, 2002). Self-affirmation theory may offer a useful 
perspective to explain why this therapist skill may be important in in the context of addressing 
substance use in opportunistic settings. According to self-affirmation theory, people are 
motivated to protect, maintain, and restore their self-integrity, or the experience of themselves as 
“adaptively and morally adequate” (Steele, 1988, p. 262). Affirming the self may allow people to 
process information related to behaviors that may be harmful to their health in a less biased 
manner because when one is affirmed in a domain unrelated to the potentially threatening health 
information (i.e., that their behavior may be putting their health at risk), the self is enhanced and 
the threat to self-integrity is reduced. Affirmation may serve the purpose of allowing one to 
consider the conflict instead of avoiding the conflict. Because resources are not being utilized 
defending against the threat, this theoretically should enable one to consider health information in 
a different way (Sherman & Cohen, 2006; Steele, 1988). A review of the literature indicates that 
experimentally manipulated self-affirmation alters cognitions about health-related messages 
(Harris & Epton, 2009, 2010), but much less is known about intentions and behavior change 
(Harris & Epton, 2009, 2010; McQueen & Klein, 2006). Affirmation impacted intentions to 
reduce drinking in heavy-drinking, although no behavior change was observed (Harris & Napper, 
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2005). Affirmation improved message acceptance and behavior of taking an information leaflet 
about smoking (Armitage, Harris, Hepton, & Napper, 2008). One study indicates that self-
affirmation and health information related to alcohol consumption may be effective for reducing 
alcohol consumption (Armitage, Harris, & Arden, 2011). Finally, frequency of affirm statements 
by clinicians was correlated with reduced heavy drinking days (Gaume et al., 2008). While the 
results on behavior change related to Affirmation are preliminary, this variable may be promising 
for futher research.  
Both Enhancing Self-Efficacy and Affirmation are specifically delineated as processes 
thought to be important according to Miller and Rollnick (2002). This study expanded the way in 
which these variables have been measured. While Affirm behavior counts are already measured 
as part the umbrella of MICO in the MITI (Moyers et al., 2012), a global variable related to 
measuring Affirmation processes was developed. Measurement of client self-efficacy is often 
incorporated into research on health behavior change including substance use and MI (Kadden & 
Litt, 2011), although enhancing self-efficacy on the part of the therapist has not been measured. 
This study used global ratings (1-5) of therapist skill in Enhancing Self-Efficacy and Affirmation 
(as well as a composite Self-Enhancement variable) of two types of MI-based interventions 
conducted in primary care to explore the relationship between these processes and drug use 
outcomes (i.e., number of days of drug use in the past thirty days) measured both 6-weeks and 6-
months later. 
The current study tested the hypotheses that high level of therapist skill in Enhancing 
Self-Efficacy, Affirmation, and Self-Enhancement composite would be associated with fewer 
days of drug use at 6-week and 6-month follow-up. Moderator analyses were also conducted to 
explore the interaction between variables related to MI process and outcome. We expected high 
quality of MI Spirit to enhance the impact of Affirmation on drug use outcomes. We expected 
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that Self-Enhancement would have a greater impact on drug use outcomes for clients low in self-
efficacy. Finally, we expected that Affirmation would moderate the relationship between 
Delivery of Health Information and drug use outcomes.  
METHODS 	  
The current study is a secondary data analysis based on a randomized controlled trial of 
brief intervention for substance use in primary care, the Assessing Screening Plus brief 
Intervention’s Resulting Efficacy to reduce drug use study (Saitz et al., under review). The 
ASPIRE study was approved by the Institutional Review Board at Boston Medical Center. 
Participants in the research project received one of three conditions: Brief Negotiated Interview 
[BNI], one 15-minute session); Enhanced – Motivational Interview [EMI], one 45-min sessions 
with an optional booster session; and a Wait-list control condition. All participants completed 
follow-up assessments at 6-weeks and 6-months after baseline. Data for this study consist of 
coded audio recordings of the interventions delivered at baseline and assessments conducted 
throughout the study.   
Participants 
 
 Participants were patients presenting to primary care clinics at Boston Medical Center. 
Individuals who had used any drug (other than alcohol and nicotine) at least once in the past 90 
days were eligible. The sample is made up of 528 individuals, with 178 participants in the control 
condition (33.7%), 174 participants in the BNI (32.9%), and 176 in the EMI (33.3%). The present 
sample includes the BNI and EMI intervention conditions; thus, the sample for the present study 
includes 350 individuals. 
Study Interventions 
The Brief Negotiated Interview (BNI) was a 15-minute structured interview delivered by 
health educators who had completed high school (or equivalent) and had either a Bachelor’s 
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degree or relevant experience. The BNI uses some features of MI and was designed to be 
structured, with incorporated feedback, exploration of the “pros and cons” of substance use, and 
completion of a change plan.  
The Enhanced Motivational Interview (EMI) was designed to be an AMI and was a 45-
minute intervention followed up by an optional booster session. EMIs were delivered by graduate 
student clinicians in the Department of Psychology at Boston University who received training in 
MI and weekly supervision. EMIs were structured to be flexible, 45-minute sessions that focused 
on the drug of most concern through the use of a menu of potential strategies, including 
delivering feedback about substance use behavior, delivery of health-related information tied to 
substance use, exploring pros and cons of substance use from the client’s perspective, developing 
discrepancy, enhancing self-efficacy, exploring change-related options, and eliciting change talk 
and self-motivational statements. More details about the interventions can be found in Saitz et al., 
(under review).  
Procedure 
 All BNI and EMI interventions were audio-recorded and audible files were coded. The 
audio-recorded counseling sessions were coded by three graduate research assistants at Boston 
University using the 1) Motivational Interviewing Treatment Integrity (MITI) manual (Moyers, 
Martin, Manuel, Hendrickson, & Miller, 2005); the latest version of this manual is version 3.1 
(Moyers et al., 2012); and 2) and a series of global items developed for both the ASPIRE study. 
 The MITI 3.1 is an instrument that includes both behavior counts of therapist behaviors 
(i.e., MICO and MIIN behaviors) and global ratings (1-5 scale, with 1 being the least skilled and 
5 being the most skilled). The MITI 3.1 is available at 
<http://casaa.unm.edu/download/miti3_1.pdf>. The global items for the ASPIRE project were 
developed collaboratively by experts who developed the EMI and BNI conditions. Similar to the 
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MITI, the ASPIRE-specific global items were rated on a 1-5 scale. The ASPIRE global items 
included the following: 1) Opening and orientation to the interview 2) Optimal use of self-report 
assessment and medical record information 3) Delivery of health-related information 4) 
Pros/Cons/Ambivalence 5) Developing discrepancy 6) Enhancing self-efficacy 7) Direct 
affirmation of the patient 8) Assess readiness to change and 9) Change plan. The global items for 
Enhancing Self-Efficacy and Affirmation can be made available from the authors upon request.   
 All raters attended a two-day workshop on coding with the MITI 3.1 with an expert who 
helped develop these instruments, and participated in practice exercises with sample MI sessions 
until an adequate level of accuracy was achieved. The coding training took place over 
approximately 8 weeks with a total of about 40 hours of training. There were three raters, and 
each rater listened to both EMI and BNI interventions. Twenty percent of the sample was coded 
by multiple coders for the purposes of reliability analysis. Ratings for the double- or triple-coded 
sessions were assessed for reliability using intraclass correlation coefficients (ICCs) (Cicchetti, 
1994). Rating for multiply coded tapes were combined into a mean rating when added to the 
overall database including all coded files. The coders met with an expert on MI weekly for coding 
supervision in order to maintain a high level of inter-rater reliability and prevent coding drift. All 
raters maintained their ratings after discussion, which were entered into the overall dataset. The 
scores for both behavior counts and global ratings of the double- and triple-coded sessions were 
averaged across raters for the final data set in order to preserve one rating per session for the 
regression analyses, and the reliability dataset was maintained with all ratings separately.  
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Measures 
Primary Independent Variables 
Enhancing Self-Efficacy.  Measured with the global score for the therapist’s Enhancing Self-
Efficacy from the ASPIRE coding manual. The reliability of this variable based on ICCs is .73 
indicating good reliability (Cichetti, 1994; Saitz et al., in press).  
Affirmation.  Measured with the global score for therapist Affirmation from the ASPIRE 
intervention coding manual. The reliability of this variable based on ICCs is .71 indicating good 
reliability (Cichetti, 1994; Saitz et al., in press).  
Composite Score for “Self-Enhancement” Processes.  The construct of “Self-Enhancement” used 
for this study was constructed from two intervention components: Affirmation and Enhancing 
Self-Efficacy codes from the ASPIRE instrument. The following were utilized for this construct: 
global scores for Enhancing Self-Efficacy and Affirmation of the Patient from the ASPIRE 
intervention manual, and behavior counts of Affirm frequency (i.e., number of affirm coded 
behaviors) from the MITI 3.1 (Moyers et al., 2005; Moyers et al., 2012). Behavior counts and 
global ratings for each of the three components was transformed to a z-score and the mean of 
these three z-scores reflects the Self-Enhancement composite within the ASPIRE interventions.  
Covariates and Moderators  
Drug Use Severity. The Alcohol Smoking and Substance Involvement Screening Test (ASSIST) 
(Humeniuk et al., 2008) score for the Drug of Most Concern (DOMC) was used as a covariate to 
control for drug use severity at baseline.  
Indices of MI Quality. To control for other variables within MI that may predict outcomes, 
analyses controlled for the global score of Empathy as measured with the MITI 3.1.  The one 
exception is for the analyses for Hypothesis 7, in which the impact of MI Spirit on the 
relationship between Affirmation and substance use outcomes was tested, and as these two 
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variables are highly correlated (BNI=.714; EMI=.615), Empathy was not included in the model 
testing Hypothesis 7. The reliability of the Empathy variable was .75 indicating excellent 
reliability (Cichetti, 1994; Saitz et al., under review).  
Confidence Rulers. Client self-efficacy to abstain and reduce drug use will be measured with the 
use of confidence rulers (Miller & Rollnick, 2002, p. 53), which are scales from 1-10 of the 
patient’s self-reported confidence to reduce or abstain drug use with 10 indicating the most 
confidence. This variable was split at the median to create variables indicative of high self-
efficacy to reduce/abstain and low self-efficacy to reduce/abstain.  
Delivery of Health Information.  Measured with a global code from the ASPIRE coding manual. 
The reliability of this variable based on ICCs is .76 indicating excellent reliability (Cicchetti, 
1994; Saitz et al., in press).  
Additional Covariates.  To account for sources of variability in outcomes that are likely to be 
distinct from intervention processes, analyses were run including Number of days of use of the 
DOMC in the past 30 days at Baseline, ASSIST score for the drug of most concern, and 
comparison of marijuana as the drug of most concern as compared to other drugs (e.g., marijuana 
Y/N) at baseline in the model. 
Dependent Variables 
Substance Use Outcomes.  Substance use outcomes were assessed using the Timeline Follow-
Back method (TLFB; Sobell & Sobell, 1980; Ehrman & Robbins, 1994) at both the 6-week 
follow-up and 6-month follow-up time points. The primary outcome was number of days of use 
of the drug of most concern in the past 30 days at the 6-month follow-up. Secondary analyses for 
the main effects models evaluated the number of days of use of the drug of most concern in the 
past 30 days at 6-weeks, and secondary and tertiary moderator analyses explored both 6-week and 
6-month outcomes.  
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Data Analysis 
All statistical analyses were performed using SPSS v. 22. Data were entered and accuracy 
checks were conducted prior to conducting the analyses. As per the main ASPIRE trial, the study 
was designed to detect an absolute difference of approximately 15% in drug use outcomes 
accounting for up to 10% loss of follow-up data (in the present study, uncodable audio-
recordings) and an overall α of 0.05 (Saitz et al., under review).   
The primary dependent variables of interest in this investigation are substance use 
outcomes, operationalized as number of days of use in the past 30 days of the drug of most 
concern identified at screening at both 6-week and 6-month outcome. The moderating variables 
for secondary aims are those related to MI Spirit, including global scores for Collaboration, 
Evocation, and Autonomy Support as measured by the MITI 3.1. The moderating variables for 
tertiary aims are client’s ratings of confidence to a) abstain or b) reduce drug use on a 1-10 scale 
with 10 indicating the most confidence (Miller & Rollnick, 2002) and Delivery of Health 
Information. All analyses were conducted on EMI and BNI interventions separately. This 
stratified analysis approach was necessary as the interventions are of different length, have 
different emphasis on MI style, and emphasize unique components relevant to Self-Enhancement. 
Frequency distributions and descriptive statistics were generated for all variables under study 
prior to testing the study hypotheses. Bivariate correlations among the independent variables and 
covariates were calculated and assessed for possible multicollinearity. Negative binomial 
regression models were chosen because the outcomes were overdispersed count data of number 
of days of drug use in the past 30 days. Tertiles were created for the main independent variables 
of enhancing self-efficacy, affirmation, and self-enhancement composite in order to account for 
non-linear associations between independent and dependent variables.  
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The moderator analyses testing the impact of patient self-efficacy to abstain and self-
efficacy to reduce drug use at baseline used a subsample of the BNI and EMI conditions 
including those who had one or more days of drug use in the past 30 days as measured at 
baseline.  
RESULTS 
Descriptive Statistics 
The sample included in the present analyses are participants with an ASSIST Score 
greater than or equal to 4 who were assigned to the BNI condition (N= 174; 32.9%) and the EMI 
condition (N=176; 33.3%). In the BNI condition, the mean age is 40.00 (SD  = 12.24). The 
majority of participants were African American at 68.2%, with 18.8% Caucasian, 10.6% 
Hispanic, and 2.4% who identified as Other. Only 28.7% of the sample was female. The majority 
identified their drug of most concern as marijuana, with 62.6% of the sample, 18.4% cocaine, 
17.8% opioids, and 1.1% PCP/Amphetamines/Other. The mean number of days of use of the 
DOMC in the past 30 days is 15.11 (SD=11.70) with a range of 0-30. The mean total ASSIST 
score was 21.76 (SD=18.41) and the ASSIST score for the DOMC was 16.57 (SD= 9.90), which 
is indicative of an overall moderate level of risk related to substance use (Humeniuk et al., 2008).  
In the EMI condition, the mean age is 42.4 (SD=12.06). The majority of participants were 
African American at 72.8%, with 20.8% Caucasian, 6.4% Hispanic, and 0% who identified as 
Other. Only 29% of the sample were female. The majority identified their drug of most concern 
as marijuana, with 62.5% of the sample, 18.8% cocaine, 15.9% opioids, and 2.8% 
PCP/Amphetamines/Other. The mean number of days of use of the DOMC in the past 30 days is 
13.77 (SD=11.24) with a range of 0-30. The mean total ASSIST score was 22.07 (SD=18.59) and 
the mean ASSIST score for the DOMC was 16.60 (SD=8.78), which is indicative of an overall 
	  	  
87	  
moderate level of risk related to substance use (Humeniuk et al., 2008). Please refer to Table 1 for 
descriptive statistics by intervention condition.  
Main Effects Models 
The results for all of the main effects models testing the impact of Enhancing Self-
Efficacy, Affirmation, and Self-Enhancement Composite on both 6-month and 6-week outcomes 
stratified by condition (EMI vs. BNI) controlling for baseline substance use and empathy were 
insignificant. Please see Table 2 for the Test of Model Effects for the main effects models.  
Moderator Analyses 
Results for the Test of Model Effects for the Interaction Models for both the BNI and 
EMI conditions are presented in Table 3. No significant interaction effects were observed 
between MI Spirit and Self-Enhancement Composite on 6-week outcomes in the BNI condition 
(p = .501) or the EMI condition (p = .309). No significant interaction effects were observed 
between MI Spirit and Self-Enhancement Composite on 6-month outcomes in the BNI condition 
(p = .603) or the EMI condition (p = .407).  
  There was a significant interaction between patient Self-Efficacy to abstain and Self-
Enhancement Composite on 6-week outcomes in the BNI condition (p = .021). Further tests of 
this interaction effect with a subsample of patients with low Self-Efficacy at baseline (N=78) 
revealed that high Self-Enhancement Composite was associated with reduced drug use at 6-weeks 
in the BNI condition [IRR = .584; 95% CI (396, .863); p = .007] and the middle tertile of Self-
Enhancement Composite was not significant (p=.115). Thus, high level of interventionist skill in 
Self-Enhancement as measured by the Self-Enhancement Composite variable was associated with 
a 42% reduction in frequency of drug use 6-weeks later for patients low in Self-Efficacy to 
abstain from drug use in the BNI condition. This effect was not observed in the subsample with 
	  	  
88	  
high Self-Efficacy (N=63) which was not significant for either the high tertile (p = .360) or the 
middle tertile (p = .673) of Self-Enhancement Composite.  
No significant interaction effects were observed between Self-Efficacy to abstain and 
Self-Enhancement Composite on 6-month outcomes in the BNI condition (p = .592). No 
significant interaction effects were observed between Self-Efficacy to abstain and Self-
Enhancement Composite on 6-week outcomes (p = .273) or 6-month outcomes (p = .082) in the 
EMI condition.   
  There was a significant interaction between patient Self-Efficacy to reduce drug use and 
Self-Enhancement Composite on 6-week outcomes in the BNI condition (p = .027). Further tests 
of this interaction effects with a subsample of patients with low Self-Efficacy to reduce drug use 
at baseline (N=81) revealed that high Self-Enhancement Composite was marginally associated 
with lower frequency of drug use at 6-weeks in the BNI condition [IRR = .676; 95% CI (.441, 
1.035); p= .072] whereas the middle tertile of Self-Enhancement Composite was significant [IRR 
= .680; 95% CI (.464, .996); p = .047]. This effect was not observed in the subsample with high 
Self-Efficacy (N=60) which was not significant for either the high tertile (p = .608) or middle 
tertile (p = .137) of Self-Enhancement Composite.  
 No significant interaction effects were observed between Self-Efficacy to reduce and 
Self-Enhancement Composite on 6-month outcomes in the BNI condition p = (.883). No 
significant interaction effects were observed between Self-Efficacy to reduce and Self-
Enhancement Composite on 6-week outcomes (p = .761) or 6-month outcomes (p = .159) in the 
EMI condition  
No significant interaction effects were observed between Affirmation and Delivery of 
Health Information on 6-week outcomes (p = .512) or 6-month outcomes (p = .629) in the BNI 
condition. No significant interaction effects were observed between Affirmation and Delivery of 
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Health Information on 6-week outcomes (p = .687) or 6-month outcomes (p = .832) in the EMI 
condition. 
DISCUSSION 	   Overall,	  the results of the present study did not support the hypotheses that therapist skill 
level in Enhancing Self-Efficacy and Affirmation (as well as a composite variable of Self-
Enhancement processes) was associated with improved drug use outcomes either six weeks or six 
months later in the context of a one-session AMI conducted in the primary care setting, despite 
the fact that they are hypothesized to be important factors in MI (Miller & Rollnick, 2002).   
Moderator analyses on whether MI Spirit moderated the impact of Affirmation on drug 
use outcomes proved insignificant. Findings from the present study are consistent with the 
literature in that MI Spirit is not consistently associated with improved outcomes (Apodaca & 
Longabaugh, 2009; Bertholet et al., 2013; Gaume et al., 2008; McNally et al., 2005; Morgenstern, 
Kuerbis, Amrhein, Hail, & Lynch, 2012; Strang & McCambridge, 2004).  
Moderator analyses of client Self-Efficacy on the relationship between Self-Enhancement 
and drug use outcomes indicated that client Self-Efficacy at baseline moderates the relationship 
between the Self-Enhancement composite variable and drug use outcomes under certain 
conditions. In the BNI condition, a significant interaction was observed between client Self-
Efficacy to abstain from drug use and the Self-Enhancement composite on the 6-week drug use 
outcome, controlling for baseline drug use indicators and Empathy. When this interaction effect 
was explored, it was found that for the subsample of clients that for the subsample of clients that 
were low in Self-Efficacy to abstain at baseline (N = 78), high levels of therapist Self-
Enhancement was associated in significantly less drug use at 6-week outcome (IRR = .584; 
p=.007). This can be interpreted as interventions high in Self-Enhancement Composite were 
associated with a 42% reduction in drug use in the past 30 days measured at 6-weeks compared to 
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the low tertile of Self-Enhancement composite for those low in Self-Efficacy at baseline in the 
BNI condition. Results for the moderating effects of Self-Efficacy to abstain were insignificant 
for the 6-month outcome.  
A similar finding emerged in the analyses of Self-Efficacy to reduce drug use (as 
compared to Self-Efficacy to abstain) in the BNI condition, although in this case the findings are 
somewhat more difficult to interpret. A significant interaction was again observed for the 
moderating effect of Self-Efficacy to reduce substance use on 6-week outcomes. Again, among 
the subsample of clients with high Self-Efficacy to reduce drug use at baseline (N = 60), the 
findings were not significant. However, further exploration among the subsample of clients low 
in Self-Efficacy to reduce drug use (N = 81) indicated that the middle tertile of Self-Enhancement 
was associated with significantly less drug use (IRR = .680; p=.047), whereas the high tertile only 
approached significance (IRR = .676; p=.072). This would suggest that middle level of Self-
Enhancement was associated with a 32% reduction in drug use for clients who were low in Self-
Efficacy to reduce drug use at baseline in the BNI condition. It is unclear why a middle level of 
Self-Enhancement would be more helpful in reducing drug use outcomes than a high level of 
Self-Enhancement among those low in Self-Efficacy to reduce drug use. Furthermore, the IRRs 
were almost identical. Given that both moderator analyses for Self-Efficacy to abstain and Self-
Efficacy to reduce drug use broke down the BNI condition into smaller subsamples based on a 
median split of the Self-Efficacy to abstain/reduce drug use variables, it is possible that the 
smaller sample size could be influencing these findings, therefore these results should be 
interpreted with an abundance of caution.  
In the EMI condition, there were no significant findings for either self-efficacy to abstain 
and reduce drug use at both the 6-week and 6-month outcomes. Taken together, these results 
provide suggestive evidence that interventionist Self-Enhancement (i.e., processes related to both 
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Affirmation and Enhancing Self-Efficacy) may be particularly important for clients who are low 
in Self-Efficacy to abstain or reduce drug use at baseline in the context of a BNI conducted in 
primary care. Further research would be necessary to replicate these findings and gain a better 
understanding of the interaction of client variables and interventionist variables. 
Moderator analyses on whether Affirmation moderated the impact of Delivery of Health 
Information on drug use outcomes were also insignificant. The research on the impact of self-
affirmation to-date has explored mostly proximal variables (i.e., message acceptance) around the 
health message delivered, and very little is known about how the affirmation process interacts 
with health information to influence behavior change (Harris & Epton, 2009, 2010). Thus, the 
results of the current study suggest that the interaction between Affirmation and Delivery of 
Health Information may interact differently with outcomes related to substance use in a one-
session intervention in primary care. 
There are several ways to interpret the current findings. While MI accounts for these 
processes in its overall theory, it is possible that Affirmation and Enhancing Self-Efficacy either 
do not play a role in drug use outcomes, or do not play a role in the way one might expect. 
Alternate explanations are also possible, and several comments in regards to the main study and 
the current secondary analysis involving process variables warrant attention. Overall, the results 
of the main study (Saitz et al., in press) indicated that neither the BNI or EMI condition were 
significantly better than the control condition in reducing drug use either 6-weeks or 6-months 
later, which could in part explain the results of the present analyses. The ASPIRE trial 
investigated drug use other than alcohol, which could account for the results of the main trial, as 
there may be something very different about illicit drug use as compared to alcohol use, which is 
legal and generally more socially accepted. The sample also had a wide range of drug use 
behavior, including frequency of use, drug of choice, severity of associated consequences, and 
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comorbid medical and mental health conditions. Prior research on substances other than alcohol 
indicates that it may be difficult to detect change due to the variability across different substances 
(Carroll et al., 2006; Rounsaville, Petry, & Carroll, 2003).  
There was limited variability in the coding of the global items for both the MITI 3.1 and 
the ASPIRE-related codes. The ASPIRE study was not designed to enhance variability in 
therapist skill level or dismantle various elements of MI, so the limited variability may in fact 
indicate that this goal was achieved. However, if this is the case, one consequence could be that 
the limited variability made differences process variables on outcomes less likely to be detected.  
It is also possible that the dose of the EMI and BNI interventions was not adequate, and 
meta-analytic research suggests that high dose of treatment produces larger effect sizes than small 
dose of treatment (Burke et al., 2003). Perhaps the processes of Affirmation and Enhancing Self-
Efficacy would in fact result in improved drug use outcomes, given an adequate dose of 
treatment. There also may be something unique about primary care patients versus individuals 
who are specifically seeking treatment for alcohol or drug use disorders or those being treated in a 
mental health clinic (VanBuskirk & Wetherell, 2013).  
 Despite the mostly null findings and limitations of the present study, several strengths 
deserve mention. The ASPIRE trial was a large, well-controlled trial of two interventions that 
were delivered with fidelity (Saitz et al., under review), with a sample size larger than most other 
analyses including process variables. The current study was grounded in both theory and practice, 
and explored processes not yet studied extensively in the literature related to MI process. The 
coders received extensive supervision and achieved good to excellent reliability throughout the 
coding process. Twenty percent of the large sample was coded by more than one rater, which 
provides strong support for the reliability of the overall codes, despite the low variability in 
ratings.  
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 Future research should explore these variables in the context of studies that employed 
efficacious interventions. It may also be useful to explore other indicators of behavior change, 
including more proximal indicators such as client engagement in treatment, referral to more 
intensive substance use treatment, intention to change, readiness to change, and discrepancy-
related processes (Miller et al., 2003). Research on these variables may prove more fruitful in 
other samples, for instance in individuals seeking substance use treatment or already in 
specialized substance use services. While the overall results were null, the current findings 
suggest that these variables may interact with client moderators, including self-efficacy, and 
future research should also explore other moderators that may influence the relationship between 
Self-Enhancement processes and client in-session behavior, proximal indicators, and substance 
use outcomes. 
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TABLES 
 
Table 1: Participant Characteristics by Intervention Condition 
 
 BNI 
n=174 
EMI 
n=176 
Demographics 
Age M (SD) 40.0 (12.24) 42.4 (12.06) 
Women n (%) 50 (28.7) 51 (29) 
Race/Ethnicity n (%) -- -- 
African American n (%) 116 (68.2) 126 (72.8) 
Hispanic n (%) 18 (10.6) 11 (6.4) 
White n (%) 32 (18.8) 36 (20.8) 
Other n (%) 4 (2.4) 0 (0) 
Homeless in the past 3 months 24 (13.8) 32 (18.2) 
Married 16 (9.2) 22 (12.5) 
Drug Use 
Drug of Most Concern -- -- 
Opioids n (%) 31 (17.8) 28 (15.9) 
Cocaine n (%) 32 (18.4) 33 (18.8) 
Marijuana n (%) 109 (62.6) 110 (62.5) 
PCP/Amphetamines/Other n (%) 2 (1.1) 5 (2.8) 
Total ASSIST Score M (SD) 21.76 (18.41) 22.07 (18.59) 
ASSIST Score for DOMC M (SD) 16.57 (9.90) 16.60 (8.78) 
#Number of Days Drug Use Past 30 Days 
at BL M (SD) 
15.11 (11.70) 13.77 (11.24) 
SIP at BL M (SD) 12.05 (13.80) 12.77 (13.72) 
Predictors 
Affirmation M (SD) 2.25 (.76) 3.49 (1.15) 
Enhancing Self-Efficacy M (SD) 2.64 (1.06) 3.56 (1.19) 
Self-Enhancement Composite M (SD) -.48 (.51) .44 (.79) 
Covariates 
Delivery of Health Information M (SD) 2.50 (1.32) 2.84 (1.55) 
MI-Spirit M (SD) 3.60 (.68) 4.56 (.46) 
Empathy M (SD) 3.71 (.94) 4.68 (.55) 
Self-Efficacy to Abstain at BL M (SD) 7.32 (3.08) 7.55 (2.93) 
Self-Efficacy to Reduce Use at BL M (SD) 7.52 (2.93) 7.47 (2.77) 
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Table 2: Test of Model Effects – Main Effects Models for BNI and EMI 
 
Hypotheses Condition/Model N 6-month Sig 6-week Sig 
Brief Negotiated Interview 
H1/H4 Enhancing Self-Efficacy 153 .813 .337 
H2/H5 Affirmation .769 .570 
H3/H6 Self-Enhancement Composite .545 .674 
Enhanced Motivational Interview 
H1/H4 Enhancing Self-Efficacy 168 .335 .908 
H2/H5 Affirmation .105 .248 
H3/H6 Self-Enhancement Composite .141 .483 
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Table 3: Test of Model Effects – Interaction Models for BNI and EMI 
 
Hypothesis Condition/Model N 6-month Sig 6-week Sig 
Brief Negotiated Interview 
H7 MI Spirit High*Self-Enh 153 .603 .501 
H8 High S.E. Abstain*Self-Enh 141 .592 .021* 
High S.E. Abstain subsample 63 .909 .657 
Low S.E. Abstain subsample 78 .240 .025* 
H9 High S.E. Reduce*Self-Enh 141 .883 .027* 
High S.E. Reduce subsample 60 .761 .304 
Low S.E. Reduce subsample 81 .619 .086 
H10 Health Info*Affirmation 153 .629 .512 
Enhanced Motivational Interview 
H7 MI Spirit High*Self-Enh 168 .407 .309 
H8 High S.E. Abstain*Self-Enh 156 .082 .273 
High S.E. Abstain subsample 77 .221 .101 
Low S.E. Abstain subsample 79 .265 .589 
H9 High S.E. Reduce*Self-Enh 156 .159 .761 
High S.E. Reduce subsample 70 .581 .376 
Low S.E. Reduce subsample 86 .249 .840 
H10 Health Info*Affirmation 168 .832 .687 
*p<.05; Self-Enh = Self-Enhancement Composite; S.E. = Self-Efficacy (patient report)  
	  	  
97	  
BIBLIOGRAPHY 
Amrhein, P. C., Miller, W. R., Yahne, C. E., Palmer, M., & Fulcher, L. (2003). Client 
commitment language during motivational interviewing predicts drug use outcomes. 
Journal of Consulting and Clinical Psychology, 71, 862-878.  
Apodaca, T. R., & Longabaugh, R. (2009). Mechanisms of change in Motivational Interviewing: 
A review and preliminary evaluation of the evidence. Addiction, 104, 705-715.  
Armitage, C. J., Harris, P. R., & Arden, M. A. (2011). Evidence that self-affirmation reduces 
alcohol consumption: Randomized exploratory trial with a new, brief means of self-
affirming. Health Psychology, 30, 633-641.  
Armitage, C. J., Harris, P. R., Hepton, G., & Napper, L. (2008). Self-affirmation increases 
acceptance of health-risk information among UK adult smokers with low socioeconomic 
status. Psychology of Addictive Behaviors, 22, 88-95.  
Bernstein, E., Bernstein, J., & Levenson, S. (1997). Project ASSERT: An ED-based intervention 
to increase access to primary care, preventive services, and the substance abuse treatment 
system. Annals of Emergency Medicine, 30, 181-189.  
Bernstein, J., Bernstein, E., Tassiopoulos, K., Heereen, T., Levenson, S., & Hingson, R. (2005). 
Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug and 
Alcohol Dependence, 77, 49-59.  
Bertholet, N., Palfai, T., Gaume, J., Daeppen, J., & Saitz, R. (2013). Do motivational 
interventions work like we think they do? Alcoholism: Clinical and Experimental 
Research, 1-7. DOI: 10.1111/acer.12274. 
Bien, T. H., Miller, W. R., & Boroughs, J. M. (1993). Motivational interviewing with alcohol 
outpatients. Behavioural and Cognitive Psychotherapy, 21, 347-356. 
	  	  
98	  
Bien, T. H., Miller, W. R., & Tonigan, J. S. (1993). Brief interventions for alcohol problems: A 
review. Addiction, 88, 315-335.  
Britt, E., Hudson, S. M., & Blampied, N. M. (2004). Motivational interviewing in health settings: 
A review. Patient Education and Counseling, 53, 147-155.  
Burke, B., Arkowitz, H., & Dunn, C. (2002). The efficacy of motivational interviewing and its 
adaptations: What we know so far. In W. R. Miller & S. Rollnick (Eds.), Motivational 
interviewing: Preparing people for change (2nd ed., pp. 217-250). New York: Guildford 
Press.   
Burke, B. L., Arkowitz, H., & Menchola, M. (2003). The efficacy of motivational interviewing: A 
meta-analysis of controlled clinical trials. Journal of Consulting and Clinical Psychology, 
71, 843-861. 
Carroll, K. M., Ball, S. A., Nich, C., Martino, S., Frankforter, T. L., Farentinos, C., et al. (2006). 
Motivational interviewing to improve treatment engagement and outcome in individuals 
seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol 
Dependence, 81, 301-312. 
Cicchetti, D. V. (1994). Guidelines, criteria, and rules of thumb for evaluating normed and 
standardized assessment instruments in psychology. Psychological Assessment, 6, 284-
290.  
Claus, R. E. & Kindleberger, L. R. (2002). Engaging substance abusers after centralized 
assessment: Predictors of treatment entry and dropout. Journal of Psychoactive Drugs, 
34, 25-31. 
Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, 
disability, and comorbidity of DSM-IV drug abuse and dependence in the United States. 
	  	  
99	  
Results from the National Epidemiologic Survey on alcohol and related conditions. 
Archives of General Psychiatry, 64, 566-576.  
Deci, E. L., & Ryan, R. M. (1985). Intrinsic motivation and self-determination in human 
behavior. New York: Plenum. 
Deci, E. L., & Ryan, R. M. (1991). A motivational approach to self: Integration in personality. In 
R. Dienstbier (Ed.), Nebraska Symposium on Motivation: Vol. 38. Perspectives on 
motivation (pp. 237-288). Lincoln: University of Nebraska Press. 
Deci, E. L. & Ryan, R. M. (2012). Self-determination theory in health care and its relations to 
motivational interviewing: A few comments. International Journal of Behavioral 
Nutrition and Physical Activity, 9, 1-6. 
D’Amico, E. J., Miles, J. N. V., Stern, S. A., & Meredith, L. S. (2008). Brief motivational 
interviewing for teens at risk of substance use consequences: A randomized pilot study in 
a primary care clinic. Journal of Substance Abuse Treatment, 35, 53-61.  
Dunn, C., Deroo, L., & Rivara, F. P. (2001). The use of brief interventions adapted from 
motivational interviewing across behavioral domains: A systematic review. Addiction, 
96, 1725-1742.  
Ehrman, R. N. & Robbins, S. J. (1994). Reliability and validity of six-month timeline reports of 
cocaine and heroin use in a methadone population. Journal of Consulting and Clinical 
Psychology, 62, 843–850. 
Emmons, K. M., & Rollnick, S. (2009). Motivational interviewing in health care settings: 
Opportunities and limitations. American Journal of Preventive Medicine, 20, 68-74.  
Gaume, J., Bertholet, N., Faouzi, M., Gmel, G., & Daeppen, J. B. (2013). Does change talk 
during brief motivational interventions with young men predict change in alcohol use? 
Journal of Substance Abuse Treatment, 44, 177-185.   
	  	  
100	  
Gaume, J., Gmel, G., & Daeppen, J. (2008). Brief alcohol interventions: Do counsellors’ and 
patients’ communication characteristics predict change? Alcohol and Alcoholism, 43, 62-
69. 
Gaume, J., Gmel, G., Faouzi, M., & Daeppen, J. B. (2008). Counsellor behaviours and patient 
language during brief motivational interventions: A sequential analysis of speech. 
Addiction, 103, 1793-1800.  
Gaume  J., Gmel, G., Faouzi, M., Daeppen, J. B. (2009). Counselor skill influences outcomes of 
brief motivational interventions. Journal of Substance Abuse Treatment, 37, 151–159. 
Gentilello, L. M., Rivara, F. P., Donovan, D. M., Jurkovich, G. J., Daranciang, E., Dunn, C. W., 
Villaveces, A., Copass, M., & Ries, R. R. (1999). Alcohol interventions in a trauma 
center as a means of reducing the risk of injury recurrence. Annals of Surgery, 230, 473-
483.  
Greenfield, S. F., Brooks, A. J., Gordon, S. M., Green, C. A., Kropp, F., McHugh, R. K., et al. 
(2007). Substance abuse treatment entry, retention, and outcome in women: A review of 
the literature. Drug and Alcohol Dependence, 86, 1-12.  
Harris, P. R., & Epton, T. (2009). The impact of self-affirmation on health cognition, health 
behaviour and other health-related responses: A narrative review. Social and Personality 
Psychology Compass, 3, 962-978.  
Harris, P. R., & Epton, T. (2010). The impact of self-affirmation on health-related cognition and 
health behaviour: Issues and prospects. Social and Personality Psychology Compass, 4, 
439-454.  
Harris, P. R. & Napper, L. (2005). Self-affirmation and the biased processing of threatening 
health-risk information. Personality and Social Psychology Bulletin, 31, 1250-1263.  
Hettema, J., Steele, J., & Miller, W. R. (2005). Motivational interviewing. Annual Review of 
	  	  
101	  
Clinical Psychology, 1, 91–111. 
Humeniuk, R., Ali, R., Babor, T. F., Farrell, M. Formigoni, M. L., Jittiwutikarn, J., et al. (2008). 
Validation of the alcohol, smoking and substance involvement screening test (ASSIST). 
Addiction, 103, 1039-1047.  
Kadden, R. M., & Litt, M. D. (2011). The role of self-efficacy in the treatment of substance use 
disorders. Addictive Behaviors, 36, 1120-1126.   
Karno, M. P., & Longabaugh, R. (2004). What do we know? Process analysis and the search for a 
better understanding of Project MATCH’s anger-by-treatment matching effect. Journal of 
Studies on Alcohol, 65, 501-512.  
Karno, M. P., & Longabaugh, R. (2005). Less directiveness by therapists improves drinking 
outcomes of reactant clients in alcoholism treatment. Journal of Consulting and Clinical 
Psychology, 73, 262-267. 
Kazdin, A. E. (2007). Mediators and mechanisms of change in psychotherapy research. Annual 
Review of Clinical Psychology, 3, 1-27.  
Keijsers, G. P. J., Schaap, C. P. D. R, & Hoogduin, C. A. L. (2000). The impact of interpersonal 
patient and therapist behavior on outcome in cognitive-behavior therapy. Behavior 
Modification, 24, 264-297.  
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and 
comorbidity of DSM-IV disorders in the National Comorbidity Survey Replication. 
Archives of General Psychiatry, 62, 617-627.  
LaBrie, J. W., Pederson, E. R., Earleywine, M., & Olsen, H. (2006). Reducing heavy drinking in 
college males with the decisional balance: Analyzing an element of motivational 
interviewing. Addictive Behaviors, 31, 254-263. 
	  	  
102	  
Lambert, M. J., & Barley, D. E. (2001). Research summary on the therapeutic relationship and 
psychotherapy outcome. Psychotherapy, 38, 357-361.  
Lundahl, B., Moleni, T., Burke, B. L., Butters, R., Tollefson, D., Butler, C., & Rollnick, S. 
(2013). Motivational interviewing in medical care settings: A systematic review and 
meta-analysis of randomized controlled trials. Patient Education and Counseling, 93, 
157-168.    
Madras, B. K., Compton, W. M., Avula, D., Stegbauer, T., Stein, J. B., & Clark, H. W. (2009). 
Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol 
use at multiple healthcare sites: Comparison at intake and 6 months later. Drug and 
Alcohol Dependence, 99, 280-295.  
Markland, D., Ryan, R. M., Tobin, V. J., & Rollnick, S. (2005). Motivational interviewing and 
self-determination theory. Journal of Social and Clinical Psychology, 24, 811-831. 
McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. A. (2000). Drug dependence, a 
chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. 
Journal of the American Medical Association, 284, 1689-1695. 
McNally, A. M., Palfai, T. P. & Kahler, C. W. (2005). Motivational interventions for heavy 
drinking college students: Examining the role of discrepancy-related psychological 
processes. Psychology of Addictive Behaviors, 19, 79-87. 
McQueen, A. & Klein, W. M. P. (2006). Experimental manipulations of self-affirmation: A 
systematic review. Self and Identity, 5, 289-354. 
Miller, W. R., Moyers, T. B., Ernst, D., & Amrhein, P. C. (2003). Manual for the Motivational 
Interviewing Skill Code (MISC) Version 2.1. Retrieved June 13, 2012 from 
http://casaa.unm.edu/download/misc.pdf. 
Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change 
	  	  
103	  
addictive behavior. New York: Guilford Press. 
Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people to change (2nd 
ed.). New York: Guilford Press. 
Miller, W. R., & Rollnick, S. (2012). Meeting in the middle: Motivational interviewing and self-
determination theory. International Journal of Behavioral Nutrition and Physical 
Activity, 9: 25 doi:10.1186/1479-5868-9-25	  
Miller, W. R., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd  ed.). 
New York: Guilford Press. 
Miller, W. R. & Rose, G. S. (2009). Toward a theory of motivational interviewing. American 
Psychologist, 64, 527-537. 
Miller, W. R., Taylor, C. A., & West, J. C. (1980). Focused versus broad spectrum behavior 
therapy for problem drinkers. Journal of Consulting and Clinical Psychology, 48, 590–
601. 
Monti, P. M., Colby, S. M., Barnett, N. P., Spirito, A., & Rohsenow, D. J. (1999). Brief 
intervention for harm reduction with alcohol-positive older adolescents in a hospital 
emergency department. Journal of Consulting and Clinical Psychology, 67, 989-994.  
Morgenstern, J., Kuerbis, A., Amrhein, P., Hail, K., & Lynch, J. R. (2012). Motivational 
Interviewing: A pilot test of active ingredients and mechanisms of change. Psychology of 
Addictive Behaviors, 26, 859-869.  
Morgenstern, J. & McKay, J.R. (2007). Rethinking the paradigms that inform behavioral 
treatment research for substance use disorders. Addiction, 102, 1377-1389.  
Moyers, T. B. & Martin, T. (2006). Therapist influence on client language during motivational 
interviewing sessions. Journal of Substance Abuse Treatment, 30, 245-251.  
	  	  
104	  
Moyers, T. B., Martin, T., Christopher, P. J., Houck, J. M., Tonigan, J. S., & Amrhein, P. C. 
(2007). Client language as a mediator of motivational interviewing efficacy: Where is the 
evidence? Alcoholism: Clinical and Experimental Research, 31, 40S-47S.  
Moyers, T. B., Martin, T., Houck, J. M., Christopher, P. J., Tonigan, J. S. (2009). From in-session 
behaviors to drinking outcomes: A causal chain for motivational interviewing. Journal of 
Consulting and Clinical Psychology, 77, 1113-1124. 
Moyers, T. B., Martin, T., Manuel, J. K., Hendrickson, S. M., & Miller, W. R. (2005). Assessing 
competence in the use of motivational interviewing. Journal of Substance Abuse 
Treatment, 28, 19−26. 
Moyers, T. B., Martin, T., Manual, J. K., Miller, W. R., & Ernst, D. (2012). Motivational 
Interviewing Treatment Integrity 3.1, unpublished manual.  
Moyers, T. B., Miller, W. R., & Hendrickson, S. M. L. (2005). How does motivational 
interviewing work? Therapist interpersonal skill predicts client involvement within 
motivational interviewing sessions. Journal of Consulting and Clinical Psychology, 73, 
590-598.  
Najavits, L. M. & Weiss, R. D. (1994). Variations in therapist effectiveness in the treatment of 
patients with substance use disorders: An empirical review. Addiction, 89, 679-688.  
Napper, L., Harris, P. R., & Epton, T. (2009). Developing and testing a self-affirmation 
manipulation. Self and Identity, 8, 45-62.  
National Institute on Drug Abuse (2012). Drug Facts. Retrieved September 5, 2012 from 
http://www.drugabuse.gov/publications/term/160/DrugFacts  
Noonan, W. C., & Moyers, T. B. (1997). Motivational interviewing: A review. Journal of 
Substance Misuse, 2, 8-16.  
	  	  
105	  
Rohsenow, D. J., Monti, P. M., Martin, R. A., Colby, S. M., Myers, M. G., Gulliver, S. B. et al. 
(2004). Motivational enhancement and coping skills training for cocaine abusers: Effects 
on substance use outcomes. Addiction, 99, 862-874.  
Rounsville, B. J., Petry, N. M., Carroll, K. M. (2003). Single versus multiple drug focus in 
substance abuse clinical trials research. Drug and Alcohol Dependence, 70, 117-125.  
Ryan, R. M. (1995). Psychological needs and the facilitation of integrative processes. Journal of 
Personality, 63, 397-427. 
Ryan, R. M., & Deci, E. L. (2000). Self-determination theory and the facilitation of intrinsic 
motivation, social development, and well-being. American Psychologist, 55, 68-78.  
Saitz, R., Alford, D. P., Bernstein, J., Cheng, D. M., Samet, J., & Palfai, T. (2010). Screening and 
brief intervention for unhealthy drug use in primary care settings: Randomized clinical 
trials are needed. Journal of Addiction Medicine, 4, 123-130.  
Saitz., R., Palfai, T. P. A., Cheng, D. M., Alford, D. P., Bernstein, J. A., Lloyd-Travaglini, C. A., 
et al. (under review). Screening and brief intervention for drug use in primary care: The 
ASPIRE randomized clinical trial.  
Sherman, D. K., & Cohen, G. L. (2006). The psychology of self-defense: Self-affirmation theory. 
In M. Zanna (Ed.) Advances in Experimental Social Psychology (Vol. 38, pp. 183-242.) 
New York: Academic Press.  
Sobell, L. C. & Sobell, M. B. (1980). Convergent validity: An approach to increasing confidence 
in treatment outcome conclusions with alcohol and drug abusers. In: L.C. Sobell, M. B. 
Sobell, & E. Ward, (Eds.), Evaluating Alcohol and Drug Abuse Treatment Effectiveness: 
Recent Advances, (pp. 177–183). New York: Pergamon Press. 
Sobell, M. B. & Sobell, L. C. (1993). Problem drinkers: Guided self-change treatment. New 
York: Guilford Press.  
	  	  
106	  
Steele, C. M. (1988). The psychology of self-affirmation: Sustaining the integrity of the self. In L. 
Berkowitz (Ed.), Advances in Experimental Social Psychology (Vol. 21, pp. 261-302). 
New York: Academic Press. 
Strang, J., & McCambridge, J. (2004). Can the practitioner correctly predict outcome in 
motivational interviewing? Journal of Substance Abuse Treatment, 27, 83-88. 
Vader, A. M., Walters, S. T., Prabhu, G. C., Houck, J. M., & Field, C. A. (2010). The language of 
motivational interviewing and feedback: Counselor language, client language, and client 
drinking outcomes. Psychology of Addictive Behaviors, 24, 190-197.  
VanBuskirk, K. A. & Wetherell, J. L. (2013). Motivational interviewing with primary care 
populations: A systematic review and meta-analysis. Journal of Behavioral Medicine, 
DOI 10.1007/s10865-013-9527-4 
Vansteenkiste, M. & Sheldon, K. M. (2006). There’s nothing more practical than a good theory: 
Integrating motivational interviewing and self-determination theory. British Journal of 
Clinical Psychology, 45, 63-82.  
Vansteenkiste, M., Williams, G. C., Resnicow, K. (2012). Toward systematic integration between 
self-determination theory and motivational interviewing as examples of top-down and 
bottom-up intervention development: Autonomy or volition as a fundamental theoretical 
principle. International Journal of Behavioral Nutrition and Physical Activity, 9, 1-11.  
Winhusen, T., Kropp, F., Babcock, D., Hague, D., Erickson, S. J., Renz, C., et al. (2008). 
Motivational enhancement therapy to improve treatment utilization and outcome in 
pregnant substance users. Journal of Substance Abuse Treatment, 35, 161-173.  
World Health Organization (2012). World Drug Report: Executive Summary (2012). Retrieved 
September 5, 2012 from http://www.unodc.org/documents/data-and-
analysis/WDR2012/Executive_summary_24may.pdf  	    
	  	  
107	  
TABLES 
 
Table 1: Participant Characteristics by Intervention Condition 
 
 BNI 
n=174 
EMI 
n=176 
Demographics 
Age M (SD) 40.0 (12.24) 42.4 (12.06) 
Women n (%) 50 (28.7) 51 (29) 
Race/Ethnicity n (%) -- -- 
African American n (%) 116 (68.2) 126 (72.8) 
Hispanic n (%) 18 (10.6) 11 (6.4) 
White n (%) 32 (18.8) 36 (20.8) 
Other n (%) 4 (2.4) 0 (0) 
Homeless in the past 3 months 24 (13.8) 32 (18.2) 
Married 16 (9.2) 22 (12.5) 
Drug Use 
Drug of Most Concern -- -- 
Opioids n (%) 31 (17.8) 28 (15.9) 
Cocaine n (%) 32 (18.4) 33 (18.8) 
Marijuana n (%) 109 (62.6) 110 (62.5) 
PCP/Amphetamines/Other n (%) 2 (1.1) 5 (2.8) 
Total ASSIST Score M (SD) 21.76 (18.41) 22.07 (18.59) 
ASSIST Score for DOMC M (SD) 16.57 (9.90) 16.60 (8.78) 
Number of Days Drug Use Past 30 
Days at BL M (SD) 
15.11 (11.70) 13.77 (11.24) 
SIP at BL M (SD) 12.05 (13.80) 12.77 (13.72) 
Predictors 
Affirmation M (SD) 2.25 (.76) 3.49 (1.15) 
Enhancing Self-Efficacy M (SD) 2.64 (1.06) 3.56 (1.19) 
Self-Enhancement Composite M (SD) -.48 (.51) .44 (.79) 
Covariates 
Delivery of Health Information M 
(SD) 
2.50 (1.32) 2.84 (1.55) 
MI-Spirit M (SD) 3.60 (.68) 4.56 (.46) 
Empathy M (SD) 3.71 (.94) 4.68 (.55) 
Self-Efficacy to Abstain at BL M (SD) 7.32 (3.08) 7.55 (2.93) 
Self-Efficacy to Reduce Use at BL M 
(SD) 
7.52 (2.93) 7.47 (2.77) 
 
	  	  
108	  
Table 2 : Intercorrelations between Predictors and Covariates Among BNI Participants 
 
 
Variable 1 2 3 4 5 6 7 8 9 10 
1. ASSIST Score for drug of 
most concern 
-- .212** -.344** -.330** .076 .029 .076 -.046 .054 -.081 
2. # of Days Use of DOMC 
in Past 30 Days at BL 
-- -- -.310** -.368** .026 -.032 -.030 -.009 .047 .151 
3. Self-Efficacy to Reduce   -- -- -- .707** .080 .037 .063 .159* .096 .081 
4. Self-Efficacy to Abstain  -- -- -- -- -.026 .000 .011 .097 .036 .080 
5. Global Enhancing Self-
Efficacy 
-- -- -- -- -- .182* .639** .296** .391** -.089 
6. Global Affirmation  -- -- -- -- -- -- .778** .234** .277** -.033 
7. Self-Enhancement 
Composite 
-- -- -- -- -- -- -- .353** .377** -.008 
8.  Global Empathy -- -- -- -- -- -- -- -- .714** .254** 
9. Global Spirit Mean -- -- -- -- -- -- -- -- -- .194* 
10.  Global Health Info -- -- -- -- -- -- -- -- -- -- 
      *p< .05, ** p< .01  
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Table 3 : Intercorrelations between Predictors and Covariates Among EMI Participants 
 
Variable 1 2 3 4 5 6 7 8 9 10 
1. ASSIST Score for drug of 
most concern 
-- .113 -.405** -.347** -.028 -.146 -.126 .078 -.012 -
.270** 
2. # Days Use of DOMC 
Past 30 Days at BL 
-- -- -.083 -.082 .085 .137 .110 .072 .163* .213** 
3. Self-Efficacy to Reduce   -- -- -- .772** .121 .139 .166* -.079 -.022 .139 
4. Self-Efficacy to Abstain  -- -- -- -- .090 .066 .084 -.111 -.075 .082 
5. Global Enhancing Self-
Efficacy 
-- -- -- -- -- .290** .661** .414** .605** .015 
6. Global Affirmation  -- -- -- -- -- -- .816** .311** .463** .042 
7. Self-Enhancement 
Composite 
-- -- -- -- -- -- -- .424** .663** .085 
8.  Global Empathy -- -- -- -- -- -- -- -- .615** .058 
9. Global Spirit Mean -- -- -- -- -- -- -- -- -- .189* 
10.  Global Health Info  -- -- -- -- -- -- -- -- -- -- 
       *p< .05, ** p< .01  
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Table 4: Test of Model Effects – Main Effects Models for BNI and EMI 
 
Hypotheses Condition/Model N 6-month Sig 6-week Sig 
Brief Negotiated Interview 
H1/H4 Enhancing Self-Efficacy 153 .813 .337 
H2/H5 Affirmation .769 .570 
H3/H6 Self-Enhancement 
Composite 
.545 .674 
Enhanced Motivational Interview 
H1/H4 Enhancing Self-Efficacy 168 .335 .908 
H2/H5 Affirmation .105 .248 
H3/H6 Self-Enhancement 
Composite 
.141 .483 
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Table 5: Test of Model Effects – Interaction Models for BNI and EMI 
 
Hypothesis Condition/Model N 6-month Sig 6-week Sig 
Brief Negotiated Interview 
H7 MI Spirit High*Self-Enh 153 .603 .501 
H8 High S.E. Abstain*Self-Enh 141 .592 .021* 
High S.E. Abstain subsample 63 .909 .657 
Low S.E. Abstain subsample 78 .240 .025* 
H9 High S.E. Reduce*Self-Enh 141 .883 .027* 
High S.E. Reduce subsample 60 .761 .304 
Low S.E. Reduce subsample 81 .619 .086 
H10 Health Info*Affirmation 153 .629 .512 
Enhanced Motivational Interview 
H7 MI Spirit High*Self-Enh 168 .407 .309 
H8 High S.E. Abstain*Self-Enh 156 .082 .273 
High S.E. Abstain subsample 77 .221 .101 
Low S.E. Abstain subsample 79 .265 .589 
H9 High S.E. Reduce*Self-Enh 156 .159 .761 
High S.E. Reduce subsample 70 .581 .376 
Low S.E. Reduce subsample 86 .249 .840 
H10 Health Info*Affirmation 168 .832 .687 
    *p<.05; Self-Enh = Self-Enhancement Composite; S.E. = Self-Efficacy (patient report)  
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Table 6 : Main Effects Models for the BNI condition (Hypotheses 1-6) 
 
Brief Negotiated 
Interview 
 
N Sig IRR 95% CI 
Enhancing Self-Efficacy 
6-week 
outcome 
High tertile 153 .433 .857 (.583, 1.260) 
Middle tertile .144 .799 (.591, 1.080) 
6-month 
outcome 
High tertile .891 .965 (.581, 1.602) 
Middle tertile .611 1.113 (.737, 1.680) 
Affirmation 
6-week 
outcome 
High tertile 153 .507 .867 (.569, 1.321) 
Middle tertile .925 1.019 (.692, 1.499) 
6-month 
outcome 
High tertile .521 .829 (.467, 1.470) 
Middle tertile .820 .940 (.551, 1.603) 
Self-Enhancement Composite 
6-week 
outcome 
High tertile 153 .447 .877 (.626, 1.229) 
Middle tertile .442 .882 (.640, 1.215) 
6-month 
outcome 
High tertile .373 .812 (.514, 1.284) 
Middle tertile .890 1.032 (.659, 1.615) 
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Table 7 : Main Effects Models for the EMI condition (Hypotheses 1-6) 
 
Enhanced 
Motivational 
Intervention 
N Sig IRR 95% CI 
Enhancing Self-Efficacy 
6-week 
outcome 
High tertile 168 .726 .916 (.561, 1.497) 
Middle tertile .686 .915 (.596, 1.405) 
6-month 
outcome 
High tertile .761 1.065 (.711, 1.594) 
Middle tertile .160 1.288 (.905, 1.831) 
Affirmation 
6-week 
outcome 
High tertile 168 .683 .896 (.530, 1.515) 
Middle tertile .131 .710 (.456, 1.107) 
6-month 
outcome 
High tertile .677 1.102 (.698, 1.738) 
Middle tertile .171 .767 (.524, 1.122) 
Self-Enhancement Composite 
6-week 
outcome 
High tertile 168 .702 .912 (.569, 1.463) 
Middle tertile .245 .764 (.485, 1.203) 
6-month 
outcome 
High tertile .937 .984 (.658, 1.472) 
Middle tertile .094 .721 (.492, 1.057) 
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Table 8 : Exploration of the Interaction Between Self-Efficacy to Abstain and Self-
Enhancement Composite on 6-week Drug Use Outcomes in the BNI condition 
(Hypothesis 8) 
 
 N Sig IRR 95% CI 
BNI – High Self-Efficacy Subsample 
6-week 
outcome 
Self-Enh High tertile 63 .360 1.296 (.744, 2.259) 
Self-Enh Mid tertile .673 1.138 (.623, 2.080) 
BNI – Low Self-Efficacy Subsample 
6-week 
outcome 
Self-Enh High tertile 78 .007** .584 (.396, .863) 
Self-Enh Mid tertile .115 .749 (.523, 1.073) 
** p<.01; IRR = Incidence Rate Ratio; 95% CI = 95% Confidence Interval; Self-Enh      
= Self-Enhancement Composite 
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Table 9 : Exploration of the Interaction Between Self-Efficacy to Abstain and Self-
Enhancement Composite on 6-month Drug Use Outcomes in the EMI condition 
(Hypothesis 8) 
IRR = Incidence Rate Ratio; 95% CI = 95% Confidence Interval; Self-Enh = Self-
Enhancement Composite   
 N Sig IRR 95% CI 
EMI – High Self-Efficacy Subsample 
6-month 
outcome 
Self-Enh High tertile 77 .227 1.420 (.804, 2.506) 
Self-Enh Mid tertile .776 .931 (.569, 1.523) 
EMI – Low Self-Efficacy Subsample 
6-month 
outcome 
Self-Enh High tertile 79 .104 .589 (.312, 1.114) 
Self-Enh Mid tertile .406 .768 (.413, 1.430) 
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Table 10 : Exploration of the Interaction Between Self-Efficacy to Reduce and Self-
Enhancement Composite on 6-week Drug Use Outcomes in the BNI condition 
(Hypothesis 9) 
 
 N Sig IRR 95% CI 
BNI – High Self-Efficacy Subsample 
6-week 
outcome 
Self-Enh High tertile 60 .608 1.151 (.672, 1.972) 
Self-Enh Mid tertile .137 1.581 (.864, 2.891) 
BNI – Low Self-Efficacy Subsample 
6-week 
outcome 
Self-Enh High tertile 81 .072 .676 (.441, 1.035) 
Self-Enh Mid tertile .047* .680 (.464, .996) 
* p<.05; IRR = Incidence Rate Ratio; 95% CI = 95% Confidence Interval; Self-Enh = 
Self-Enhancement Composite 
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Table 11 : Exploration of the Interaction Between Self-Efficacy to Reduce and Self-
Enhancement Composite on 6-month Drug Use Outcomes in the EMI condition 
(Hypothesis 9) 
 
 N Sig IRR 95% CI 
EMI – High Self-Efficacy Subsample 
6-month 
outcome 
Self-Enh High tertile 70 .561 1.212 (.634, 2.316) 
Self-Enh Mid tertile .822 .937 (.533, 1.647) 
EMI – Low Self-Efficacy Subsample 
6-month 
outcome 
Self-Enh High tertile 86 .112 .634 (.361, 1.113) 
Self-Enh Mid tertile .240 .731 (.433, 1.233) 
IRR = Incidence Rate Ratio; 95% CI = 95% Confidence Interval; Self-Enh = Self-
Enhancement Composite 
  
	  	  
118	  
BIBLIOGRAPHY 
Amrhein, P. C., Miller, W. R., Yahne, C. E., Palmer, M., & Fulcher, L. (2003). Client 
commitment language during motivational interviewing predicts drug use 
outcomes. Journal of Consulting and Clinical Psychology, 71, 862-878.  
Apodaca, T. R., & Longabaugh, R. (2009). Mechanisms of change in Motivational 
Interviewing: A review and preliminary evaluation of the evidence. Addiction, 
104, 705-715.  
Arkowitz, H., Miller, W. R., Westra, H. A., & Rollnick, S. (2008). Motivational 
Interviewing in the treatment of psychological problems: Conclusions and future 
directions. In H., Arkowitz, H. A. Westra, W. R. Miller, & S. Rollnick (Eds.), 
Motivational interviewing in the treatment of psychological problems. New York, 
NY: Guilford. 
Armitage, C. J., Harris, P. R., & Arden, M. A. (2011). Evidence that self-affirmation 
reduces alcohol consumption: Randomized exploratory trial with a new, brief 
means of self-affirming. Health Psychology, 30, 633-641.  
Armitage, C. J., Harris, P. R., Hepton, G., & Napper, L. (2008). Self-affirmation 
increases acceptance of health-risk information among UK adult smokers with 
low socioeconomic status. Psychology of Addictive Behaviors, 22, 88-95.  
Babor, T. F., & Del Boca, F. (2003). Treatment matching in alcoholism. Cambridge: 
Cambridge University Press. 
	  	  
119	  
Baer, J. S., Beadnell, B., Garrett, S. B., Hartzler, B., Wells, E. A., & Peterson, P. L. 
(2008). Adolescent change language within a brief motivational intervention and 
substance use outcomes. Psychology of Addictive Behaviors, 22, 570-575. 
Baird, J., Longabaugh, R., Lee, C. S., Nirenberg, T. D., Woolard, R., Mello, M. J., 
Becker, B., et al. (2007). Treatment completion in a brief motivational 
intervention in the emergency department: The effect of multiple interventions 
and therapists’ behavior. Alcoholism: Clinical and Experimental Research, 31, 
71S-75S.  
Barrowclough, C., Haddock, G., Tarrier, N., Lewis, S. W., Moring, J., O’Brien, R., et al. 
(2001). Randomized controlled trial of motivational interviewing, cognitive 
behavior therapy, and family intervention for patients with comorbid 
schizophrenia and substance use disorders. American Journal of Psychiatry, 158, 
1706-1713.  
Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. 
Psychological Review, 84, 191–215. 
Bandura, A. (1982). Self-efficacy mechanism in human agency. American Psychologist, 
37, 122-147. 
Bandura, A., & Locke, E. A. (2003). Negative self-efficacy and goal effects revisited. 
The Journal of Applied Psychology, 88, 87–99. 
Bem, D. J. (1967). Self-perception: An alternative interpretation of cognitive dissonance 
phenomena. Psychological Review, 74, 183-200. 
Bem, D. J. (1972). Self-perception theory. In L. Berkowitz (Ed.), Advances in 
	  	  
120	  
experimental social psychology. New York: Academic Press. 
Berman, A. H., Forsberg, L., Durbeej, N., Kallmen, H., & Hermansson, U. (2010). 
Single-session motivational interviewing for drug detoxification inpatients: 
Effects on self-efficacy, stages of change, and substance use. Substance Use and 
Misuse, 45, 384-402.   
Bernstein, E., Bernstein, J., & Levenson, S. (1997). Project ASSERT: An ED-based 
intervention to increase access to primary care, preventive services, and the 
substance abuse treatment system. Annals of Emergency Medicine, 30, 181-189.  
Bernstein, J., Bernstein, E., Tassiopoulos, K., Heereen, T., Levenson, S., & Hingson, R. 
(2005). Brief motivational intervention at a clinic visit reduces cocaine and heroin 
use. Drug and Alcohol Dependence, 77, 49-59.  
Bertholet, N., Cheng, D. M., Palfai, T. P., Samet, J. H., & Saitz, R. (2009). Does 
readiness to change predict subsequent alcohol consumption in medical inpatients 
with unhealthy alcohol use? Addictive Behaviors, 24, 636-640.  
Bertholet, N., Palfai, T., Gaume, J., Daeppen, J., & Saitz, R. (2013). Do motivational 
interventions work like we think they do? Alcoholism: Clinical and Experimental 
Research, 1-7. DOI: 10.1111/acer.12274. 
Bien, T. H., Miller, W. R., & Boroughs, J. M. (1993). Motivational interviewing with 
alcohol outpatients. Behavioural and Cognitive Psychotherapy, 21, 347-356. 
Bien, T. H., Miller, W. R., & Tonigan, J. S. (1993). Brief interventions for alcohol 
problems: A review. Addiction, 88, 315-335.  
Boardman, T., Catley, D., Grobe, J. E., Little, T. D. & Ahluwalia, J. S. (2006). Using 
	  	  
121	  
motivational interviewing with smokers: Do therapist behaviors relate to 
engagement and therapeutic alliance? Journal of Substance Abuse Treatment, 31, 
329-339.  
Borsari B., & Carey, K. B. (2000). Effects of a brief motivational intervention with 
college student drinkers. Journal of Consulting and Clinical Psychology, 68, 728-
733. 
Borsari, B., Carey, K. B. (2005). Two brief alcohol interventions for mandated college 
students. Psychology of Addictive Behaviors, 19, 296-302. 
Britt, E., Hudson, S. M., & Blampied, N. M. (2004). Motivational interviewing in health 
settings: A review. Patient Education and Counseling, 53, 147-155.  
Brown, J. M., & Miller, W. R. (1993). Impact of motivational interviewing on 
participation and outcome in residential alcoholism treatment. Psychology of 
Addictive Behaviors, 7, 211-218.  
Budney, A. J., Higgins, S. T., Radonovich, K. J.,  & Novy, P. L. (2000). Adding voucher-
based incentives to coping skills and motivational enhancement improves 
outcomes during treatment for marijuana dependence. Journal of Consulting and 
Clinical Psychology, 68, 1051-1061.  
Burke, B., Arkowitz, H., & Dunn, C. (2002). The efficacy of motivational interviewing 
and its adaptations: What we know so far. In W. R. Miller & S. Rollnick (Eds.), 
Motivational interviewing: Preparing people for change (2nd ed., pp. 217-250). 
New York: Guildford Press.   
	  	  
122	  
Burke, B. L., Arkowitz, H., & Menchola, M. (2003). The efficacy of motivational 
interviewing: A meta-analysis of controlled clinical trials. Journal of Consulting 
and Clinical Psychology, 71, 843-861. 
Burlew, A. K., Montgomery, L., Kosinski, A. S., & Forcehimes, A. A. (2013). Does 
treatment readiness enhance the response of African American substance users to 
motivational enhancement therapy? Psychology of Addictive Behaviors, 27, 744-
753.  
Carroll, K. M., Ball, S. A., Nich, C., Martino, S., Frankforter, T. L., Farentinos, C., et al. 
(2006). Motivational interviewing to improve treatment engagement and outcome 
in individuals seeking treatment for substance abuse: A multisite effectiveness 
study. Drug and Alcohol Dependence, 81, 301-312. 
Chen, S. M., Creedy, D., Lin, H. S., & Wollin, J. (2012). Effects of motivational 
interviewing on self-management, psychological and glycemic outcomes in type 2 
diabetes: A randomized controlled trial. International Journal of Nursing Studies, 
49, 637-644.  
Cherpitel, C. J. (2003). Changes in substance use associated with emergency room and 
primary care services utilization in the United States general population: 1995-
2000. American Journal of Drug and Alcohol Abuse, 29, 789-802.  
Cicchetti, D. V. (1994). Guidelines, criteria, and rules of thumb for evaluating normed 
and standardized assessment instruments in psychology. Psychological 
Assessment, 6, 284-290.  
	  	  
123	  
Claus, R. E. & Kindleberger, L. R. (2002). Engaging substance abusers after centralized 
assessment: Predictors of treatment entry and dropout. Journal of Psychoactive 
Drugs, 34, 25-31. 
Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd Edition. 
Hillside, NJ: Lawrence Erlbaum Associates. 
Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, 
correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in 
the United States. Results from the National Epidemiologic Survey on alcohol and 
related conditions. Archives of General Psychiatry, 64, 566-576.  
Cupertino, A. P., Berg, C., Gajewski, B., Hui, S. K. A., Richter, K., Catley, D., et al. 
(2011). Change in self-efficacy, autonomous and controlled motivation predicting 
smoking. Journal of Health Psychology, 17, 640-652.  
Daeppen J. B., Bertholet, N., Gmel, G., & Gaume J. (2007).  Communication during brief 
intervention, intention to change, and outcome. Substance Abuse, 28, 43–51. 
Deci, E. L., & Ryan, R. M. (1985). Intrinsic motivation and self-determination in human 
behavior. New York: Plenum. 
Deci, E. L., & Ryan, R. M. (1991). A motivational approach to self: Integration in 
personality. In R. Dienstbier (Ed.), Nebraska Symposium on Motivation: Vol. 38. 
Perspectives on motivation (pp. 237-288). Lincoln: University of Nebraska Press. 
Deci, E. L. & Ryan, R. M. (2012). Self-determination theory in health care and its 
relations to motivational interviewing: A few comments. International Journal of 
Behavioral Nutrition and Physical Activity, 9, 1-6. 
	  	  
124	  
De Micheli, D., Fisberg, M., Formigoni, M. L. (2004). Study on the effectiveness of brief 
intervention for alcohol and other drug use directed to adolescents in a primary 
care unit. Revista da Associacao Medica Brasileira, 50, 305-313.  
DiClemente, C., Carroll, K. M., Miller, W. R., Connors, G. J., & Donovan, D. M. (2003). 
A look inside treatment: Therapist effects, the therapeutic alliance and the process 
of intentional behavior change. In T. Babor & F. Del Boca (eds.), Treatment 
matching in alcoholism (pp. 166–183). Cambridge: Cambridge University press. 
DiClemente, C. C. & Velasquez, M. M. (2002). Motivational Interviewing and the Stages 
of Change. In W. R. Miller & S. Rollnick (Eds.), Motivational interviewing: 
Preparing people for change (2nd ed., pp. 217-250). New York: Guildford Press.   
D’Amico, E. J., Miles, J. N. V., Stern, S. A., & Meredith, L. S. (2008). Brief motivational 
interviewing for teens at risk of substance use consequences: A randomized pilot 
study in a primary care clinic. Journal of Substance Abuse Treatment, 35, 53-61.  
Dimeff, L. A., Baer, J. S., Kivlahan, D. R., & Marlatt, A. G. (1999). Brief alcohol 
screening and intervention for college students: A harm reduction approach. New 
York: Guilford Press.  
Dunn, C., Deroo, L., & Rivara, F. P. (2001). The use of brief interventions adapted from 
motivational interviewing across behavioral domains: A systematic review. 
Addiction, 96, 1725-1742.  
Ehrman, R. N. & Robbins, S. J. (1994). Reliability and validity of six-month timeline 
reports of cocaine and heroin use in a methadone population. Journal of 
Consulting and Clinical Psychology, 62, 843–850. 
	  	  
125	  
Emmons, K. M., & Rollnick, S. (2009). Motivational interviewing in health care settings: 
Opportunities and limitations. American Journal of Preventive Medicine, 20, 68-
74.  
Epton, T. & Harris, P. R. (2008). Self-affirmation promotes health behavior change. 
Health Psychology, 27, 746-752.  
Festinger, L. (1957). A theory of cognitive dissonance. Evanston, IL: Row, Peterson, and 
Company.  
Gaume, J., Bertholet, N., Faouzi, M., Gmel, G., & Daeppen, J. B. (2013). Does change 
talk during brief motivational interventions with young men predict change in 
alcohol use? Journal of Substance Abuse Treatment, 44, 177-185.   
Gaume, J., Gmel, G., & Daeppen, J. (2008). Brief alcohol interventions: Do counsellors’ 
and patients’ communication characteristics predict change? Alcohol and 
Alcoholism, 43, 62-69. 
Gaume, J., Gmel, G., Faouzi, M., & Daeppen, J. B. (2008). Counsellor behaviours and 
patient language during brief motivational interventions: A sequential analysis of 
speech. Addiction, 103, 1793-1800.  
Gaume  J., Gmel, G., Faouzi, M., Daeppen, J. B. (2009). Counselor skill influences 
outcomes of brief motivational interventions. Journal of Substance Abuse 
Treatment, 37, 151–159. 
Gentilello, L. M., Rivara, F. P., Donovan, D. M., Jurkovich, G. J., Daranciang, E., Dunn, 
C. W., Villaveces, A., Copass, M., & Ries, R. R. (1999). Alcohol interventions in 
	  	  
126	  
a trauma center as a means of reducing the risk of injury recurrence. Annals of 
Surgery, 230, 473-483.  
Glynn, L. H. & Moyers, T. B. (2010). Chasing change talk: The clinician’s role in 
evoking client language about change. Journal of Substance Abuse Treatment, 39, 
65-70.  
Greenfield, S. F., Brooks, A. J., Gordon, S. M., Green, C. A., Kropp, F., McHugh, R. K., 
et al. (2007). Substance abuse treatment entry, retention, and outcome in women: 
A review of the literature. Drug and Alcohol Dependence, 86, 1-12.  
Hallgren, K. A., & Moyers, T. B. (2011). Does readiness to change predict in-session 
motivational language? Correspondence between two conceptualizations of client 
motivation. Addiction, 106, 1261–1269.  
Hardcastle, S., Blake, N., & Hagger, M. A. (2012). The effectiveness of a motivational 
interviewing primary-care based intervention on physical activity and predictors 
of change in a disadvantaged community. Journal of Behavioral Medicine, 35, 
318-333. 
Harris, P. R., & Epton, T. (2009). The impact of self-affirmation on health cognition, 
health behaviour and other health-related responses: A narrative review. Social 
and Personality Psychology Compass, 3, 962-978.  
Harris, P. R., & Epton, T. (2010). The impact of self-affirmation on health-related 
cognition and health behaviour: Issues and prospects. Social and Personality 
Psychology Compass, 4, 439-454.  
Harris, P. R., Mayle, K., Mabbott, L. & Napper, L. (2007). Self-affirmation reduces 
	  	  
127	  
smokers’ defensiveness to graphic on-pack cigarette warning labels. Health 
Psychology, 26, 434-446. 
Harris, P. R. & Napper, L. (2005). Self-affirmation and the biased processing of 
threatening health-risk information. Personality and Social Psychology Bulletin, 
31, 1250-1263.  
Heather, N. (1995). Brief intervention strategies. In: R. K. Hester, & W. R. Miller, (Eds.) 
Handbook of alcoholism treatment approaches: Effective alternatives. Needham 
Heights, MA: Allyn and Bacon. 
Heather, N. (2014). Toward an understanding of the effective mechanisms of alcohol 
brief interventions. Alcoholism: Clinical and Experimental Research, DOI: 
10.1111/acer.12336. 
Heather, N., & McCambridge, J. (2013). Post-treatment stage of change predicts 12-
month outcome of treatment for alcohol problems. Alcohol and Alcoholism, 48, 
329-336.  
Heather, N., Rollnick, S., Bell, A., & Richmond, R. (1996). Effects of brief counseling 
among heavy drinkers identified on general hospital wards. Drug & Alcohol 
Review, 15, 29-38.  
Hettema, J., Steele, J., & Miller, W. R. (2005). Motivational interviewing. Annual Review 
of Clinical Psychology, 1, 91–111. 
Houck, J. M., Moyers, T. B., Miller, W. M., Glynn, L. H., & Hallgren, K. A. (2012). 
Motivational interviewing skill coding 2.5, unpublished manual. 
Humeniuk, R., Ali, R., Babor, T. F., Farrell, M. Formigoni, M. L., Jittiwutikarn, J., et al. 
	  	  
128	  
(2008). Validation of the alcohol, smoking and substance involvement screening 
test (ASSIST). Addiction, 103, 1039-1047.  
Humeniuk, R., Ali, R., Babor, T., Souza-Formigoni, M. L. O., Boerngen de Lacerda, R., 
Ling, W., et al. (2012). A randomized controlled trial of a brief intervention for 
illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening 
Test (ASSIST) in clients recruited from primary health-care settings in four 
countries. Addiction, 107, 957-966.  
Institute of Medicine (1990). Broadening the base of treatment for alcohol problems. 
Washington, DC: National Academy Press.  
Jemmot, J. B., Ditto, P. H., & Croyle, R. T. (1986). Judging health status: Effects of 
perceived prevalence and personal relevance. Journal of Personality and Social 
Psychology, 50, 899-905. 
Jessop, D. C., Simmonds, L. V., & Sparks, P. (2009). Motivational and behavioural 
consequences of self-affirmation interventions: A study of sunscreen use among 
women. Psychology and Health, 24, 529-544.  
Juarez, P., Walters, S. T., Daugherty, M. & Radi, C. (2006). A randomized trial of 
motivational interviewing and feedback with heavy drinking college students. 
Journal of Drug Education, 36, 233-246.  
Kadden, R. M., & Litt, M. D. (2011). The role of self-efficacy in the treatment of 
substance use disorders. Addictive Behaviors, 36, 1120-1126.   
	  	  
129	  
Karno, M. P., Beutler, L. E., & Harwood, T. M. (2002). Interactions between 
psychotherapy procedures and patient attributes that predict alcohol treatment 
effectiveness: A preliminary report. Addictive Behaviors, 27, 779-797.  
Karno, M. P., & Longabaugh, R. (2004). What do we know? Process analysis and the 
search for a better understanding of Project MATCH’s anger-by-treatment 
matching effect. Journal of Studies on Alcohol, 65, 501-512.  
Karno, M. P., & Longabaugh, R. (2005). Less directiveness by therapists improves 
drinking outcomes of reactant clients in alcoholism treatment. Journal of 
Consulting and Clinical Psychology, 73, 262-267. 
Kazdin, A. E. (2007). Mediators and mechanisms of change in psychotherapy research. 
Annual Review of Clinical Psychology, 3, 1-27.  
Keijsers, G. P. J., Schaap, C. P. D. R, & Hoogduin, C. A. L. (2000). The impact of 
interpersonal patient and therapist behavior on outcome in cognitive-behavior 
therapy. Behavior Modification, 24, 264-297.  
Kessler, R. C. (2004). Impact of substance abuse on the diagnosis, course, and treatment 
of mood disorders: The epidemiology of dual diagnosis. Biological Psychiatry, 
56, 730-737.  
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, 
and comorbidity of DSM-IV disorders in the National Comorbidity Survey 
Replication. Archives of General Psychiatry, 62, 617-627.  
Kuerbis, A., Armeli, S., Muench, F., & Morgenstern, J. (2013). Motivation and self-
efficacy in the context of moderated drinking: Global self-report and ecological 
	  	  
130	  
momentary assessment. Psychology of Addictive Behaviors, 27, 934-943.  
Kunda, Z. (1987). Motivation and inference: Self-serving generation and evaluation of 
evidence. Journal of Experimental Social Psychology, 25, 272-285. 
LaBrie, J. W., Pederson, E. R., Earleywine, M., & Olsen, H. (2006). Reducing heavy 
drinking in college males with the decisional balance: Analyzing an element of 
motivational interviewing. Addictive Behaviors, 31, 254-263. 
LaChance, H., Ewing, S. W. F., Bryan, A. D., & Hutchison, K. E. (2009). What makes 
group MET work? A randomized controlled trial of college student drinkers in 
mandated alcohol diversion. Psychology of Addictive Behaviors, 23, 598–612. 
Lambert, M. J., & Barley, D. E. (2001). Research summary on the therapeutic 
relationship and psychotherapy outcome. Psychotherapy, 38, 357-361.  
Leshner, A. I. (1997). Addiction is a brain disease, and it matters. Science, 278, 45-47. 
Longabaugh, R. (2007). The search for mechanisms of change in behavioral treatments 
for alcohol use disorders: A commentary. Alcoholism: Clinical and Experimental 
Research, 31, 21S-32S. 
Longabaugh, R., & Magill, M. (2011). Recent advances in behavioral addiction 
treatments: Focusing on mechanisms of change. Current Psychiatry Reports, 13, 
382–389.  
Longshore, D., Grills, C., & Annon, K. (1999). Effects of a culturally congruent 
intervention on cognitive factors related to drug-use recovery. Substance Use and 
Misuse, 34, 1223-1241. 
Lundahl, B., Moleni, T., Burke, B. L., Butters, R., Tollefson, D., Butler, C., & Rollnick, 
	  	  
131	  
S. (2013). Motivational interviewing in medical care settings: A systematic 
review and meta-analysis of randomized controlled trials. Patient Education and 
Counseling, 93, 157-168.    
Madras, B. K., Compton, W. M., Avula, D., Stegbauer, T., Stein, J. B., & Clark, H. W. 
(2009). Screening, brief interventions, referral to treatment (SBIRT) for illicit 
drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 
months later. Drug and Alcohol Dependence, 99, 280-295.  
Magill, M., Apodaca, T. R., Barnett, N. P., & Monti, P. M. (2010). The route to change: 
Within-session predictors of change plan completion in a motivational interview. 
Journal of Substance Abuse Treatment, 38, 299-305.  
Magill, M., Stout, R. L., & Apodaca, T. R. (2013). Therapist focus on ambivalence and 
commitment: A longitudinal analysis of motivational interviewing treatment 
ingredients. Psychology of Addictive Behaviors, 27, 754-762.  
Markland, D., Ryan, R. M., Tobin, V. J., & Rollnick, S. (2005). Motivational 
interviewing and self-determination theory. Journal of Social and Clinical 
Psychology, 24, 811-831. 
Marlatt, G. A., Baer, J. S., Kivlahan, D. R., Dimeff, L. A., Larimer, M. E., Quigley, L. A. 
et al. (1998). Screening and brief intervention for high-risk college student 
drinkers: Results from a 2-year follow-up assessment. Journal of Consulting and 
Clinical Psychology, 66, 604-615.  
McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. A. (2000). Drug dependence, 
a chronic medical illness: Implications for treatment, insurance, and outcomes 
	  	  
132	  
evaluation. JAMA:  The Journal of the American Medical Association, 284, 1689-
1695. 
McNally, A. M., Palfai, T. P. & Kahler, C. W. (2005). Motivational interventions for 
heavy drinking college students: Examining the role of discrepancy-related 
psychological processes. Psychology of Addictive Behaviors, 19, 79-87. 
McQueen, A. & Klein, W. M. P. (2006). Experimental manipulations of self-affirmation: 
A systematic review. Self and Identity, 5, 289-354. 
Miller, W. R. (1983). Motivational interviewing with problem drinkers. Behavioural 
Psychotherapy, 11, 147-172.  
Miller, W. R., Benefield, R. G., & Tonigan, J. S. (1993). Enhancing motivation for 
change in problem drinking: A controlled comparison of two therapist styles. 
Journal of Consulting and Clinical Psychology, 61, 455-461.  
Miller, W. R., Moyers, T. B., Ernst, D., & Amrhein, P. C. (2003). Manual for the 
Motivational Interviewing Skill Code (MISC) Version 2.1. Retrieved June 13, 
2012 from http://casaa.unm.edu/download/misc.pdf. 
Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to 
change addictive behavior. New York: Guilford Press. 
Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people to 
change (2nd ed.). New York: Guilford Press. 
Miller, W. R., & Rollnick, S. (2012). Meeting in the middle: Motivational interviewing 
and self-determination theory. International Journal of Behavioral Nutrition and 
Physical Activity, 9: 25 doi:10.1186/1479-5868-9-25	  
	  	  
133	  
Miller, W. R., & Rollnick, S. (2013). Motivational interviewing: Helping people change 
(3rd  ed.). New York: Guilford Press. 
Miller, W. R. & Rose, G. S. (2009). Toward a theory of motivational interviewing. 
American Psychologist, 64, 527-537. 
Miller, W. R., Sovereign, R. G., & Krege, B. (1988). Motivational interviewing with 
problem drinkers: II. The Drinker’s Check-Up as a preventive intervention. 
Behavioural Psychotherapy, 16, 251-268.  
Miller, W. R., Taylor, C. A., & West, J. C. (1980). Focused versus broad spectrum 
behavior therapy for problem drinkers. Journal of Consulting and Clinical 
Psychology, 48, 590–601. 
Miller, W. R., Yahne, C. E., & Tonigan, J. S. (2003). Motivational interviewing in drug 
abuse services: A randomized trial. Journal of Consulting and Clinical 
Psychology, 71, 754-763.  
Moore, A. A., Beck, J. C., Babor, T. F., Hays, R. D., & Reuben, D. B. (2002). Beyond 
alcoholism: Identifying older, at-risk drinkers in primary care. Journal of Studies 
on Alcohol, 63, 316-324.  
Monti, P. M., Colby, S. M., Barnett, N. P., Spirito, A., & Rohsenow, D. J. (1999). Brief 
intervention for harm reduction with alcohol-positive older adolescents in a 
hospital emergency department. Journal of Consulting and Clinical Psychology, 
67, 989-994.  
Morgenstern, J., Kuerbis, A., Amrhein, P., Hail, K., & Lynch, J. R. (2012). Motivational 
Interviewing: A pilot test of active ingredients and mechanisms of change. 
	  	  
134	  
Psychology of Addictive Behaviors, 26, 859-869.  
Morgenstern, J. & McKay, J.R. (2007). Rethinking the paradigms that inform behavioral 
treatment research for substance use disorders. Addiction, 102, 1377-1389.  
Moyers, T. B. & Martin, T. (2006). Therapist influence on client language during 
motivational interviewing sessions. Journal of Substance Abuse Treatment, 30, 
245-251.  
Moyers, T. B., Martin, T., Christopher, P. J., Houck, J. M., Tonigan, J. S., & Amrhein, P. 
C. (2007). Client language as a mediator of motivational interviewing efficacy: 
Where is the evidence? Alcoholism: Clinical and Experimental Research, 31, 
40S-47S.  
Moyers, T. B., Martin, T., Houck, J. M., Christopher, P. J., Tonigan, J. S. (2009). From 
in-session behaviors to drinking outcomes: A causal chain for motivational 
interviewing. Journal of Consulting and Clinical Psychology, 77, 1113-1124. 
Moyers, T. B., Martin, T., Manuel, J. K., Hendrickson, S. M., & Miller, W. R. (2005). 
Assessing competence in the use of motivational interviewing. Journal of 
Substance Abuse Treatment, 28, 19−26. 
Moyers, T. B., Martin, T., Manual, J. K., Miller, W. R., & Ernst, D. (2012). Motivational 
Interviewing Treatment Integrity 3.1, unpublished manual.  
Moyers, T. B., Miller, W. R., & Hendrickson, S. M. L. (2005). How does motivational 
interviewing work? Therapist interpersonal skill predicts client involvement 
within motivational interviewing sessions. Journal of Consulting and Clinical 
Psychology, 73, 590-598.  
	  	  
135	  
Najavits, L. M. & Weiss, R. D. (1994). Variations in therapist effectiveness in the 
treatment of patients with substance use disorders: An empirical review. 
Addiction, 89, 679-688.  
Napper, L., Harris, P. R., & Epton, T. (2009). Developing and testing a self-affirmation 
manipulation. Self and Identity, 8, 45-62.  
National Association of Public Hospitals and Health Systems (2013). What is a Safety 
Net Hospital? Retrieved March 14, 2013 from  
http://www.naph.org/Main-Menu-Category/About-NAPH/About-Our-
Members/what-is-a-safety-net-hospital.aspx 
National Institute on Drug Abuse (2012). Drug Facts. Retrieved September 5, 2012 from 
http://www.drugabuse.gov/publications/term/160/DrugFacts  
Noonan, W. C., & Moyers, T. B. (1997). Motivational interviewing: A review. Journal of 
Substance Misuse, 2, 8-16.  
Project MATCH Research Group. (1997). Matching alcoholism treatments to client 
heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of 
Studies on Alcohol, 58, 7–29. 
Reed, M. B., & Aspinwall, L. G. (1998). Self-affirmation reduces biased processing 
of health-risk information. Motivation and Emotion, 22, 99-132. 
Rogers, C. R. (1959). A theory of therapy, personality, and interpersonal relationships as 
developed in the client-centered framework. In S. Koch (Ed.), Psychology: The 
study of a science: Volume 3. Formulations of the person and the social context 
(pp. 184-256). New York: McGraw-Hill.  
	  	  
136	  
Rohsenow, D. J., Monti, P. M., Martin, R. A., Colby, S. M., Myers, M. G., Gulliver, S. B. 
et al. (2004). Motivational enhancement and coping skills training for cocaine 
abusers: Effects on substance use outcomes. Addiction, 99, 862-874.  
Rounsville, B. J., Petry, N. M., Carroll, K. M. (2003). Single versus multiple drug focus 
in substance abuse clinical trials research. Drug and Alcohol Dependence, 70, 
117-125.  
Ryan, R. M. (1995). Psychological needs and the facilitation of integrative processes. 
Journal of Personality, 63, 397-427. 
Ryan, R. M., & Deci, E. L. (2000). Self-determination theory and the facilitation of 
intrinsic motivation, social development, and well-being. American Psychologist, 
55, 68-78.  
Saitz, R., Alford, D. P., Bernstein, J., Cheng, D. M., Samet, J., & Palfai, T. (2010). 
Screening and brief intervention for unhealthy drug use in primary care settings: 
Randomized clinical trials are needed. Journal of Addiction Medicine, 4, 123-130.  
Saitz., R., Palfai, T. P. A., Cheng, D. M., Alford, D. P., Bernstein, J. A., Lloyd-
Travaglini, C. A., et al. (under review). Screening and brief intervention for drug 
use in primary care: The ASPIRE randomized clinical trial.  
Shaikh, A. R., Vinokur, A. D., Yaroch, A. L., Williams, G. C., & Resnicow, K. (2011). 
Direct and mediated effects of two theoretically based interventions to increase 
consumption of fruits and vegetables in the Healthy Body Healthy Spirit trial. 
Health Education and Behavior, 38, 492-501.  
Sheldon, K. M., Joiner, T., & Williams, G. (2003). Motivating health: Applying self-
	  	  
137	  
determination theory in the clinic. New Haven: Yale University Press.  
Sherman, D. K., & Cohen, G. L. (2006). The psychology of self-defense: Self-affirmation 
theory. In M. Zanna (Ed.) Advances in Experimental Social Psychology (Vol. 38, 
pp. 183-242.) New York: Academic Press.  
Sherman, D. K., & Hartson, K. A. (2011). Reconciling self-protection with self-
improvement: Self-affirmation theory. In M. D. Alicke & C. Sedikides (Eds.). 
Handbook of Self-Enhancement and Self-Protection (pp. 128-154). Guilford 
Press: New York.  
Sherman, D. A., Nelson, L. D., & Steele, C. M. (2000). Do messages about health risks 
threaten the self? Increasing the acceptance of threatening health messages via 
self affirmation. Personality and Social Psychology Bulletin, 26, 1046 – 1058. 
Sobell, L. C. & Sobell, M. B. (1980). Convergent validity: An approach to increasing 
confidence in treatment outcome conclusions with alcohol and drug abusers. In: 
L.C. Sobell, M. B. Sobell, & E. Ward, (Eds.), Evaluating Alcohol and Drug 
Abuse Treatment Effectiveness: Recent Advances, (pp. 177–183). New York: 
Pergamon Press. 
Sobell, M. B. & Sobell, L. C. (1993). Problem drinkers: Guided self-change treatment. 
New York: Guilford Press.  
Stapel, D. A., & van der Linde, L. A. J. G. (2011). What drives self-affirmation effects? 
On the importance of differentiating value affirmation and attribute affirmation. 
Journal of Personality and Social Psychology, 101, 34-45. 
	  	  
138	  
Steele, C. M. (1988). The psychology of self-affirmation: Sustaining the integrity of the 
self. In L. Berkowitz (Ed.), Advances in Experimental Social Psychology (Vol. 
21, pp. 261-302). New York: Academic Press. 
Strang, J., & McCambridge, J. (2004). Can the practitioner correctly predict outcome in 
motivational interviewing? Journal of Substance Abuse Treatment, 27, 83-88. 
Taylor, S. E. & Brown, J. D. (1988). Illusion and well-being: A social psychological 
perspective on mental health. Psychological Bulletin, 103, 193-210.  
UKATT Research Team. (2005). Effectiveness of treatment for alcohol problems: 
Findings of the randomized UK Alcohol Treatment Trial (UKATT). British 
Medical Journal, 331, 544-548.  
Vader, A. M., Walters, S. T., Prabhu, G. C., Houck, J. M., & Field, C. A. (2010). The 
language of motivational interviewing and feedback: Counselor language, client 
language, and client drinking outcomes. Psychology of Addictive Behaviors, 24, 
190-197.  
Valle, S. K. (1981). Interpersonal functioning of alcoholism counselors and treatment 
outcome. Journal of Studies on Alcohol, 42, 783–790. 
VanBuskirk, K. A. & Wetherell, J. L. (2013). Motivational interviewing with primary 
care populations: A systematic review and meta-analysis. Journal of Behavioral 
Medicine, DOI 10.1007/s10865-013-9527-4 
van Koningsbruggen, G., & Das, E. (2009). Don’t derogate this message! Self-
affirmation promotes online Type 2 diabetes risk test taking. Psychology & 
Health, 24, 635-649.  
	  	  
139	  
Vansteenkiste, M. & Sheldon, K. M. (2006). There’s nothing more practical than a good 
theory: Integrating motivational interviewing and self-determination theory. 
British Journal of Clinical Psychology, 45, 63-82.  
Vansteenkiste, M., Williams, G. C., Resnicow, K. (2012). Toward systematic integration 
between self-determination theory and motivational interviewing as examples of 
top-down and bottom-up intervention development: Autonomy or volition as a 
fundamental theoretical principle. International Journal of Behavioral Nutrition 
and Physical Activity, 9, 1-11.  
Villanueva, M., Tonigan, J. S., & Miller, W. R. (2007). Response of Native American 
clients to three treatment methods for alcohol dependence. Journal of Ethnicity in 
Substance Abuse, 6, 41–48. 
Wagner, C. C. & Sanchez, F. P. (2002). The role of values in motivational interviewing. 
In W. R. Miller & S. Rollnick (Eds.), Motivational interviewing: Preparing 
people for change (2nd ed., pp. 284-298). New York: Guildford Press.   
Walpole, B., Dettmer, E., Morrongiello, B., McCrindle, B., & Hamilton, J. (2011). 
Motivational interviewing as an intervention to increase adolescent self-efficacy 
and promote weight loss: Methodology and design. BMC Public Health, 11, 459-
467. 
Westra, H. A., & Aviram, A. (2013). Core skills in motivational interviewing. 
Psychotherapy, 50, 273-278.  
Williams, G. C., McGregor, H. A., Sharp, D., Levesque, C., Kouides, R. W., Ryan, R. 
M., et al., (2006). Testing a self-determination theory intervention for motivating 
	  	  
140	  
tobacco cessation: Supporting autonomy and competence in a clinical trial. Health 
Psychology, 25, 91-101.  
Winhusen, T., Kropp, F., Babcock, D., Hague, D., Erickson, S. J., Renz, C., et al. (2008). 
Motivational enhancement therapy to improve treatment utilization and outcome 
in pregnant substance users. Journal of Substance Abuse Treatment, 35, 161-173.  
World Health Organization (2012). World Drug Report: Executive Summary (2012). 
Retrieved September 5, 2012 from http://www.unodc.org/documents/data-and-
analysis/WDR2012/Executive_summary_24may.pdf   
 
 
 
 
	  	  
141	  
CURRICULUM VITAE 
 
Leslie Wright, M.A. 
wrightl@bu.edu 
Address:        
648 Beacon Street, 4th floor 
Boston, MA 02215 
C: (908) 565-1545         
 
EDUCATION: 
 Boston University Graduate School of Arts and Sciences, Boston, MA 
 Doctoral Candidate 
Clinical Psychology  
 Addictive Behaviors Research Program 
 Master of Arts : May, 2009 
 Anticipated Graduation Date : September, 2014 
 
Dissertation title: Enhancing Brief Motivational Interventions for Substance Use: 
Examining the Influence of Affirmation and Self-Efficacy Strategies on Drug Use 
Outcomes in Primary Care. 
Dissertation Defense : May 21, 2014 
 
Barnard College, Columbia University, New York, NY  
 Bachelor of Arts : May 2004, cum laude 
 Majors: Psychology and Political Science 
 Dean’s List 2000-2004 
 
CLINICAL EXPERIENCE: 
 
Boston Consortium in Clinical Psychology, VA Boston Healthcare System  
Boston, MA 
Psychology Intern, PTSD-SUD Dual Diagnosis rotation ; Inpatient rotation  
Clinical Fellow in Psychology within the Department of Psychiatry,  
Harvard Medical School 
Teaching Fellow in Psychiatry, Boston University School of Medicine 
September 1, 2013-August 31, 2014 
• Co-facilitate two group psychotherapy sessions per week in the PTSD Clinic.  
• PTSD Modular Skills Group 
• Seeking Safety 
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• Co-facilitate two group psychotherapy sessions per week in the Intensive Alcohol 
and Drug Addiction Program of Treatment.  
• Relapse Prevention 
• Coping with Internal Experiences 
• Conduct weekly individual psychotherapy with five clients.  
• Conduct intake assessments and formal psychological assessments (including the 
Clinician-Administered PTSD Scale-5). 
• Participate in weekly Cognitive Processing Therapy consultation meetings, in 
pursuit of certified provider status. 
• Participate in training in Behavioral Couples Therapy for Alcoholism and Drug 
Abuse and will conduct weekly couples therapy with 1-2 couples. 
• Attend and participate in team meetings, rounds, didactic seminars, and case 
conferences. 
• Will complete associated administrative duties and report writing. 
• Will fulfill the training requirements of the Psychology Internship Program by the 
completion of the Internship year (August, 2014). 
 
Psychological Services Center at the Center for Anxiety and Related Disorders 
Boston University, Boston, MA 
Clinical Supervisor, September 2011-August 2013 
• Completed didactic training in clinical supervision.  
• Provided clinical supervision for a second year graduate student at the 
Psychological Services Center at CARD under the licensed clinical supervision of the 
director.  
• Participated in group supervision meetings, provided ongoing live, audio, and 
self-report supervision to trainee, and conducted biannual evaluations. 
 
Behavioral Sciences Division, National Center for PTSD, VA Boston Healthcare 
System  
Boston, MA 
Practicum Trainee, September 2011-August 2012 
• Completed training in evidence-based treatment for PTSD. 
• Cognitive Behavioral Couples Therapy (August, 2011)   
• Cognitive Processing Therapy (September, 2011) 
• Conducted Cognitive Processing Therapy with two individual clients and coping-
skills/supportive psychotherapy related to PTSD and dementia for one couple weekly.  
• Co-facilitated the Understanding PTSD and Coping Skills Group. 
• Co-facilitated the Intake education group.  
• Co-facilitated the PTSD and Sleep group based on Cognitive-Behavioral Therapy 
for Insomnia.  
• Participated in weekly supervision meetings.  
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Substance Abuse Residential Rehabilitation Treatment Program, VA Boston 
Healthcare System 
Boston, MA 
Practicum Trainee, September 2010-August 2011  
• Integral member of a multidisciplinary treatment team including psychologists, 
psychiatrists, social workers, and health technicians in a residential and outpatient 
treatment program serving veterans diagnosed with substance dependence.  
• Conducted psychotherapy implementing various evidence-based treatment 
protocols for substance dependence and comorbid conditions (Seeking Safety, Dialectical 
Behavior Therapy skills, Relapse Prevention, Cognitive Processing Therapy) with four 
individual clients weekly.  
• Co-facilitated five groups within a variety of orientations, including: 
• Early Intervention 
• Relapse Prevention 
• Life Skills 
• Relationships in Recovery 
• Making AA Easier (12-step facilitation) 
• Performed 25 assessments for eligibility for the residential treatment program and 
facilitated referrals as necessary.  
• Participated in weekly supervision meetings for individuals, groups, and 
assessments. 
• Conducted treatment planning, case management, and case conferences. 
 
Psychological Services Center, Boston University 
Boston, MA 
Graduate Student Clinician, Neuropsychology Trainee, September, 2009-August 2010 
• Performed evidence-based clinical assessments (Anxiety Disorders Interview 
Schedule) and wrote clinical reports.  
• Conducted individual cognitive-behavioral therapy with three individual 
outpatients weekly.  
• Completed two full neuropsychological evaluations, including testing, scoring, 
and written reports. Provided feedback to clients and coordinated referrals. 
• Participated in weekly supervision meetings including live and audio-recorded 
supervision.  
 
RESEARCH EXPERIENCE:  
 
Addictive Behaviors Research Program, Boston University Department of Clinical 
Psychology 
Boston, MA 
Graduate Research Assistant, September 2008-present 
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Dissertation title: Enhancing Brief Motivational Interventions for Substance Use: 
Examining the Influence of Affirmation and Self-Efficacy Strategies on Drug Use 
Outcomes in Primary Care. 
• Master’s thesis title: Life Goal Appraisal and Marijuana Use Among College 
Students (published, Wright & Palfai, 2012). 
• Completed detailed coding of audio-recorded interventions from the Assessing 
Screening Plus brief Intervention’s Resulting Efficacy to stop drug use (ASPIRE) study 
at Boston Medical Center. 
• Recruited and screened participants for a trial investigating web-based 
interventions for marijuana use in the Boston University Student Health Clinic. 
• Designed and implemented experimental and survey-based studies exploring 
college students’ perceptions of norms, attitudes, motives and goal systems related to 
marijuana use.  
• Performed assessments for a clinical trial investigating novel goal-systems and 
motivational interventions for risky drinking college students with comorbid depressive 
symptoms. 
• Conducted experimental research sessions investigating the effects of alcohol on 
communication and sexual behavior in Men Who Have Sex with Men.  
 
Clinical Addiction Research and Education Unit, Boston University Medical School 
Boston, MA 
Research Therapist, January 2009-January 2011 
• Trained in Motivational Interviewing and completed study-specific certification. 
• Was on-call one day per week as a research therapist for the Assessing Screening 
Plus brief Intervention’s Resulting Efficacy to stop drug use (ASPIRE) study. 
• Conducted brief interventions targeting substance use for patients recruited from 
primary care offices at Boston Medical Center. 
 
New York University School of Medicine/VANYHHS, Mental Health and Addictive 
Disorders Research Program 
New York, NY 
Protocol Manager, August 2007 – August 2008,  
Research Coordinator, June 2006 – August 2008 
• Coordinated clinical trials for ADHD and prescription opiate dependence.  
• Received promotion to Protocol Manager at the New York node (Bellevue 
Hospital) of the Clinical Trials Network for the Prescription Opioid Addiction Treatment 
Study. 
• Received training in assessment (i.e., Structural Clinical Interview for the DSM-
IV; Adult ADHD Symptom Rating Scale).  
• Conducted in-depth interviews to evaluate eligibility for and monitor progress 
through clinical trials including diagnostic scales and severity ratings.  
• Supervised research coordinators and facilitated training.  
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Center for Education Research and Evaluation, Columbia Medical Center  
New York, NY  
Program Coordinator, May 2004 – August 2005 
Research Assistant, September 2003 – June 2004  
• Assisted Director of Research on all aspects of project management including 
literature searches, grant writing, gaining IRB approval, aiding in the creation of web-
based surveys, collecting and analyzing data, and editing abstracts and papers.  
• Coordinated a research team investigating medical students’ perceptions of 
psychiatry as a career choice, and implemented NVivo qualitative research software to 
analyze interviews. 
 
Department of Biomedical Informatics, Columbia University 
New York, NY  
Research Assistant, Fall 2002, Summer 2003 
• Assisted supervisor in compiling and coding qualitative data.  
• Organized and analyzed results and aided in drafting papers.  
• Edited papers and posters for conferences.  
 
Laboratory of Thinking and Decision Making, Columbia University 
New York, NY  
Research Assistant, Summer 2002 
• Assisted supervisor in compiling and editing data in SPSS and running statistical 
analyses. 
• Coordinated and ran experiments on participants and aided in analyzing the 
results.  
 
TEACHING EXPERIENCE: 
 
Psychology Department, Boston University 
Boston, MA 
Teaching Fellow, Spring 2011-Spring 2012 
• Social Psychology (Spring 2011 & Spring 2012); Developmental Psychology 
(Fall 2011).  
• Taught four weekly discussion sections with an average total of 105 students each 
semester.  
• Developed interactive lesson plans to engage students with the material, 
incorporating relevant readings of scientific articles, video, presentations, discussion, and 
applications of psychology. 
• Wrote and edited exams and provided administrative support.  
• Guest lectured on social and cognitive processes in elderly adults for the 
Developmental Psychology course.  
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International Center for Pedagogic Studies  
Paris, France 
English Teacher, September 2005 – May 2006 
• Independently designed engaging lesson plans for eight English classes in three 
elementary schools for students aged 8-11 years old.  
• Responsible for curriculum and grading.  
 
VOLUNTEER EXPERIENCE: 
 
Boston Area Rape Crisis Center  
Boston, MA 
Volunteer Medical Advocate, March 2009 – January 2011 
• Completed 40 hours Department of Health Training for Massachusetts.  
• Provided on-call services to seven Boston-area Hospital Emergency Rooms eight 
hours per week. 
• Provided emotional support, information about options concerning evidence 
collection, emergency contraception, and advocacy for survivors of sexual assault.    
• Provided support to significant others of survivors.  
• Dedicated to promoting healing and recovery in individuals and advocating for 
change in communities.  
 
Bellevue Hospital Rape Crisis Advocate Program 
New York, NY 
Volunteer Rape Crisis Advocate, October 2007 – September 2008 
• Completed 40 hours Department of Health Training for New York State.  
• Provided on-call services to the Bellevue Hospital and New York University 
Emergency Rooms twice per month. 
• Provided emotional support, information about options concerning evidence 
collection, police reporting, emergency contraception, and advocacy for survivors of 
sexual assault.    
 
Nightline Peer Counseling Hotline, Columbia University 
New York, NY  
Training Coordinator, September 2003 – May 2004 
Peer Counselor, September 2001 – May 2004 
• Achieved certification after a semester of training that covered a wide variety of 
issues including drug and alcohol abuse, eating disorders, self-mutilation, depression and 
suicide.  
• Lead training of prospective members with weekly lectures and practice role-play 
calls. 
• Counseled callers from 10pm-3am once per week. 
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DEPARTMENTAL SERVICE:  
 
• Serve as Intern Representative to the VA Boston (Brockton site) Internship 
Faculty meeting. 
• Coordinated welcome activities and interviews for prospective students (Winter, 
2009). 
• Screener, National Depression Screening Day, Boston University (October, 
2009). 
• Student Life Representative for the first year class, Boston University Clinical 
Psychology Program (Fall 2008-Spring 2009).  
 
PUBLICATIONS and ABSTRACTS/POSTERS: 
 
Wright, L. L., & Palfai, T. P. Perception of norms and attitudes around decriminalization 
of marijuana in college students (manuscript in preparation). 
 
Palfai, T. P., Winter, M., O’Brien, L., Goodness, T. M., Wright, L., Saitz, R. (August, 
2013). Do descriptive norms influence motivation to change cannabis use among college 
students? Poster session presented at the American Psychological Association 
Conference in Honolulu, Hawaii.  
 
Wright, L. L., Squires, L. E., Goodness, T. M., Maisto, S. A., Palfai, T. P. (2013). 
Effects of alcohol cues and alcohol intoxication on drug use expectancies among men 
who have sex with men. Addictive Behaviors, 38, 2317-2320.  
 
Wright, L. L. & Palfai, T. P. (2012). Life goal appraisal and marijuana use in college 
students. Addictive Behaviors, 37, 797-802. 
 
Palfai, T. P., Ralston, T. E. & Wright, L. L. (2011). Understanding university student 
drinking in the context of life goal pursuits : The mediational role of enhancement 
motives. Personality and Individual Differences, 50, 169-174. 
 
Palfai, T. P., Ralston, T. E., Wright, L. L., & Brown, T. (September, 2011). Reducing 
co-occurring alcohol-related consequences and depressive symptoms in college students. 
Poster session presented at the 8th annual International Network of Brief Interventions for 
Alcohol Problems, Boston, MA. 
 
Palfai, T. P., Ralston, T. E., Wright, L. L. (May, 2010). Understanding college student 
drinking in the context of life goal pursuits. Poster session presented at the Association of 
Psychological Sciences Conference, Boston, MA.  
 
Cutler, J. L., Harding, K. J., Monzian, S. A., Wright, L. L., Pica, A. G., Masters, S. R., & 
Graham, M. J. (2008). Discrediting the notion « working with ‘crazies’ will make you 
crazy » : Addressing stigma and  enhancing empathy in medical student education. 
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Advances in Health Sciences Education, 
http://www.springerlink.com/content/w44nmq561411m164/  
 
Wright, L., Gourevitch, M., Lee, J., Grossman, E., Horowitz, A., Flammino, F., 
McClure, B., & Rotrosen, J. (2007). The Prescription Opioid Addiction Treatment Study 
(POATS): Design and Implementation in an Urban Primary Care Setting. Poster session 
presented at the NYU School of Medicine Psychiatry Research Day, New York, NY.  
 
Cutler, J., Alspecter, S., Harding, K., & Wright, L., & Graham, M. J. (2006). Medical 
students’ perceptions of psychiatry as a career choice.  Academic Psychiatry, 30, 144-
149. 
 
Curry, S., Wright, L., & Graham, M. J. (2005). If What You See is Actually What You 
Do: Students Witnessing Professional Behavior in the OR. Proceedings of the 44th 
Annual Conference on Research in Medical Education, American Association of Medical 
Colleges, Washington, DC.  
  
Cutler, J., Alspecter, S., Harding, K., Wright, L., & Graham, M. J. (2005). The Couch in 
the OR: Relevance of Psychiatric Education to all non-psychiatric future physicians. 
Proceedings of the 44th Annual Conference on Research in Medical Education, American 
Association of Medical Colleges.  Washington, DC. 
 
SKILLS: 
 Languages: Proficient-fluent in French. Beginner Spanish.  
Computer:  Microsoft Word, Excel, Power Point, SPSS, and NVivo. 
Enthusiastic amateur singer, bicyclist and aspiring triathlete. 
 
